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1. Introduction 
1.1 Historical N-heterocyclic carbene organocatalysis 
Carbenes are defined as a class of neutral and highly reactive compounds with a 
divalent carbon atom and two non-bonding electrons. The two unshared electrons 
occupy the two empty orbitals via sp or sp
2
-hybridization leading to a triplet carbene. 
Alternatively, a singlet carbene contains two electrons in an sp
2
 hybridized orbital and 
a vacant p orbital. N-heterocyclic carbenes, as a kind of important singlet carbenes, 
contain two π-electron-donating groups. The interaction of the two π-donors with the 
pπ orbital on the carbene carbon builts a three-centre four-electron π system and 
increases the energy gap of the σ and pπ orbitals (Figure 1). 
      
Figure 1 Electronic structure and orbital diagram of N-heterocyclic carbenes. 
Since the first isolation of a stable phosphanylsilycarbene 1 by Bertrand et al. in 
1988
[1]
 and Arduengo’s imidazol-2-ylidene 2 in 1991 (Scheme 1),[2] N-heterocyclic 
carbenes (NHCs), as the most popular carbene family, have been known as excellent 
ligands in various transition-metal catalyzed reactions.
[3]
 Furthermore, the 
nucleophilic NHCs proved to be effective organocatalysts in the formation of C-C 
bonds.
[4]
 Figure 2 showed an obvious sudden rush of publications containing 
“N-Heterocyclic Carbene” over the last fifteen years. 
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Scheme 1 Stable carbenes by Bertrand et al. (1) and Arduengo et al. (2). 
 
Figure 2 Publications (per annum) containing “N-Heterocyclic Carbene” via Scifinder. 
NHCs in organocatalysis are typically employed in the following four common 
carbene cores: the imidazol-2-ylidenes (A), imidazolin-2-ylidenes (B), triazol-5- 
ylidenes (C) and thiazol-2-ylidenes (D) (Scheme 2). 
 
Scheme 2 General structures of N-heterocyclic carbenes used in organocatalysis. 
1.1.1 Benzoin reaction 
The first NHC-organocatalytic reaction may date back to 1943. Ukai et al. initially 
reported a benzoin condensation of benzaldehyde in the presence of coenzyme 
thiamine (3, vitamin B1, Figure 3).
[5]
 However, the mechanism of the reaction was 
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unknown until in 1958 Breslow et al. postulated a mechanistic explanation for the 
thiazolium salt-catalyzed benzoin condensation via reversed polarity (Scheme 3). As 
the proposal, thiazolium salt 4 was deprotonated under basic conditions to form the 
thiazol-2-ylidene 5, followed by the nucleophilic attack to benzaldehyde via its lone 
pair. The generated nucleophilic acyl anion equivalent 6, the so-called “Breslow 
intermediate” then reacts with the second benzaldehyde molecule to give the target 
benzoin product 8, and regenerate the active carbene catalyst 5 for the next catalytic 
cycle.
[6]
 
 
Figure 3 Thiamin, Vitamin B1. 
 
Scheme 3 Proposed mechanism of the NHC-catalyzed benzoin reaction by Breslow. 
In addition to the construction of a new C-C bond, the benzoin condensation also 
created a stereogenic center in 8. Since the first report by Sheehan et al. in 1966,
[7]
 it 
then naturally draw many chemists’ attention on developing NHC-catalyzed 
asymmetric benzoin condensations (Scheme 4).
[8] 
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Scheme 4 Selected catalysts for NHC-catalyzed asymmetric Benzoin reactions. 
1.1.2 Stetter reaction 
Another acyl anion equivalent mediated reaction was the Stetter reaction which was 
pioneered by Stetter et al. in 1973. The nucleophilc acylation of aldehyde to the 
Michael acceptors afforded a series of 1,4-bifunctional molecules (Scheme 5).
[9]
 
 
Scheme 5 Stetter reaction. 
In 1990 our group reported the first asymmetric intermolecular Stetter reactions 
employing a series of chiral thiazolium derived NHCs reaching 30% yield and 40% ee  
(Scheme 6).
[10a] 
Subsequently, our research group also reported a first asymmetric intramolecular 
Stetter reaction with the use of the chiral thiazolium salt 11 in 1996, which is 
concurrent with the research on the asymmetric benzoin reaction. The enantioselective 
synthesis of various 4-chromanones (R)-15 was performed with 22-73% yields and up 
to 74% ee (Scheme 7).
[10b]
 Later on, Rovis et al. further improved the yields and ee 
values by using the aminoindanol-based triazolium salt 16a.
[11]
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Scheme 6 The first asymmetric Stetter reaction by Enders et al. 
 
Scheme 7 Asymmetric intramolecular Stetter reaction. 
Recently, highly enantioselective intermolecular Stetter reactions were also  
achieved by the reactions of aldehydes with various Michael acceptors, such as 
chalcones,
[12]
 nitroalkenes,
[13]
 unactivated alkynes,
[14]
 α,β-unsaturated sulfones,[15] and 
vinylphosphonates.
[16]
 
1.1.3 Conjugate Umpolung 
Since the first reports by the research groups of Glorius
[17]
 and Bode
[18]
 in 2004, the 
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conjugate umpolung of α,β-unsaturated aldehydes via homoenolate equivalents 
opened a new access to the formation of C-C bonds. The enals were easily activated 
into nucleophiles at the β-carbon when the Ar groups on the NHC catalysts were 
sterically hindered, such as mesityl groups (Scheme 8). 
Scheme 8 NHC-catalytic generation of homoenolates. 
Glorius et al. and Bode et al. simultaneously reported the chemoselective 
formation of γ-butyrolactones 17 via the cyclization of enals and aromatic aldehydes 
under the same imidazolium salt (IMes-Cl) conditions. Subsequent to the seminal 
reports, the homoneolate equivalents served as 3C components and enabled various 
[3+2] cyclizations with ketones or imines to afford γ-lactones 17, 18 or γ-lactams 
19,
[19]
 a [3+3] access to spiro-heterocycles 20
[20]
 or [3+4] cyclizations with aurones
[21]
, 
ο-quinone methides[22] and azoalkenes in the formations of 21-23 (Scheme 9).[23] 
 
Scheme 9 Cyclizations of NHC-generated homoenolates. 
Furthermore, the homoenolate equivalent can be extended to 
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homoenolate/enolate domino reactions with dielectrophiles, such as chalcones or 
α,β-unsaturated ketimines. Nair et al. first reported such domino processes of 
NHC-derived homoenolates with chalcones in 2006.
[24]
 As shown in Scheme 10, the 
NHC-bound homoenolate nucleophilic Michael addition to chalcone 24 gave adduct 
25. Then the azolium enolate motif of adduct 25 underwent an intramolecular aldol 
reaction with the activated carbonyl group. The delivered cyclopentane carbinolate 26 
led to a β-lactonization to liberate the NHC. The decarboxylation of unstable 
β-lactone 27 released an equivalent of CO2 and gave the final cyclopentene 28 in 
55-88% yields and excellent dr. 
 
Scheme 10 The domino homoenolate/enolate cyclizations. 
Bode et al. developed enantioselective reactions of enals 29 with 4-oxoenones 
30
[25]
 and α,β-unsaturated ketimines 31[26] in the presence of chiral triazolium 
precatalyst 16b. The cis-cyclopentenes 32 and bicyclo-β-lactams 33 were obtained 
with high ee and good dr.  
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Scheme 11 Enantioselective cyclizations of 4-oxoenoates by Bode et al. 
Later, Scheidt et al. further improved the methodology and achieved perfect 
results on both stereoselectivity and the tolerance of substrate scope utilizing 
cooperative catalysis of N-heterocyclic carbene 16c and a Lewis acid. Notabely, in 
contrast to Nair’s work, introducing a Lewis acid exclusively produced the cis 
diastereomer (Scheme 12).
[27]
 
 
Scheme 12 Synthesis of cis-cyclopentenes by Scheidt et al. 
Chi et al. demonstrated that the annulation of enals 29 and benzodienones 35 
generated benzotricyclic products 36 in moderate to good yields (43-84%) and 
excellent stereoselectivity (up to 20:1 dr, 99% ee). Interestingly, β- and α-carbon 
atoms of the enals proceeded in a Michael/Michael domino sequence via homoenolate 
and enolate intermediates respectively, followed by intramolecular lactonization to 
yield the products 36 (Scheme 13).
[28]
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Scheme 13 NHC-mediated domino reaction via a Michael/Michael sequence by Chi et al. 
1.2 NHC-catalyzed cyclizations via azolium enolates 
The early studies of azolium enolates mainly focoused on redox esterification or 
redox amidation under protic solvent conditions. The azolium enolate tautomerized to 
electrophilic acylazoliums and regenerated the NHC by nucleophilic alcohol or amine 
addition (Scheme 14).
[29]
 
 
Scheme 14 NHC-redox acylation. 
More importantly, the generation of azolium enolates as alternative intermediates 
contributed a nucleophilic 2C synthon in the synthesis of various important 
heterocyclic scaffolds via formal [2+2]-, [2+4]- and very few [2+3]-cyclizations. To 
the best of our knowledge, there are five kinds of precursors for the generation of 
azolium enolates, such as α-functionalized aldehydes, enals, ketenes, stoichiometric 
oxidation of acyl anion equivalents, and saturated esters (Scheme 15). Besides this, a 
very recent seminal report using aliphatic acids as azolium enolate precursors is also 
introduced. The detail indroduction for the cyclization with azolium enolates is as 
follows. 
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Scheme 15 NHC-mediated generation of azolium enolates. 
1.2.1 [2+2] Cycloaddition 
The β-lactam and β-lactone motifs have been interesting targets for organic synthesis 
due to the extensive bioactivities. NHC-catalyzed [2+2] cyclizations provided an 
alternative approach to the synthesis of β-lactams and β-lactones. In 2008, the groups 
of Ye and Smith independently established the NHC-catalyzed enantioselective 
Staudinger reaction of ketenes 37 with N-tosyl or N-Boc imines 38 to give β-lactams 
40.
[30]
 Ye et al. demonstrated the use of the triazolium precatalyst 39a bearing a bulky 
diphenyl(trialkylsilyloxy)methyl group, which promoted the generation of β-lactams 
40 with excellent diastereo- and enantioselectivities (Scheme 16). 
 
Scheme 16 NHC-catalyzed Staudinger reaction of ketenes with aldimines by Ye et al. 
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Later, Ye and co-workers exploited alternative electrophiles in related [2+2] 
cyclizations with ketenes. The synthetic utility of 2-oxoaldehydes 41 furnished 
β-lactones 42 in good yields with excellent levels of diastereo- and 
enantioselectivities.
[31]
 Further investigations showed that ketones 43 were also found 
to be appropriate partners, providing β-lactones 44 in good yields and excellent 
diastereo- and enantioselectivities (Scheme 17).
[32]
  
 
Scheme 17 [2+2]-Cyclizations of ketenes with ketones and diazenedicarboxylates by Ye et al. 
Interestingly, Ye et al. demonstrated that the azolium enolates generated from 
ketenes enabled formal [2+2] strategies with various hetero atom electrophiles 
(Scheme 18). Stereoselective cyclizations of ketenes with diazenedicarboxylates 45 
afforded aza-β-lactams 46 in good yields with up to 91% ee.[33] They also realized that 
[2+2] cycloaddition of ketenes 37 with nitroso compounds 47 in good yields with 
high ee. Reductive ring-opening of the resulting 1,2-oxazetidin-3-ones constructed 
α-hydroxy amides in good results.[34] Furthermore, they successfully underwent the 
asymmetric formal [2+2] cycloaddition of ketenes 37 and N-sulfinylanilines 50 to 
give chiral thiazetidinone-1-oxides 51 in very good yields with excellent ee. The 
transformation of the cycloadduct was versatile. Oxidation by m-CPBA derived the 
3-oxo-β-sultams 52 and reductive ring-opening with DIBAL-H afforded α-mercapto- 
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amides 53.
[35]
  
 
Scheme 18 [2+2]- Cyclizations of ketenes with ketones with hetero atom electrophiles by Ye et 
al. 
 
Scheme 19 [2+2]-annulations of ketenes with isatins and isatin-derived ketimines by Ye et al. 
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In 2010, Ye et al. revealed that annulations of isatins 54
[36]
 with ketenes 37 
produced the potential biological spirocyclic oxindoles 55 in good yields with good to 
excellent stereoselectivities. And very recently, they developed the Staudinger 
reaction of ketenes 37 with isatin-derived ketimines 56 catalyzed by bifunctional 
NHC 57a, which constructed spirocyclic oxindolo-β-lactams 58 in high yields with 
excellent dr and ee (Scheme 19).
[37]
 In addition to ketene, enal was an alternative 
precursor to generate a azolium enolate via protonation of the homoenolate. Very 
recently, the group of Scheidt demonstrated the kinetic resolution of racemic 
α-substituted-β-ketoesters 59 for the synthesis of bicyclic β-lactones 60 by a formal 
aldol/lactonization process (Scheme 20).
[38]
 
 
Scheme 20 NHC-catalyzed intramolecular aldol/lactonization. 
1.2.2 [2+3] Cycloaddition 
The [2+3] cycloadditions via NHC-based azolium enolates are rarely investigated. To 
proceed the [2+3] annulation, the 3C-building block must be a bifunctional 
component, which contains nucleophilic and electrophilic motifs at the 1 and 3 
position of the 3C-building block. To the best of our knowledge, there are only two 
publications referred to this topic. Ye et al. reported a highly enantioselective [2+3] 
cycloaddition of ketenes 37 to racemic oxaziridines 61 for the synthesis of 
oxazolin-4-ones 62, which were easily conversed into α-hydroxy acids or 1, 2-diols 
(Scheme 21).
[39]
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Scheme 21 Formal [2+3] cycloaddition of ketenes and oxaziridine by Ye et al. 
Furthermore, Wang et al. addressed the NHC-catalyzed 
Knoevenagel/lactamization domino reaction of indol-2-carbaldehydes with 
α-cyclopropyl aldehydes yielding racemic pyrroloindolones in moderate yields 
(Scheme 22).
[40]
 
 
Scheme 22 NHC-catalyzed Knoevenagel/lactamization domino reaction by Wang et al. 
1.2.3 [2+4] Cycloaddition 
The first example of azolium enolates to undergo [2+4] annulations was disclosed by 
Bode et al. in 2006 on the aza-Diels–Alder reaction of enal 67 with the azadiene 
analogue 68. Protonation of the homoenolate generated the reactive azolium enolate. 
Interestingly, the use of imidazolium salt 69a as precatalyst preferred to the formation 
of the γ-lactams 70 via homoenolate intermediates. In contrast, triazolium catalyst 
16b dominated protonation of the homoenolate and led to the formation of 
dihydropyridinone 71 in 90% yield and 99% ee (Scheme 23).
[41]
 
Moreover, they demonstrated an oxa-Diels–Alder reaction of α,β-unsaturated 
aldehydes 72 with a range of electron-deficient enones 73, afforded dihydropyranones 
74 in excellent yields and stereoselectivities under triazolium precatalyst ent-16b in 
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conjunction with a weak base, such as DMAP or DIPEA (Scheme 24).
[42]
  
 
Scheme 23 NHC-catalyzed aza-Diels–Alder reactions by Bode et al. 
 
Scheme 24 NHC-catalyzed oxa-Diels–Alder reactions by Bode et al. 
 
Scheme 25 Hetero-Diels–Alder reaction with α-modified chalcones by Chi et al. 
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Chi et al. reported the [2+4] cycloaddition of NHC-derived azolium enolates 
from enals with enones. The utilization of α-modified chalcones as reaction partners 
toward the NHC-catalyzed hetero-Diels–Alder reaction was investigated. With β-aryl 
enal substrates, the Diels–Alder adducts were obtained in good yields and outstanding 
stereoselectivities (Scheme 25).
[43]
 
Scheidt and co-workers developed an intramolecular Michael/lactonization 
reaction of enals 77. Triazolium salt ent-16d was identified to be an optimal 
precatalyst to provide cis-bicyclic adducts 78 with good yields, excellent dr and ee, 
even for two alkyl tethered substrates (Scheme 26).
[44]
  
 
Scheme 26 Intramolecular Michael/lactonization reaction by Scheidt et al. 
Another intensely investigated precursor for the generation of azolium enolate 
are α-functionalized aldehydes, especially when focused on the [2+4] cycloadditon. 
Nucleophilic addition of the triazolium derived carbene to the α-functionalized 
aldehydes 79 affords the adducts 80. The sequential elimination of the leaving group 
in the presence of base forms the azolium enolate species 81, which can then undergo 
various [2+4] cycloadditons (Scheme 27).
[29a, 29b]
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Scheme 27 Generation of the azolium enolate species via α-functionalized aldehydes. 
 
Scheme 28 NHC-catalyzed [2+4] cyclization with α-chloroaldehydes. 
Bode et al. identified racemic α-chloroaldehydes 79 to be effective enolate 
precursors in the [4+2] oxa-Diels–Alder reaction with enones 73. 0.5 Mol% of 
triazolium salt 16b afforded dihydropyran-2-one adducts 82 in excellent yields, and 
high stereoselectivities (Scheme 28a).
[45]
 Ye and co-workers realized the 
NHC-catalyzed [4+2] cycloaddition of α-chloroaldehydes 79 and 1-azadienes 83, 
providing access to a range of dihydropyridinones 84 in good yields (57-93%) with 
good to excellent enantioselectivities (>20:1 dr, 82-99% ee) (Scheme 28b).
[46]
 Very 
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recently, Zhong et al. employed oxodiazenes 85 as electrophilic diene, and underwent 
the aza-Diels–Alder reaction with dienophiles derived from α-chloroaldehydes to 
provide oxadiazin-6-ones 86 in 67-93% yields and 94-99% ee (Scheme 28c).
[47]
 The 
latest report concerning α-chloroaldehydes was from our workgroup on the NHC 
catalyzed aza-Diels–Alder reactions with 2-alkenylbenzothiazoles 87, afforded 
bioactive dihydrobenzothiazolopyridin-1-ones 88 in 44-97% yields with good to 
excellent stereoselectivities (up to 9:1 dr, 98% ee) and with broad substrate tolerance 
(Scheme 28d).
[48]
 
In analogous work, the in situ generated azolium enolates from aliphatic 
aldehydes were employed as [4+2] coupling partners to react with a range of 
electron-deficient dienes. A stoichiometric oxidant was necessary to oxidize the 
Breslow intermediate to the acylazolium, subsequent deprotonation under a basic 
environment yielded the active enolate 81. Rovis et al.
[49]
 and Chi et al.
[50]
 
independently realized the formal asymmetric [4+2] processes of simple aliphatic 
aldehydes 89 with enones 90, generating cis-lactones 94 in high yields with excellent 
diastereo- and enantiocontrol with the use of triazolium salt 16d or ent-16d and 
stoichiometric oxidant 92 or 93a. Interestingly, aryl-substituted 1-azadienes 91 were 
demonstrated by Rovis et al. to provide trans-lactams 95 under similar conditions 
(Scheme 29). 
 
Scheme 29 NHC-catalyzed [2+4] cyclization with aliphatic aldehydes. 
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Followed by the previous work, Ye et al. extended the ability of azolium enolate 
from ketenes to the construction of [2+4] cycloadditions. Oxadiazin-6-ones 96 were 
obtained in good yields and good to excellent ee when employing N-benzoyldiazenes 
85 as the electrophilic component.
[51]
 Another analogous work demonstrated the 
synthesis of indole-fused dihydropyranones 98 through the [2+4] annulation of 
ketenes 37 with 3-alkenyloxindoles 97. Triazolium salt 57c, bearing a free hydroxy 
group, proved to be effective in improving the enantioselectivity via its H-bonding 
with the substrate (Scheme 30).
[52]
 
 
Scheme 30 NHC-catalyzed [2+4] cyclization with ketenes by Ye et al. 
 
Scheme 31 Chi’s [2+4] cyclization with activated esters. 
In 2012, Chi and co-workers observed that activated carboxylate esters 99 could 
be converted to azolium enolates and underwent formal asymmetric [2+4] 
cycloadditions with 1-azadienes 91 by using precatalyst 100a, providing 
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trans-lactams 101 in good yields with good to excellent diastereo- and enantiocontrol 
(Scheme 31).
[53]
 
Very recently, Scheidt et al. uncovered a new method to access azolium enolate 
equivalents in the NHC-catalyzed formal [2+4] cycloaddition. The in situ generated 
acyl imidazole from carboxylic acids 102 and CDI enabled access to azolium enolates, 
which underwent an aza-Diels–Alder pathway or a stepwise Michael/lactamization 
process with the aza-o-quinone methide 105 via 2-aminobenzyl chloride 104, 
affording dihydroquinolones 106 in good yields (52-84%) and enantioselectivities 
(74-96% ee) (Scheme 32).
[54]
 
 
Scheme 32 Scheidt’s [2+4] cyclization with carboxylic acids. 
1.3 NHC-catalyzed annulations via α,β-unsaturated 
acylazolium intermediates 
As shown in Figure 4, the α,β-unsaturated acylazoliums 107 exhibited much more 
electrophilic character than kinds of electron-poor olefins, such as nitroolefins, N-Boc 
imines, benzoquinones and chalcones, due to the activation by the NHC-based 
iminium ion.
[55]
 Therefore, a variety of nucleophiles were investigated towards the 
unique and highly activated Michael acceptors, providing an efficient route to 
construct a range of heterocycles via stepwise Michael/acylation or “Claisen-type” 
rearrangement. Moreover, azolium enolate was formed after the inital Michael type 
1,4-addition, which could then undergo an intramolecular nucleophilic addition to 
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generate cycloadducts. Up to now, six distinct approaches of α,β-unsaturated 
acylazolium generation have been widely introduced, such as stoichiometric oxidation 
of homoenolates, 2-bromoenals 108, ynals 109, α,β-unsaturated acyl fluorides 110, 
α,β-unsaturated esters 111 and a single recent report concerning α,β-unsaturated 
carboxylic acids 112 (Scheme 33). Some selected examples are introduced according 
to the activation modes. 
 
Figure 4 Electrophilicity parameter E of 107 and other electrophiles. 
 
Scheme 33 Formation of NHC-derived α,β-unsaturated acylazolium and general 
transformations. 
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1.3.1 Generation via oxidation of homoenolates 
In 2010, Studer et al. initially disclosed NHC-catalyzed Michael/lactonization 
reactions of α,β-unsaturated acylazolium intermediates with 1,3-diketones. 
Nucleophilic addition of the achiral triazole carbene 114 to the enal 29 formed the 
homoenolate. Subsequent oxidation of the homoenolate by mild organic oxidants 93b 
generated α,β-unsaturated acylazolium intermediates 113, which could then undergo 
1,4-addition with 1,3-diketones 115 to afford dihydropyranones 116 in 34-92% yield 
(Scheme 34).
[56]
 Later, You and co-worker realized the enantioselective synthesis of 
dihydropyranones in good yields and excellent ee through the same reaction catalyzed 
by camphor-derived triazolium salt 117 (Scheme 35).
[57]
 
 
Scheme 34 NHC-catalyzed Michael/acylation reaction of enasl with 1,3-diketones by Studer et 
al. 
 
Scheme 35 Asymmetric synthesis of dihydropyranones by You et al.  
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Following this work, a study of NHC-catalyzed asymmetric aza-Claisen 
reactions was reported by Bode et al. The vinylogous enamine 118 was employed as 
coupling partner with the catalytically formed α,β-unsaturated acylazolium 
intermediates 113 from enals. Combining the triazolium salt 16b and stoichiometric 
oxidant 93b produced the dihydropyridinones 119 in good to excellent yields (60-99%) 
and enantioselectivities (79-96% ee). Interestingly, they also realized the conversion 
of α'-hydroxy enone surrogates 117 into intermediates 113 via a retro benzoin reaction 
catalyzed by the NHC precursor (Scheme 36).
[58] 
 
Scheme 36 Bode’s aza-Claisen reaction. 
 
Scheme 37 NHC-catalyzed Michael/Michael/acylation. 
Based on the previous observations, Studer et al. disclosed NHC-catalyzed 
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domino reactions of enals 120 with 1,3-diketones 115, building the tricyclic indane 
derivatives in good yields (38-74%) and excellent stereoselectivities (4:1->98:2 dr, 
93-99% ee). Oxidation of the homoenolate generated the intermediates 121, followed 
by a regioselective Michael addition of 1,3-diketones 115 to the α,β-unsaturated 
acylazolium motifs. The formed enolate synthon on 122 could undergo an 
intramolecular Michael/acylation to afford products 123 (Scheme 37).
[59]
 
Further studies by the Studer group uncovered the reaction of α,β-unsaturated 
acylazoliums generated via oxidation of homoenolates with sulfur ylides 124.
[60]
 
Cyclopropyl carboxylic esters 125 were obtained in moderate to good yields (24-74%) 
and good to excellent stereoselectivities (Scheme 38). 
 
Scheme 38 NHC-catalyzed cyclopropanation of enals with sulfur ylides. 
1.3.2 Generation via 2-bromoenals 
2-Bromoenals could also be employed as precursors for the generation of 
α,β-unsaturated acylazoliums. In contrast to enals, this approach avoided the use of an 
external oxidant. As shown in Scheme 39, the nucleophilic addition of the 
NHC-catalyst to the bromoenals 108 afforded the Breslow intermediates 126 shown 
also as the mesomeric structures. Subsequent tautomerization and elimination of 
bromide from 127 generated the key α,β-unsaturated acylazoliums 113. 
In 2011, Ye et al. demonstrated a formal [3+3] cycloaddition reaction of 
2-bromoenals 108 and 1,3-dicarbonyl compounds 115 catalyzed by the bifunctional 
triazolium salt 57a, furnishing the dihydropyranones 116 in good yields with good to 
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excellent enantioselectivities (Scheme 40).
[61]
 It was found that bromoenals bearing 
aliphatic substituents was tolerated with good enantioselectivities. 
 
Scheme 39 Generation of α,β-unsaturated acylazolium via 2-bromoenals. 
 
Scheme 40 Formal [3+3] cycloaddition reactions of 2-bromoenals and 1,3-dicarbonyl 
compounds. 
Biju et al. presented an NHC-catalyzed formal [3+3] annulation of 2-bromoenals 
108 with enolizable aldehydes 128 by the aminoindanol-derived triazolium salt 
ent-16b.
[62]
 Later they found that enamines 130 were suitable nucleophiles to 
NHC-derived α,β-unsaturated acylazoliums from 2-bromoenals, resulting 
dihydropyridinones 131 in high yields with excellent ee.
[63]
 The Ye group extended 
the scope to the use of cyclic imines 132, which could process the 1,4-addition to the 
key intermediates 113 via the enamine tautomers (Scheme 41).
[64]
 Very recently, Biju 
et al. presented a successful asymmetric NHC-catalyzed domino reaction of 
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2-bromoenals with malonic ester-derived nucleophiles 134. The initial Michael 
addition of the malonate derivatives to the NHC-derived α,β-unsaturated acylazoliums 
from 2-bromoenals generated the intermediates 135. The subsequent intramolecular 
aldol reaction of the enolate motifs to the keto group led to cyclopentane 
intermediates 136. The following lactonization and decarboxylation afforded 
cyclopentenes 137 in good yields and excellent ee (Scheme 42).
[65] 
 
Scheme 41 NHC-catalyzed annulation of 2-bromoenals with enolizable aldehydes. 
 
Scheme 42 Biju’s NHC-derived Michael/aldol/acylation/decarboxylation reaction. 
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1.3.3 Generation via ynals 
In 2010, Bode et al. discovered a new access to α,β-unsaturated acylazoliums via 
ynals 109 in the process to kojic acid derivatives 138 in excellent yields (80-98%) and 
ee values (92-99%). Interestingly, this reaction proceeded without additional base. 
The basic counterion chloride ion may be a weak Lewis base to generate the free 
carbene. They proposed a key Claisen rearrangement on intermediates 139 after the 
1,2 addition of kojic acids 138 to α,β-unsaturated acylazoliums (Scheme 43).[66] 
 
Scheme 43 NHC-catalyzed Claisen rearrangement of ynals with kojic acid. 
 
Scheme 44 Synthesis of spirooxindole 4H-pran-2-one derivatives by Du et al. 
Du and co-workers achieved an NHC-derived three-component domino reaction 
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of oxindoles 142 with two molecules of ynals 109 in the presence of 30 mol% 
imidazolium salt 69a, affording the biologically relevant heterocyclic spirooxindoles 
143 in good yields (40-91%) with good to high dr (Scheme 44).
[67]
 
Recently, Li et al. also realized the synthesis of spirooxindole derivatives 145 via 
the reaction of ynals 109 with 3-substituted oxindoles 144. It was found that after the 
first Michael addition of oxindole to the α,β-unsaturated acylazoliums, the in situ 
generated enolate equivalent underwent the intramolecular Michael addition to the 
chalcone motif on the 3-substituent. The subsequent lactonization generated 
spirooxindole 145 in moderate to excellent yield and good dr (Scheme 45).
[68]
 
 
Scheme 45 NHC-derived Michael/Michael/lactonization process to spirooxindoles. 
1.3.4 Generation via α,β-unsaturated acyl fluorides 
In 2009, Lupton et al. initially demonstrated that α,β-unsaturated acyl fluorides 110 
could act as precursors to α,β-unsaturated acylazoliums in combination with TMS 
enol ethers 146 and precatalyst 69b (Scheme 46). The nucleophilic substitution of the 
NHC with acyl fluorides displaced the fluoride ion, which deprotected the enol ethers 
and genetated enolates. When the electrophilic α,β-unsaturated acylazoliums reacted 
with the nucleophilic enolates, the expected dihydropyranones were formed in good 
yields (37-75%).
[69]
 
Introduction 
29 
 
 
Scheme 46 Synthesis of dihydropyranones via α,β-unsaturated acyl fluorides and TMS enol 
ethers. 
Later, they further extended the application of α,β-unsaturated acyl fluorides 110 
to the reaction with TMS dienol ethers 148, providing cyclohexadienes 152 in good to 
excellent yields (56-98%) and excellent dr. As shown in Scheme 47, nucleophilic 
addition of the NHC to the acyl fluoride provided the α,β-unsaturated acylazoliums 
113 and dienolates 149, which could undergo a Michael addition, followed by aldol 
cyclization to generate the intermediate 150. The subsequent lactonization and 
decarboxylation formed the cycloadducts 152.
[70]
 Recently the same group 
alternatively used nucleophilic cyclopropanes 153 to react with α,β-unsaturated acyl 
fluorides 110 providing the bicyclic β-lactones 155 in good yields and excellent dr 
(Scheme 48). Cyclopropanes 153 were identified as appropriate precursors to generate 
bifunctional enolates 154, which proceeded in a Claisen rearrangement/aldol/β-lacto- 
nization cascade reaction with the in situ generated α,β-unsaturated acylazoliums.[71] 
 
Scheme 47 Synthesis of cyclohexadienes via Michael/aldol sequence by Lupton et al. 
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Scheme 48 Synthesis of functionalized β-lactones by Lupton et al. 
1.3.5 Generation via α,β-unsaturated esters 
α,β-Unsaturated esters were proved to be acessible precursors in the generation of 
α,β-unsaturated acylazoliums first reported by Lupton et al. (Scheme 49). The 
imidazole carbene reacted as a strong Lewis base in the nucleophilic substitution of 
α,β-unsaturated enol esters 156. The resulting two fragments restructured via a 
Michael/lactonization sequence to afford the dihydropyranones 157 in good yields 
(32-86%).
[69]
 
 
Scheme 49 Lupton’s intramolecular [3+3] cyclization. 
Another NHC-catalyzed activation of α,β-unsaturated esters 111 was invoked by 
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Chi et al. in the formal [3+3] cycloaddition to produce dihydropyranones 159 in good 
yields with excellent ee. Interestingly, β,β-disubstituted esters were also tolerated to 
yield lactams bearing a quaternary stereogenic center (Scheme 50).
[72]
 
 
Scheme 50 NHC-catalyzed activation of α,β-unsaturated esters by Chi et al. 
1.3.6 Generation via α,β-unsaturated acids 
 
Scheme 51 NHC-catalyzed cycloadditions of α,β-unsaturated acids. 
Very recently, Ye et al. realized the use of α,β-unsaturated acids 112 as the starting 
materials to generate α,β-unsaturated acylazoliums 113 via in situ formed mixed 
anhydrides 160 by adding PivCl as additive. The generated α,β-unsaturated 
acylazoliums 113 then reacted with 1,2-binucleophilc α-amino ketones 161 via [3+2] 
cyclization, giving γ-butyrolactams 162 in good yields with good to excellent 
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stereoselectivities. Moreover, it was identified that sulfamate-derived cyclic imines 
163 were suitable 1,3-binucleophiles in this process with α,β-unsaturated 
acylazoliums 113 to provide the dihydropyridinones 164 in 52-90% yields and 
77-99% ee (Scheme 51).
[73]
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1.4 Overview of the doctoral work 
My doctoral work was composed of four projects: 
The first two projects focused on the development of reactions involving the 
NHC-derived azolium enolates generated from α-chloroaldehydes. These excellent 
nucleophiles were applied to the synthesis of lactams with suitable acceptor-donor 
substrates. As shown in Scheme 52, project 1 involved [2+3] annulation of in situ 
generated azolium enolates with nitrovinylindoles 165 to access pyrroloindolones 166 
via a Michael/lactamization domino reaction. Moreover, project 2 continued the 
application of azolium enolates to the [2+4] annulation with 2-benzothiazolimines 
167 via a Mannich/lactamization sequence. 
 
Scheme 52 NHC-derived annulations via azolium enolates. 
The last two projects described our efforts on the development of NHC-derived 
activation modes to generate α,β-unsaturated acylazoliums, and their synthetic utility 
in the asymmetric synthesis of tricyclic skeletons. Project 3 detailed the 
NHC-catalyzed Michael/lactonization reactions of α,β-unsaturated acylazoliums with 
indolin-3-ones 169. Project 4 discussed the application of α,β-unsaturated 
acylazoliums for the enantioselective synthesis of dihydrobenzothiazolopyridinones 
172 (Scheme 53). 
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Scheme 53 NHC-derived annulations via α,β-unsaturated acylazoliums. 
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2. Results and Discussion 
2.1 NHC-catalyzed [2+3]-annulation of α-chloroaldehydes 
with nitrovinylindoles 
2.1.1 Background and motivation 
In the presence of an NHC catalyst, the catalytic generation of acyl anion equivalents 
from simple aldehydes (Benzoin reaction or Stetter reaction), homoenolate 
intermediates from enals and enolates from α-functionalized aldehydes, ketenes or 
simple aldehydes with external oxidant offers versatile nucleophiles in the reaction 
with various types of reactive electrophiles, such as imines, α,β-unsaturated ketones, 
or α,β-unsaturated ketimines. However, nitroalkenes as highly reactive electrophiles 
in organocatalysis attracted less attention in NHC-catalyzed reactions (Scheme 54). 
Recently, Rovis and co-workers reported efficient and enantioselective intermolecular 
Stetter reactions of simple aldehydes or enals with nitroalkenes in the presence of 
chiral fluorinated triazolium-based N-heterocyclic carbene.
[13]
 In 2009, Nair reported 
a Michael addition of enals to nitroalkenes via homoenolate intermediates catalyzed 
by an achiral imidazolium precatalyst. Under the reaction conditions, anti-nitroesters 
were obtained in good yields and good diastereoselectivities.
[74]
 Later, Liu and 
co-workers also developed a homoenolate addition reaction for asymmetric synthesis 
of anti-nitroesters. With the use of catalytic amounts of chiral triazolium precatalyst, 
both aromatic and aliphatic enals can react with a variety of aromatic nitrodienes, 
nitroenynes, and nitrostyrenes in excellent ee and good diastereoselectivities.
[75]
 Very 
recently, Rovis and co-workers found that syn-nitroesters were obtained by chiral 
N-heterocyclic carbene catalyzed homoenolate addition to aliphatic nitroalkenes with 
excellent diastereo- and enantioselectivities.
[76]
 However, an NHC mediated in situ 
generated enolate species with nitroalkenes has not been realized. 
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Scheme 54 Known NHC-mediated reactions with nitroalkenes. 
Furthermore, most NHC-catalyzed annulations involved enolate equivalents with 
α,β-unsaturated ketones or α,β-unsaturated ketimines to form [2+4] cycloadducts, or 
cycloaddition to aldehydes or imines to afford [2+2] cycloadducts. As mentioned in 
the Introduction 1.2.2, only two reports have been devoted to [2+3] cyclizations with 
NHC-mediated azolium intermediates.
[39-40]
 Herein, we envision that the NHC 
catalyzed in situ generation of enolate species from α-functionalized aldehydes could 
undergo a [2+3] cyclization with (E)-2-(2-nitrovinyl)-1H-indoles, yielding 
trans-1H-pyrrolo[1,2-a]indol-3(2H)-ones, which is in contrast to the previous work 
by Dr. Chuan Wang from our group. Cis-product was received through a one-pot 
Michael/hemiaminalization/oxidation reaction catalyzed by (R)-diphenylprolinol 
TMS-ether 173 (Scheme 55).
[77]
 
 
Scheme 55 Asymmetric synthesis of 1H-pyrrolo[1,2-a]indol-3(2H)-ones. 
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2.1.2 Optimization of conditions 
Initially, we evaluted the model reaction of α-chloroaldehyde 79a with 
(E)-2-(2-nitrovinyl)-1H-indole 165a in the presence of the imidazolium precatalyst 
69a or triazolium precatalysts 174, 16d-e. It was found that the use of achiral 
imidazolium precatalyst 69a and chiral triazolium precatalyst 16e gave no reaction 
(Table 1, entries 1 and 4). Gratifyingly, O-TBDPS triazolium precatalyst 174 showed 
good reactivity for the product 166a (52% yield), excellent diastereoselectivity (>20:1) 
and 82% ee (Table 1, entry 2). After choosing aminoindanol-derived 
mesityl-substituted triazolium precatalyst 16d instead of 174, a better yield and ee 
were obtained with a slightly loss of diastereoselectivity (Table 1, entry 3). Further 
base screening revealed that the use of inorganic bases or organic bases, such as 
NaOAc, K2CO3, Cs2CO3, K3PO4, DMAP and DIPEA, resulted in excellent 
diastereoselectivities and excellent ee values of the desired product (Table 1, entries 
5-9), except DBU which was a common base in NHC-catalyzed reactions affording 
no product in this case (Table 1, entry 10). It’s noteworthy that the use of NEt3 as base 
afforded an improved yield (Table 1, entry 11). Further screening was foused on the 
solvent. A number of solvents were tested by using precatalyst 16d as catalyst and 
NEt3 as base. Although diastereoselectivities and ee values were all excellent, no 
improvement in yield was obtained (Table 1, entries 12-15). 
Table 1 Optimization of the reaction conditions.[a] 
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Entry NHC
.
HX Solvent Base Yield [%]
[b]
 dr
[c]
 ee [%]
[d]
 
1 69a toluene NaOAc n.r. - - 
2 174 toluene NaOAc 52 >20:1 82 
3 16d toluene NaOAc 56 15:1 99 
4 16e toluene NaOAc n.r. - - 
5 16d toluene K2CO3 58 >20:1 99 
6 16d toluene Cs2CO3 26 >20:1 99 
7 16d toluene K3PO4 50 >20:1 99 
8 16d toluene DMAP 42 >20:1 92 
9 16d toluene DIPEA 38 >20:1 98 
10 16d toluene DBU n.r. - - 
11
[e]
 16d toluene NEt3 78 >20:1 99 
12 16d DCM NEt3 62 >20:1 98 
13 16d THF NEt3 33 >20:1 98 
14 16d CHCl3 NEt3 66 >20:1 96 
15 16d EtOAc NEt3 52 >20:1 99 
[a]
 Reaction conditions : 165a (0.2 mmol), 79a (0.4 mmol), NHC
.
HX (10 mol%), base (2.2 equiv), 
solvent (2 mL), at 50 °C for 15 h. 
[b]
 Isolated yield after purification by column chromatography. 
[c] 
Determined by 
1
H NMR spectroscopy. 
[d]
 The ee value was determined by HPLC on a chiral 
stationary phase. 
[e]
 The reaction was performed for 2 h. 
The in situ generated enolate species from α-functionalized aldehydes was 
formed by nucleophilic addition of the NHC catalyst to the α-functionalized 
aldehydes, followed by elimination of the corresponding acid. So we wondered 
whether different leaving groups on α position of aldehydes would influence the 
reactivity and selectivity. Under the optimized reaction conditions, we conducted the 
reactions of 2-nitrovinyl indole 165a with α-functionalized aldehydes 79a-e. As 
shown in Scheme 56, all the reactions proceeded smoothly with excellent 
stereoselectivities (94%-99% ee and >20:1 dr). The only difference was the obtained 
yield. In the cases of 79a and 79b almost the same yields were obtained in 2 h. 
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However, when 79c-e were employed as substrates, a prolonged reaction time was 
required and reduced yields were obtained. 
 
Scheme 56 Optimization of the α-functional group of 79. 
2.1.3 Substrate scope and discussion 
We next evaluated the substrate scope of (E)-2-(2-nitrovinyl)-1H-indoles 165. As 
shown in Scheme 57, this protocol tolerates a variety of electron-withdrawing or 
electron-donating substituents on indole motif of 165a-h, providing the corresponding 
products 166a-h in excellent enantioselectivities (96%-99% ee) and 
diastereoselectivities (>20:1) and good yields, with the exception of 166d. The 
decreased yield was probably due to the steric hindrance of the methyl group on the 
C3 position. Notably, (E)-2-(2-nitrovinyl)-1H-pyrrole 165i was also suitable for the 
reaction to afford 166i in excellent stereoselectivity, even though the yield was 
relatively low. Additionally, we also prepared some other 2-vinyl indoles bearing 
electron-withdrawing groups such as dicyano, ethyl ester or 2-methyl-2′-nitro group. 
Unfortunately, no products were obtained with these substrates. The further scope of 
the reaction was also tested with regard to α-chloroaldehydes. Substrate 79 with linear 
alkyl groups showed good reactivities and excellent stereoselectivities (166j-n). 
Moreover, this protocol could also be carried out smoothly on a gram scale. The 
reaction of 165a with 79a on a 5 mmol scale under the optimized conditions provided 
166a without any obvious effects on the yield (73%) and stereoselectivity (dr >20:1, 
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93% ee). In order to determine the absolute configuration of the products, a single 
crystal was prepared from a mixed Et2O/n-hexane solution of 166e by slow 
evaporation. The X-ray crystallographic analysis on compound 166e showed that the 
outlined 1H-pyrrolo[1,2-a]indol-3(2H)-ones 166 have the (1S,2R)-configuration. 
 
Scheme 57 Scope of (E)-2-(2-nitrovinyl)-1H-indoles. All reactions performed on 0.5 mmol scale. 
Isolated yield after purification by column chromatography. Diastereomeric ratios determined 
by 1H NMR spectroscopy. The ee value was determined by HPLC analysis. [a] The reaction was 
performed for 24 h. [b] Structure confirmed by X-ray crystallography. 
2.1.4 Derivatization of 1H-pyrrolo[1,2-a]indol-3(2H)-one 
The pyrrolo[1,2-a]-indole scaffold is an important substructure in various bioactive 
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molecules. With the trans-166a in hand, several transformations could be realized 
(Scheme 58). For example, the nitro group was reduced to the primary amine, 
followed by protecting with Boc2O in moderate yield and excellent stereoselectivity. 
Remarkably, the tetracyclic pyrrolo[1,2-a]indole skeleton 176a was synthesized via 
the nitro reduction and a subsequent Pictet-Spengler reaction in overall 76% yield and 
excellent stereoselectivity (dr >20:1, 97% ee). 
 
Scheme 58 Further transformations of 166a. 
2.1.5 Mechanistic studies 
With regard to the mechanism of the reaction, a plausible catalytic cycle of the 
reaction is proposed in Scheme 59. Initially, the active carbene 16d′ is generated by 
deprotonation of the precatalyst salt 16d. Subsequently, the nucleophilic addition of 
free carbene species to α-chloroaldehyde result the formation of the Breslow 
intermediate 177, followed by elimination of hydrogen chloride to afford the enol 
species 178. The chiral backbone of NHC efficiently shields the Re face of the enol to 
force the Michael addition to (E)-2-(2-nitrovinyl)-1H-indole from the Si face followed 
by a H-migration affording the adduct 179 with trans selectivity. The indole N anion 
then cyclized with the acylazolium intermediate. The subsequent lactamization leads 
to 166a and regenerates the carbene catalyst. 
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Scheme 59 Plausible mechanism for the transformation. 
2.2 NHC-catalyzed Mannich/lactamization domino reaction 
of 2-benzothiazolimines with α-chloroaldehydes 
2.2.1 Importance of the tricyclic pyrimido[2,1-b]benzothiazole core 
The tricyclic pyrimido[2,1-b]benzothiazole core exists in various bioactive 
molecules,
[78]
 such as the inhibitor of c-AMP phosphodiesterase 180 and 
antineoplastic 181. Moreover, the isothiourea-based Okamoto catalyst 182 was 
utilized as a kind of organocatalyst. The other HBTM derivatives 183-185 are widely 
used as isothiourea organocatalysts and received great attention in the field of 
asymmetric catalysis via H-bonding (Figure 5).
[79]
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Figure 5 Examples of pyrimido[2,1-b]benzothiazole derivatives. 
2.2.2 Background and motivation 
The Mannich reaction is one of the most powerful and important C-C bond forming 
reactions for the synthesis of nitrogen-containing molecules. The resulting β-amino 
carbonyl compounds are valuable synthons in the preparation of various natural 
products and useful bioactive molecules.
[80]
 Most of the reported catalytic 
enantioselective Mannich reactions employed N-Boc or N-Ts protected imines as 
substrates. However, the utilization of imines bearing a benzothiazole moiety attached 
on the nitrogen atom has been rarely reported. Actually, 2-benzothiazolimine behaved 
as an excellent electrophile and proceeded with various nucleophiles, such as 
malonates, nitroalkanes or TMSCN. In 2013, Du et al. reported the enantioselective 
synthesis of β-amino acid via the Mannich reaction of 2-benzothiazolimine 167 with 
malonates catalyzed by cinchona alkaloid squaramide 186 (Scheme 60a).
[81]
 
Subsequently, this catalyst was applied in asymmetric aza-Henry reaction of 
2-benzothiazolimine 167 with nitromethane (Scheme 60b).
[82]
 Later, the substrate 167 
was employed in the enantioselective Strecker reaction with TMSCN catalyzed by 
186 (Scheme 60c).
[83]
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Scheme 60 Squaramide catalyzed reactions of 2-benzothiazolimine. 
An azolium enolate as a nucleophile may also undergo a Mannich reaction with 
2-benzothiazolimine 167. The formed ambident anion intermediate 187 forms the 
six-member ring adduct 168a, while ambidoselective cyclization via the mesomeric 
anion 187’ affords the β-lactam 168a’ through route 2 (Scheme 61). 
 
Scheme 61 Our proposal for NHC-catalyzed Mannich/lactamization domino reaction. 
2.2.3 Optimization of conditions 
Initially, we tested several triazolium precatalysts via the model reaction of 
2-benzothiazolimine 167a with 2-chloro-3-phenylpropanal 79a at room temperature. 
We were pleased to find that the chiral triazolium salt 16d provided excellent 
stereoselectivity for ent-168a (97% ee, >20:1 dr), albeit with a low yield (19%) and 
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regioselectivity (Table 2, entry 2). In order to improve the regioselectivity and the 
yield of ent-168a, a series of bases were examined, but no further improvement was 
achieved (Table 2, entries 4-9). The subsequent solvent screening resulted in similar 
yields and selectivities (Table 2, entries 10-14). So the screening of the base and 
solvent showed that DABCO in combination with toluene gave the best yield of 
ent-168a (31%) and excellent stereoselectivity, albeit with low regioselectivity (Table 
2, entry 6). Furthermore, we noticed that the triazolium salt 188 yielded rac-168a in 
43% yield exclusively, with a drastically decreased dr (Table 2, entry 1). Inspired by 
this result, a series of pyrrolidinone-derived triazolium salts 100a-b and 189a-b were 
further screened. Fortunately, a dramatic improvement in both yield and 
regioselectivity was received (Table 2, entries 15-18). The triazolium salt 100b 
afforded the cycloadduct in a better yield, albeit with relatively low regioselectivity 
(Table 2, entry 17). With the use of 4 Å MS as an additive, an improved yield of 69% 
and regioselectivity (14:1) with excellent enantioselectivity (93% ee) were obtained 
(Table 2, entry 19). 
Table 2 Optimization of the reaction conditions.[a] 
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Entry NHC Base Solvent Yield of 
168a (%)
[b]
 
168a/a’
[c]
 
dr 
(168a)
[d]
 
ee of 
168a 
(%)
[e]
 
1 188a NEt3 toluene 43 >20:1 1.3:1 - 
2 16d NEt3 toluene 19 1:1.6 >20:1 –97 
3 16e NEt3 toluene n.r. - - - 
4 16d DIPEA toluene 30 1.4:1 >20:1 –99 
5 16d TMEDA toluene 23 1:1.7 >20:1 –98 
6 16d DABCO toluene 31 1:1.6 >20:1 –94 
7 16d DBU toluene n.r. - - - 
8 16d K2CO3 toluene 15 1:1.2 >20:1 –97 
9 16d NaOAc toluene n.r. - - - 
10 16d DABCO THF 24 1:1.3 >20:1 –99 
11 16d DABCO DCM 22 1:1.4 >20:1 –98 
12 16d DABCO EtOAc 30 1:1.2 >20:1 –99 
13 16d DABCO PhCl 14 1:1.7 >20:1 –98 
14 16d DABCO dioxane 22 1:1.9 >20:1 –97 
15 189a DABCO toluene 27 >20:1 >20:1 –90 
16 100a DABCO toluene 58 >20:1 >20:1 90 
17 100b DABCO toluene 65 7.2:1 >20:1 97 
18 189b DABCO toluene 54 >20:1 >20:1 –92 
19
[f]
 100b DABCO toluene 69 14:1 >20:1 93 
[a]
 Reaction conditions: 167a (0.1 mmol), 79a (0.2 mmol), NHC
.
HX (0.01 mmol), base (0.22 
mmol), solvent (1 mL), rt, 16 h. 
[b]
 Yields of isolated 168a after flash column chromatography. 
[c]
 
Ratio based on isolated yields. 
[d]
 Determined by 
1
H NMR. 
[e]
 The ee value was determined by 
HPLC on a chiral stationary phase. 
[f] 
Addition of 4 Å MS. 
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2.2.4 Substrate scope and discussion 
Under optimized conditions, we next focused on the substrate scope of this protocol 
on a 0.5 mmol scale. As shown in Table 3, the scope of the 2-benzothiazolimines 167 
with diverse electronic and steric properties was studied. The use of 
2-benzothiazolimine 167a gave the desired product in 63% yield with >20:1 dr and 
90% ee (Table 3, 168a). Electron-rich substituents such as 4-Me and 4-OMe on the Ar 
ring lowered the electrophilicity of the imine carbon, which led to lower yields (Table 
3, 168b,c). However, electron-withdrawing groups such as 4-Br, 4-Cl and 2-Cl on the 
Ar ring gave the desired cycloadducts 168d-f in good yields and with good to 
excellent dr and ee. Moreover, introducing a heterocyclic furyl group at the Ar 
position gave the corresponding product 168g in 69% yield, 93% ee and 11:1 dr under 
elevated temperature. It was found that several electron-rich and electron-deficient 
substituents on R
1
 were also tolerated, providing the cycloadducts 168h-k in good 
yields and excellent stereoselectivities. The α-chloroaldehyde moiety was also varied. 
An aliphatic linear α-chloroaldehyde worked well with moderate yield and good ee 
(Table 3, 168l). When a para-nitrophenyl group was engaged on R
2
, the 
corresponding product 168m was provided in good yield (69%) and excellent 
stereoselectivity (92% ee, 13:1 dr). To our surprise, this protocol could be extended by 
employing a 2-indolyl group on the Ar position. After the initial Mannich reaction, 
three nucleophilic N-sites for the subsequent lactamization were formed. Interestingly, 
only the trans-pyrrolo[1,2-a]indolone 168n was formed via cyclization of the indole 
N-anion with the acylazolium intermediate with moderate yield (45%) and excellent 
stereoselectivity (93% ee, 11:1 dr) (Scheme 62). 
Table 3 Scope of 2-benzothiazolimines 167 with α-chloroaldehydes 79.[a] 
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168 R
1
 Ar R
2
 Yield (%)
[b]
 dr
[c]
 ee (%)
[d]
 
a H Ph Ph 63 >20:1 90 
b
[e]
 H 4-MePh Ph 49 >20:1 99 
c
[f]
 H 4-MeOPh Ph 34 4:1 87 
d H 4-BrPh Ph 56 11:1 91 
e H 4-ClPh Ph 61 11:1 89 
f H 2-ClPh Ph 60 >20:1 97 
g
[f]
 H 2-Furyl Ph 69 11:1 93 
h
[e]
 Me Ph Ph 64 20:1 93 
i
[g]
 MeO Ph Ph 56 >20:1 92 
j Cl Ph Ph 78 10:1 91 
k F Ph Ph 71 17:1 89 
l H Ph n-Propyl 51 17:1 87 
m H Ph 4-NO2C6H4 69 13:1 92 
[a]
 Reaction conditions: 167 (0.5 mmol), 79 (1.0 mmol), 100b (0.05 mmol), DABCO (1.1 mmol), 
toluene (5 mL), 4 Å MS, rt, 16 h.
 [b]
 Yield of isolated 168 after flash column chromatography. 
[c]
 
Determined by 
1
H NMR.
 [d]
 The ee value was determined by HPLC on a chiral stationary phase. 
[e]
 
The reaction time is 24 h. 
[f]
 Performed at 40 
°
C.
 [g]
 The reaction time is 48 h. 
 
Scheme 62 Asymmetric synthesis of 168n via an NHC-catalyzed [2+3] annulation. 
2.2.5 Determination of the absolute configuration 
The relative configuration of the major diastereomer 168a was assigned by NOE 
measurements. As shown in Figure 6, there is a cross signal between H
a
 and H
b
, 
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which means that H
a
 and H
b
 are in cis configuration. This result was further 
confirmed by the absolute configuration of compound 168e assigned on the basis of 
X-ray crystal structure analysis (Figure 7). 
 
Figure 6 1H-1H NOESY of compound 168a. 
 
Figure 7 X-ray crystal structure of 168e grown with EtOAc/n-hexane (1:2). 
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2.2.6 Mechanistic Studies 
 
Scheme 63 Plausible mechanism of the reaction. 
According to the stereochemical outcome and previous report, we proposed a 
possible reaction pathway via a Mannich/lactamization sequence. As shown in 
Scheme 63, the nucleophilic addition of the active carbene 100b’ to 
α-chloroaldehyde 79 generates the intermediate 188, the subsequent 
HCl-elimination gives the key enolate species 189. This azolium enolate then 
reacts on its Re-face with the 2-benzothiazolimine 167 via a Mannich reaction 
to afford the adduct 187 in cis selectivity. Finally, cyclization of the 
benzothiazole N-anion with the acylazolium intermediate produces the desired 
benzothiazolopyrimidinone 168 and returns the NHC catalyst. 
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2.3 NHC-catalyzed [3+3]-annulation of indolin-3-ones with 
2-bromoenals 
2.3.1 Background and motivation 
As mentioned in the Indroduction 1.3, α,β-unsaturated acylazolium intermediates 113 
could be generated from several precursors, such as stoichiometric oxidation of 
homoenolates, 2-bromoenals, ynals, α,β-unsaturated acyl fluorides, α,β-unsaturated 
esters and the very recently reported α,β-unsaturated acids. The acylazolium 
intermediates act as Michael acceptors to conduct 1,4-addition reactions, providing a 
promising asymmetric approach to form C-C bonds. In most cases, regarding the 
reaction of 113 various 1,3-dinucleophilic reagents were employed to proceeding a 
[3+3] cycloaddition, leading to the formation of dihydropyranones or 
dihydropyridinones. 1,3-Dicarbonyl compounds,
[61, 84]
 kojic acid,
[66]
 enamines,
[58, 85]
 
ketimines,
[64]
 oxindoles
[68]
 and pyrazolones
[86]
 have been successfully applied to 
conduct NHC-catalyzed [3+3] cycloadditions. 
The utility of indolin-3-ones as nucleophiles in organocatalysis have been 
realized. Wang and co-workers reported a Michael addition of 1-acetylindolin-3-one 
to α,β-unsaturated ketones, catalyzed by primary-secondary amine 190 (Scheme 
64a).
[87]
 The Xu group has also reported an efficient access to 2-substituted 
indolin-3-ones 193 via the enantioselective conjugate addition of indolin-3-ones to 
nitroalkenes catalyzed by bifunctional thioureas 192 (Scheme 64b).
[88]
 Actually, after 
the Michael addition the afforded 2-substituted indolin-3-one could easily tautomerize 
to its enol form in the presence of base. Based on this envision, we tried to extend the 
application of indolin-3-ones 193 in NHC-organocatalytic transformations. 
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Scheme 64 Asymmetric organocatalytic Michael reaction of indolin-3-ones. 
2.3.2 Preparation of the starting materials 
The retrosynthetic analysis of indolin-3-ones showed that they can be derived from 
2-chlorobenzoic acids 194. Initially, 194 and glycine underwent an Ullmann reaction 
catalyzed by copper powder, resulting in a 77% yield of the white solid 195. The 
subsequent condensation of 195 and decarboxylation by refluxing with NaOAc in 
Ac2O led to the formation of indol-3-yl acetate 196, which was then further stirred 
under reflux in the mixture of EtOH and sat. Na2SO3 for two hours. The hydrolysis of 
acetate 196 provided the final indolin-3-ones 169 in 23% yield over the last two steps 
(Scheme 65, for the detailed procedure: see GP 9 in Experimental part). 
 
Scheme 65 The synthetic route of indolin-3-ones. 
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2.3.3 Optimization of conditions 
Initially, we proceeded the model reaction of 1-acetylindolin-3-one 169a with 
2-bromocinnamaldehyde 108a with the achiral precatalyst 188b for 2 d. Fortunately, 
the reaction gave the desired product 170a in 13% yield in the presence of NaOAc 
(Table 4, entry 1), which implied that this was a realistic protocol. However, the 
optimization of the catalyst did not go smoothly. The precatalysts 13 and 16e gave no 
reaction under the same condition (Table 4, entries 2 and 4). Gratifyingly, the use of 
the precatalysts 16d and 16f both produced good yields and ee values and the former 
one proved to be superior in terms of yield and enantioselectivity (Table 4, entries 3 
and 5). Next we tested a series of inorganic or organic bases, such as K3PO4, NEt3, 
DMAP, DIPEA, DPE or TMEDA, which resulted in good yields and good to 
excellent ee values of the desired product (Table 4, entries 6, 8, 10-13), The 
exceptions were DBU which afforded no product at all (Table 4, entry 7) and 
DABCO producing only 15% yield (Table 4, entry 9). Notably, after comparing the 
outcome TMEDA gave the highest ee value (92%) and comparable yield (Table 4, 
entry 13). The solvent screening revealed that nonpolar solvents such as mesitylene 
gave 96% ee and 66% yield (Table 4, entry 16), whereas polar solvents such as THF 
and CHCl3 resulted in inferior enantioselectivity (Table 4, entries 14-15) Moreover, 
we also tried to employ α-iodocinnamaldehyde instead of 2a. However, this reaction 
led to poor conversion (30% yield) but comparable ee (96%) (Table 4, entry 17). 
Table 4 Optimization of the reaction conditions.[a] 
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Entry NHC Solvent Base Time [d] Yield [%]
[b]
 ee [%]
[c]
 
1 188b toluene NaOAc 2 13 0 
2 13 toluene NaOAc 2 n.r. - 
3 16d toluene NaOAc 2 80 80 
4 16e toluene NaOAc 2 n.r. - 
5 16f toluene NaOAc 2 63 77 
6 16d toluene K3PO4 2 21 81 
7 16d toluene DBU 2 n.r. - 
8 16d toluene DIPEA 2 75 80 
9 16d toluene DABCO 2 15 90 
10 16d toluene NEt3 2 75 85 
11 16d toluene DMAP 0.5 75 87 
12 16d toluene DPE 1 67 89 
13 16d toluene TMEDA 1 69 92 
14 16d CHCl3 TMEDA 1 64 83 
15 16d THF TMEDA 1 70 70 
16 16d mesitylene TMEDA 1 66 96 
17
[d]
 16d mesitylene TMEDA 1 30 96 
[a]
 Reaction conditions: 169a (0.2 mmol), 108a (0.24 mmol), NHC (10 mol%), base (1.1 equiv.), 
solvent (2 mL), rt. 
[b]
 Yield of isolated product 170a after column chromatography. 
[c]
 The ee value 
was determined by HPLC on a chiral stationary phase. 
[d]
 (Z)-2-iodocinnamaldehyde instead of 
108a. 
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2.3.4 Substrate scope and discussion 
Having the optimal conditions in hand, we then continued to examine the substrate 
scope of this NHC-catalyzed annulation reaction. Initially, the tolerance of various 
substituted 1-acetylindolin-3-ones 169 with this protocol was tested. As shown in 
Table 2, indolinones bearing different substituents at the C6 position, such as 6-Cl or 
6-F were tolerated, affording the desired products 170b and 170c in good yields and 
excellent enantioselectivies. Moreover, a 5-CF3 group as R
1
 gave the desired adduct in 
67% yield and moderate ee value (Table 5, 170d). Next, we also investigated the 
variation on the 2-bromoenals moiety. It was found that electron-donating or 
-withdrawing substituents on the aromatic rings worked equally well, providing the 
dihydropyranoindol-2-ones in good yields and excellent ee values (Table 5, 170e-k). 
Furthermore, a good yield and excellent enantioselectivity were also obtained when 
we underwent the transformation with (2)-furyl-substituted 2-bromoenals (Table 5, 
170l). However, the reaction of ethyl and i-propyl substituted 2-bromoenals gave no 
reaction perhaps due to the unstable in situ generated α,β-unsaturated acylazolium 
when R
2
 was an aliphatic substituent (Table 5, 170m,n). This result revealed that this 
reaction required R
2
 to be an aromatic substituent. 
Table 5 Substrate scope of the NHC-catalyzed annulation reaction.[a] 
 
170 R
1 
R
2 
Yield [%]
[b]
 ee [%]
[c]
 
a H Ph 68 92 
b 6-Cl Ph 72 89 
c 6-F Ph 62 93 
d 5-CF3 Ph 67 67 
e H 4-MeC6H4 66 93 
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f H 4-MeOC6H4 66 98 
g H 2-MeO-5-Br-C6H3 70 94 
h H 3-MeOC6H4 61 92 
i H 4-ClC6H4 71 89 
j H 3-ClC6H4 60 97 
k H 4-FC6H4 68 93 
l H 2-furyl 60 95 
m H Et n.r. - 
n H i-Pr n.r. - 
[a]
 Reaction conditions: 169 (0.5 mmol), 108 (0.6 mmol), 16d (10 mol%), TMEDA (1.1 equiv.), 
mesitylene (5 mL), rt. 
[b]
 Yield of isolated product 170 after column chromatography. 
[c]
 The ee 
value was determined by HPLC on a chiral stationary phase. 
2.3.5 Determination of the absolute configuration 
The absolute configuration of the [3+3] annulation product was unambiguously  
determined by X-ray crystal structure of derivative 170h, which was assigned to be S 
configuration on the chiral carbon center (Figure 8). The single crystal was grown in a 
mixed solvent of EtOAc and n-hexane by solvent evaporation at room temperature. 
 
Figure 8 X-ray crystal structure of 170h. 
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2.3.6 Mechanistic studies 
 
Scheme 66 Plausible reaction mechanism for the formation of 170. 
A tentative pathway for the annulation reaction is shown in Scheme 66. Initially, the 
free NHC-catalyst 16d’ was generated by the deprotonation of 16d in the presence of 
base, which nucleophilic addition to the bromoenals 108 to afford the Breslow 
intermediates IN 197 or the mesomeric structure. After tautomerization to IN 198 and 
elimination of bromide the key α,β-unsaturated acylazoliums IN 199 were generated. 
Due to the steric demand of the chiral NHC backbone Michael addition of indolinones 
169 to the Re face of the α,β-unsaturated acylazoliums conducted the enol 
intermediates IN 200. The subsequent intramolecular acylation of IN 201 produced 
the desired products 170 with the return of the NHC catalyst for further cycles. 
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2.4 NHC-catalyzed enantioselective annulation of benzothiazolyl 
ethyl acetates with 2-bromoenals 
2.4.1 Background and motivation 
The dihydro-1H-benzothiazolopyridine framework is an important structural core, 
which is frequently found in various biologically active molecules and the  
applications in numerous pharmaceuticals.
[89]
 However, the synthesis of 
enantiomerically pure molecules has been rarely investigated. To the best of our 
knowledge, only three methods have been successfully developed to conduct the 
asymmetric synthesis of the tricyclic compounds. In 2013 an isothiourea 204 
catalyzed asymmetric annulation of benzothiazolyl ketones 202 with α,β-unsaturated 
anhydrides 203 was reported by the Smith group (Scheme 67a).
[90]
 Our workgroup 
also contributed a very recent report on 1-azadiene-Diels–Alder reactions of 
styrylbenzo[d]thiazoles 87 with -chloroaldehydes (Scheme 67b).[48] Furthermore, the 
work of project 2 provided an NHC-catalyzed [2+4]-cycloaddition of 
N-(benzothiazolyl)imines with 2-chloroaldehydes for the synthesis of 
benzothiazolo-pyrimidinones. As a continuation we tried to develop an alternative 
strategy towards dihydrobenzothiazolo- pyridinones via NHC-based α,β-unsaturated 
acylazolium intermediates.   
 
Scheme 67 Preparation of dihydro-1H-benzothiazolopyridinones. 
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2.4.2 Optimization of conditions 
To explore this new strategy, we examined the reaction between 2-(benzothiazol-2-yl) 
ethyl acetate 171a and 2-bromocinnamaldehyde 108a at room temperature in toluene 
with the base DIPEA as our model reaction and evaluated a series of triazolium 
precatalysts. As shown in Table 6, achiral triazolium 188a promoted the reaction 
smoothly and gave a 45% yield of the product 172a (Table 6, entry 1). With regard to 
the chiral triazolium salts, the use of the triazolium salt 16d generated the desired 
172a with a good yield of 83% and an ee value of 80% (Table 6, entry 3). Next we 
explored the influence of base. However, the reaction proceeded with organic bases 
such as DABCO, TMEDA, TBD or DBU and inorganic bases such as K3PO4 and 
K2CO3 gave the product 172a with ee values range from ‒22%~79% (Table 6, entries 
5-10). Subsequently, the influence of different solvents in the presence of precatalyst 
16d and DIPEA at room temperature was examined. We found that toluene was better 
than CH3CN, DCM, THF, MTBE and mesitylene (Table 6, entries 11-15), even than 
the mixed solvents of toluene-THF (Table 6, entry 16) and toluene-CH3CN (Table 6, 
entry 17). Recent reports on NHC/Lewis acid strategy showed that a Lewis acid could 
promote the reactivity and stereocontrol,
[91]
 so
 
we considered to add some Lewis acids 
as additives in this protocol. Unfortunately, the strong Lewis acid Sc(OTf)3 inhibited 
the reactivity and enantioselectivity (Table 6, entry 18), and the addition of the weak 
Lewis acid LiCl even resulted in an inversed the asymmetric indication (Table 6, entry 
19). Finally performing the reaction at 5 
°
C (Table 6, entry 20) and –20 °C (Table 6, 
entry 21) did not produce further improvement with prolonged reaction time. 
Table 6 Optimization of the reaction conditions.[a] 
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Entry NHC Solvent Base Additive 
Yield 
(%)
[b]
 
ee 
(%)
[c]
 
1 188a toluene DIPEA - 45 - 
2 100a toluene DIPEA - 29 ‒26 
3 16d toluene DIPEA - 83 80 
4 16e toluene DIPEA - n.r. - 
5 16d toluene DABCO - 66 79 
6 16d toluene TMEDA - 86 68 
7 16d toluene TBD - trace - 
8 16d toluene DBU - 23 ‒22 
9 16d toluene K3PO4 - 20 63 
10 16d toluene K2CO3 - 9 68 
11 16d CH3CN DIPEA - 80 73 
12 16d DCM DIPEA - 80 32 
13 16d THF DIPEA - 26 41 
14 16d MTBE DIPEA - 57 73 
15 16d mesitylene DIPEA - 46 82 
16 16d toluene:THF=10:1 DIPEA - 70 79 
17 16d toluene:CH3CN=10:1 DIPEA - 82 69 
18 16d toluene DIPEA Sc(OTf)3 29 66 
19 16d toluene DIPEA LiCl 29 ‒18 
20
[d]
 16d toluene DIPEA - 76 76 
21
[e]
 16d toluene DIPEA - 76 77 
[a]
 Reaction conditions: 171a (0.2 mmol), 108a (0.3 mmol), precatalyst (0.02 mmol), base (0.24 
mmol), solvent (2 mL), rt, under argon, 20 h. 
[b]
 Yield of isolated product 172a after column 
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chromatography. 
[c]
 The ee value was determined by HPLC on a chiral stationary phase. 
[d]
 
Performed at 5 °C for 4 d. 
[e]
 Performed at ‒20 °C for 4 d. 
2.4.3 Substrate scope and discussion 
We then performed the model reaction on a 0.5 mmol scale under the optimized 
conditions, which afforded 172a with comparable yield and a loss of stereocontrol. 
Fortunately, enantiopure product (99% ee) could be obtained via a single 
recrystallization from EtOAc/n-hexane. Next we turned our attention to the substrate 
scope of this protocol by variation of the 2-substituted benzo[d]thiazole component 
171. A methyl ester and a cyano group as R
1
 were well tolerated, leading to the 
desired adducts in good to excellent yields and moderate ee values (Table 7, 172b, c). 
Additionally, 2-(benzoxazol-2-yl)acetonitrile underwent the smooth conversion and 
resulted in product 172d in moderate yield and ee. Moreover, the variation on the 
bromoenals was also investigated. Electron-rich and electron-poor groups, as well as 
ortho-substituents on the aryl group of the bromoenals (R
2
) were well tolerated, 
providing the corresponding products in good yields and moderate ee values (Table 7, 
172e-j). Notably, in several cases virtually enantiopure compounds could be obtained 
(99% ee) after single recrystallization. In addition, a heterocyclic 2-furyl substituent 
on R
2
 also furnished the expected product 172k in 77% yield and 58% ee. 
Table 7 Scope with benzothiazolyl acetates with 2-bromoenals.[a] 
 
172 R
1
 R
2
 X Yield (%)
[b]
 ee (%)
[c,d]
 
a CO2Et Ph S 77 65(99) 
b CO2Me Ph S 91 64 
c CN Ph S 74 32 
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d CN Ph O 43 55 
e CO2Et 4-MeC6H4 S 64 68 
f CO2Et 4-MeOC6H4 S 69 62(99) 
g CO2Et 2-MeO-5-Br-C6H3 S 80 65(92) 
h CO2Et 2-MeOC6H4 S 86 66(99) 
i CO2Et 4-ClC6H4 S 72 73 
j CO2Et 4-BrC6H4 S 83 70(99) 
k CO2Et 2-Furyl S 77 58 
[a] 
Reaction conditions: 171 (0.5 mmol), 108 (0.75 mmol), precatalyst 16d (0.05 mmol), DIPEA 
(0.6 mmol), toluene (5 mL), rt, under argon, 20 h. 
[b] 
Yield of isolated product 172 after column 
chromatography.
 [c] 
The ee value was determined by HPLC on a chiral stationary phase. 
[d]
 The 
value in brackets refers to the ee after recrystallization 
 
Figure 9 X-ray crystal structure of (S)-172b. 
The absolute configuration of the dihydro-1H-benzothiazolopyridinones 172b was 
unambiguously determined to be S by X-ray crystal structure analysis (Figure 9). The 
configuration of the other products was assigned by analogy. 
2.4.4 Mechanistic studies 
To account for the outcome and the enantioselectivity of this protocol, a plausible 
reaction mechanism is proposed for this NHC-catalyzed formal [3+3] annulation. As 
shown in Scheme 68, the addition of the active free carbene 16d’ to the 2-bromoenal 
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108 generated the Breslow intermediate IN 206, also shown as its mesomeric 
zwitterionic form. The subsequent tautomerization to IN 207 and loss of bromide 
formed the key α,β-unsaturated acylazolium intermediate IN 208, which could 
undergo a base-mediated Michael addition with benzothiazolyl ethyl acetate 171 to 
afford the adduct IN 209. The following proton transfer and lactamization via IN 210 
furnished the final cycloadduct 172 and returned the NHC catalyst. 
 
Scheme 68 Proposed mechanism. 
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3. Research Summary 
In this thesis, the aim is to explore the generation of nucleophilic azolium enolate and 
electrophilic α,β-unsaturated acylazolium intermediates via NHC catalysis and their 
applications in various asymmetric annulations with suitable reaction partners. Four 
projects composing the full results of my doctoral studies have been presented and 
have been published in peer-reviewed journals. Here, a brief conclusion will be 
elaborated as follows: 
3.1 NHC-catalyzed [2+3]-annulation of nitrovinylindoles with α-chloroaldehydes 
 
This project investigated an asymmetric NHC-catalyzed [2+3] annulation reaction. In 
the NHC-organocatalysis with azolium enolate intermediates, various reports referred 
to the NHC-catalyzed [2+4] cycloadditions via Diels–Alder reactions or stepwise 
reactions, while few reports utilized the 2C component to conduct [2+3] annulations. 
In this protocol, an asymmetric NHC-catalyzed [2+3] annulation towards to the 
synthesis of trans-disubstituted pyrroloindolones 166 was explored through the 
Michael addition of the in situ generated enolate species from α-chloroaldehydes 79 
to electrophilic nitroalkenes 165 and followed by a lactamization of indole nitrogen 
with the NHC acylazolium. Additionally, the resulting adducts were determined to be 
trans-configurated by 
1
H-
1
H NOESY and single crystal X-ray crystallography. 
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3.2 NHC-catalyzed [2+4]-annulation of 2-benzothiazolimines with 
α-chloroaldehydes 
 
In this work we conducted an NHC-organocatalyzed regio- and stereoselective 
Mannich/lactamization domino reaction of 2-benzothiazolimines 167 with 
α-chloroaldehydes 79, which provided access to the desired benzothiazolopyrimi- 
dinones 168a-m through a formal [4+2] annulation in moderate to good yields with 
excellent regio- and stereoselectivities. Interestingly, when a 2-indolyl group at the Ar 
position was used, only trans-pyrrolo[1,2-a]indolone 168n was obtained via [2+3] 
annulation with 45% yield and excellent stereoselectivity (93% ee, 11:1 dr). 
3.3 NHC-catalyzed [3+3]-annulation of indolin-3-ones with 2-bromoenals 
 
Inspired by the previous organocatalytic reactions of indolin-3-ones 169 to enones 
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and nitroalkenes, we presented an NHC-catalyzed enantioselective [3+3] annulation 
of indolin-3-ones 169 with 2-bromoenals 108, resulting in the dihydropyrano- 
indol-2-ones 170 in good yields and good to excellent ee values. 
3.4 NHC-catalyzed [3+3]-annulation of benzothiazolyl ethyl acetates with 
2-bromoenals 
 
This protocol extended the utility of NHC-based α,β-unsaturated acylazoliums to the 
formation of dihydro-1H-benzothiazolopyridinones via the annulation of 
2-(benzothiazol-2-yl) acetates with 2-bromoenals. Even though only moderate ee 
values were obtained, several examples could be transformed into virtually 
enantiopure products (92-99% ee) after a single recrystallization. 
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4. Perspective and Outlook 
My research interests were oriented on NHC-catalyzed asymmetric 
annulations/cycloadditions via azolium enolate and α,β-unsaturated acylazolium 
intermediates. Based on the doctoral work, further extension will be explored. The 
efficient strategy for the utility of azolium enolates would be the development of 
effective electrophilic partners. The initial investigation showed that the indole 
N-anion was a promising nucleophilic N-site for the cyclization. Hence, the following 
efforts will be concentrated on the extension of this methodology. The reaction of 
7-indolimine 211 with α-chloroaldehydes 79 would be an interesting strategy for the 
preparation of 4H-pyrroloquinolinones 212 in a Mannich/lactamization sequence. 
Another promising proposal would be the NHC-catalyzed α-cyanation. For example 
the reaction of the electrophilic cyanation reagent 213 with α-chloroaldehyde 79 in 
the presence of NHC catalyst and equivalent of MeOH may afford α-cyano acetates 
214 (Scheme 69). 
 
Scheme 69 Further applications of azolium enolates. 
Subsequent future work will focus on the generation of α,β-unsaturated 
acylazoliums via α,β-unsaturated amides. The challenge of this transformation would 
be the activation of the C-N bond by an NHC organocatalyst. Preliminary studies 
showed that N-cinnamoyltriazol can be successfully transferred into the key 
α,β-unsaturated acylazoliums in the NHC-catalyzed reaction with 1,3-diketones. 
Further application of the intermediate will be undertaken with various nucleophiles 
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such as 2-substituted 1,3-diketone 216 and Hagemann’s ester 217 (Scheme 70). 
 
Scheme 70 Further applications of α,β-unsaturated acylazoliums. 
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5. Experimental Part 
General remarks: 
All reagents purchased from Sigma-Aldrich, Fluorochem, Acros, Alfa Aesar, TCI 
Europe and Apollo Chemicals were used without further purification unless otherwise 
stated. All other reagents used were available from chemical store. Dried syringes and 
cannulas were used to inject the solvents and reagents into the reaction mixtures. The 
organic solutions were concentrated under reduced pressure on an IKA rotary 
evaporator. 
Solvent 
All solvents were distilled and dried by standard procedures prior to use. Absolute 
THF, toluene and Et2O were distilled over sodium-lead alloy (Solvona
®
) under argon. 
Absolute mesitylene was distilled over Solvona
® 
under reduced pressure. MeCN was 
distilled from CaH2. EtOAc was distilled from K2CO3. Absolute CH2Cl2 was 
purchased directly from Acros. 
Chromatographic methods 
The reactions were monitored by TLC using silica gel pre-coated aluminium sheet 
(SIL G-25 UV254 from MACHERY-NAGEL) and visualized with UV light at 254 
nm or by diving with potassium permanganate stains, followed by heating with a heat 
gun. 
Glass columns with appropriate diameters and lengths were used for different scale 
purification. When running the column, a low air over-pressure (max. 0.2 bar) was 
used to push the eluting solvent. Flash column chromatography was performed using 
Merck silica gel 60, particle size 0.040-0.063 mm (230-240 mesh). After isolation and 
collection, the desired products were concentrated with a rotary evaporator under 
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reduced pressure. 
Analytical Methods: 
NMR-Spectroscopy 
1
H- and 
13
C NMR spectra were recorded at room temperature on Mercury 300 (300 
MHz), VNMRS 600 (600 MHz) and Inova 400 (400 MHz) instruments. The chemical 
shifts are reported in ppm downfield of tetramethylsilane and referenced to residual 
solvent peaks resonance as internal standard. For the 
1
H-NMR data, the order of 
citation in parentheses is multiplicity (s = singlet, d = doublet, dd = doublet of doublet, 
t = triplet, q = quartet, td = triplet of doublet, m = multiplet); coupling constants; 
number of protons and assignment. 
Mass spectra 
The EI mass spectra were measured on Finningen SSQ7000 at 70 eV and the high 
resolution mass spectra on a ThermoFisher Scientific LTQ Orbitrap XL (ESI).  
IR Spectroscopy 
IR spectra was measured on a Perkin-Elmer FT-IR Spectrum 100 with Diamant/KRS5 
ATR. The absorption bands are reported in cm
-1
. 
Elemental Analyses 
The elemental analyses were performed on a Vario EL element analyzer. Each of the 
∆C, ∆H and ∆N value must be less than 0.5% of the theoretical value. 
HPLC analyses 
The measurements were performed on Hewlett-Packard 1050 Series or Agilent 1100 
instrument with achiral or Daicel chiral columns. The chiral stationary phases are as 
Experimental Part 
71 
 
follows: 
Chiralpak AS (10 µm) (250 mm x 4.6 mm) 
Chiralpak OD (10 µm) (250 mm x 4.6 mm) 
Chiralpak AD (10 µm) (250 mm x 4.6 mm) 
Chiralpak IA (5 µm) (250 mm x 4.6 mm) 
Chiralpak OJ (10 µm) (250 mm x 4.6 mm) 
Chiralpak IC (5 µm) (150 mm x 4.6 mm) 
Melting points 
Melting points (°C) were determined in capillaries with a Büchi B-540 apparatus. 
Optical Rotation ([α]
D
T ) 
The optical rotations α were measured on a Perkin Elmer 241 polarimeter at room 
temperature using a light frequency of 589 nm (D-line of a sodium vapor lamp) in a 
cuvette (length d = 1 dm). HPLC grade CHCl3 was used as solvent. The 
concentrations (c) are given in g·100 mL
–1
. 
General procedure (GP) 1 and analytical data for the synthesis of 
trans-1H-Pyrrolo[1,2-a]indol-3(2H)-ones (166) 
To an argon-filled and oven-dried Schlenk vial was added the 
(E)-2-(2-nitrovinyl)-1H-indole 165 (0.5 mmol, 1.0 equiv) and 16d (21 mg, 0.05 mmol, 
10 mol%) in 5 mL toluene, followed by addition of 2-chloroaldehydes 79 (1 mmol, 
2.0 equiv) and Et3N (154 µL, 1.1 mmol, 2.2 equiv). The mixture was stirred at 50 ºC 
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until completion of the reaction (monitored by TLC). After purification by column 
chromatography on silica gel (n-pentane:Et2O = 10:1) the desired product 166 was 
obtained as a yellow oil or yellow solid. 
(1S,2R)-2-Benzyl-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one (166a) 
 
The compound 166a was prepared according to the GP 1. The product was purified 
by flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a yellow 
syrup. 
Yield: 75% (120 mg)  
TLC: Rf = 0.40 (n-pentane:Et2O = 1:1)  
Optical rotation: [α]
D
24  = –73.6 (c = 0.47, CHCl3) 
dr: >20:1 
ee:99%  
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 12.75 min (major), 15.14 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.08 (d, J = 7.8 Hz, 1 H, Ar-H), 7.49 (d, J = 7.8 Hz, 
1 H, Ar-H), 7.35-7.25 (m, 7 H, Ar-H), 6.28 (s, 1 H, Ar-H), 4.35 (dd, J = 13.2 Hz, 7.8 
Hz, 1 H, CHHNO2), 4.17 (dd, J = 13.2 Hz, 6.0 Hz, 1 H, CHHNO2), 3.95-3.92 (m, 1 H, 
CHCH2NO2), 3.45 (dd, J = 13.8 Hz, 4.8 Hz, 1 H, PhCHH), 3.26-3.24 (m, 1 H, BnCH), 
3.03 (dd, J = 13.8 Hz, 9.0 Hz, 1 H, PhCHH) ppm. 
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13
C NMR (150 MHz, CDCl3): δ = 170.2 (C=O), 139.8 (CAr), 136.9 (CAr), 134.7 (CAr), 
130.4 (CAr), 129.2 (2C, CHAr), 128.9 (2C, CHAr), 127.4 (CHAr), 124.6 (CHAr), 124.4 
(CHAr), 121.2 (CHAr), 113.9 (CHAr), 102.3 (CHAr), 76.6 (CH2NO2), 52.2 (BnCH), 
36.5 (CHCH2NO2), 36.2 (PhCH2) ppm. 
MS (EI, 70 eV) m/z (%): 320.2 [M
+
] (69), 273.1 (73), 244.1 (14), 183.1 (13), 154.1 
(13), 115.1 (15), 91.1 (100). 
IR(ATR): 3027, 2925, 1733, 1551, 1448, 1376, 1316, 1168, 1090, 1027, 945, 849, 
807, 747, 698 cm
-1
. 
HRMS (ESI): calcd for C19H16N2O3 [M+Na]
+
: 343.1053; found: 343.1049. 
(1S,2R)-2-Benzyl-7-methoxy-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one 
(166b) 
 
The compound 166b was prepared according to GP 1. The product was obtained as a 
red solid.  
Yield: 64% (113 mg) 
TLC: Rf = 0.40 (n-pentane:Et2O = 1:1) 
Melting point: 92-93 ºC  
Optical rotation: [α]
D
24  = –85.8 (c = 0.45, CHCl3) 
dr: >20:1 
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ee: >99% 
HPLC: Daicel AD, n-heptane:EtOH = 8:2, 0.7 mL/min, tR = 29.38 min (major), 34.92 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 7.96 (d, J = 9.0 Hz, 1 H, Ar-H), 7.32-7.26 (m, 5 H, 
Ar-H), 6.95-6.92 (m, 2 H, Ar-H), 6.25 (s, 1 H, Ar-H), 4.36 (dd, J = 13.2 Hz, 8.4 Hz, 1 
H), 4.17 (dd, J = 13.2 Hz, 8.0 Hz, 1 H, CHHNO2), 3.93-3.90 (m, 1 H, CHCH2NO2), 
3.84 (s, 3 H, OCH3), 3.44 (dd, J = 13.8 Hz, 4.8 Hz, 1 H, PhCHH), 3.24-3.20 (m, 1 H, 
BnCH), 3.04 (dd, J = 13.8 Hz, 9.0 Hz, 1 H, PhCHH) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 169.7 (C=O), 157.2 (CAr), 140.7 (CAr), 136.9 (CAr), 
135.8 (CAr), 129.1 (2C, CHAr), 128.9 (2C, CHAr), 127.4 (CHAr), 125.1 (CAr), 114.5 
(CHAr), 113.0 (CHAr), 104.0 (CHAr), 102.3 (CHAr), 76.6 (CH2NO2), 55.7 (OCH3), 52.1 
(BnCH), 36.5 (CHCH2NO2), 36.2 (PhCH2) ppm. 
MS (EI, 70 eV) m/z (%): 350.1 [M
+
] (100), 303.1 (55), 91.1 (19). 
IR (ATR): 3413, 3115, 3008, 2926, 1728, 1592, 1547, 1477, 1443, 1371, 1326, 1254, 
1198, 1162, 1094, 1027, 956, 929, 850, 804, 738, 696 cm
-1
. 
CHN-Elemental Analysis: C20H18N2O4 (350) 
Anal. calcd. : C, 68.56; H, 5.18; N, 8.00  
found: C, 68.44; H, 5.39; N, 7.91. 
(1S,2R)-2-Benzyl-7-methyl-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one 
(166c) 
 
Experimental Part 
75 
 
The compound 166c was prepared according to GP 1. The product was obtained as 
yellow syrup. 
Yield: 72% (120 mg) 
TLC: Rf = 0.50 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = –89.6 (c = 0.38, CHCl3) 
dr: >20:1 
ee: >99% 
HPLC: Daicel IA, n-heptane:EtOH = 9:1, 1.0 mL/min, tR = 21.70 min (major), 25.70 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 7.94 (d, J = 7.8 Hz, 1 H, Ar-H), 7.34-7.25 (m, 6 H, 
Ar-H), 7.15 (dd, J = 8.4 Hz, 1 H, Ar-H), 6.20 (s, 1 H, Ar-H), 4.36 (dd, J = 13.2 Hz, 8.4 
Hz, 1 H, CHHNO2), 4.17 (dd, J = 13.2 Hz, 6.0 Hz, 1 H, CHHNO2), 3.93 (m, 1 H, 
CHCH2NO2), 3.44 (dd, J = 13.8 Hz, 4.8 Hz, 1 H, PhCHH), 3.24 (m, 1 H, BnCH), 3.04 
(dd, J = 13.2 Hz, 9.0 Hz, 1 H, PhCHH), 2.43 (s, 3 H, CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 170.0 (C=O), 139.9 (CAr), 136.9 (CAr), 134.9 (CAr), 
134.4 (CAr), 129.1 (2C, CHAr), 128.9 (2C, CHAr), 128.5 (CAr), 127.2 (CHAr), 125.7 
(CHAr), 121.1 (CHAr), 113.5 (CHAr), 102.1 (CHAr), 76.7 (CH2NO2), 52.2 (BnCH), 
36.4 (CHCH2NO2), 36.2 (PhCH2), 21.6 (CH3) ppm. 
MS (EI, 70 eV) m/z (%): 334.1 [M
+
] (100), 287 (72), 91.2 (11). 
IR (ATR): 3458, 3028, 2923, 1733, 1552, 1465, 1384, 1171, 1117, 878, 809, 744, 699 
cm
-1
. 
HRMS (ESI): calcd for C20H18N2O3 [M+H]
+
: 335.1390; found: 335.1386. 
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(1S,2R)-2-Benzyl-9-methyl-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one 
(166d) 
 
The compound 166d was prepared according to GP 1. The product was obtained as a 
yellow oil. 
Yield: 30% (50 mg) 
TLC: Rf = 0.60 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = –138.1 (c = 0.27, CHCl3) 
dr: >20:1 
ee: 97% 
HPLC: Daicel OD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 10.06 min (minor), 
15.68 min (major). 
1
H NMR (600 MHz, CDCl3): δ = 8.06 (d, J = 7.2 Hz, 1 H, Ar-H), 7.44 (d, J = 7.8 Hz, 
1 H, Ar-H), 7.33-7.25 (m, 7 H, Ar-H), 5.97 (m, 1 H, Ar-H), 4.47-4.39 (m, 2 H, 
CH2NO2), 3.91-3.88 (m, 1 H, CHCH2NO2), 3.44-3.41 (m, 1 H, BnCH), 3.37 (dd, J = 
13.8 Hz, 4.8 Hz, 1 H, PhCHH), 3.05 (dd, J = 13.8 Hz, 8.4 Hz, 1 H, PhCHH), 2.15 (s, 
3 H, CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 171.2 (C=O), 136.9 (CAr), 135.8 (CAr), 134.2 (CAr), 
130.3 (CAr), 129.0 (2C, CHAr), 128.9 (2C, CHAr), 127.3 (CHAr), 124.5 (CHAr), 124.2 
(CHAr), 119.1 (CHAr), 113.9 (CHAr), 111.4 (CAr), 76.4 (CH2NO2), 53.1 (BnCH), 36.7 
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(PhCH2), 36.1(CHCH2NO2), 8.36 (CH3) ppm. 
MS (EI, 70 eV) m/z (%): 334.6 [M+1] (86), 333.8 [M
+
] (67), 333.0 (63), 287.5 (100), 
286.5 (48), 285.8 (34), 243.5 (14). 
IR (ATR): 3440, 2923, 2861, 1667, 1448, 1385, 1061, 876, 694 cm
-1
. 
HRMS (ESI): calcd for C20H18N2O3 [M+Na]
+
: 357.1209; found: 357.1209. 
(1S,2R)-2-Benzyl-7-chloro-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one 
(166e) 
 
The compound 166e was prepared according to GP 1. The product was obtained as a 
yellow solid. 
Yield: 72% (128 mg) 
Melting point: 78-79 ºC 
TLC: Rf = 0.40 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = –94.4 (c = 0.45, CHCl3) 
dr: >20:1 
ee: 96% 
HPLC: Daicel OD, n-heptane:i-PrOH = 9:1, 1.0 mL/min, tR = 28.56 min (minor), 
33.75 min (major). 
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1
H NMR (600 MHz, CDCl3): δ = 7.99 (d, J = 9.0 Hz, 1 H, Ar-H), 7.46 (d, J = 1.8 Hz, 
1 H, Ar-H), 7.34-7.25 (m, 6 H, Ar-H), 6.24 (s, 1 H, Ar-H), 4.36 (dd, J = 13.2 Hz, 8.4 
Hz, 1 H, CHHNO2), 4.20 (dd, J = 13.2 Hz, 8.0 Hz, 1 H, CHHNO2), 3.95-3.92 (m, 1 H, 
CHCH2NO2), 3.45 (dd, J = 13.8 Hz, 4.8 Hz, 1 H, PhCHH), 3.27-3.24 (m, 1 H, BnCH), 
3.05 (dd, J = 13.8 Hz, 8.4 Hz, 1 H, PhCHH) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 170.0 (C=O), 141.3 (CAr), 136.7 (CAr), 135.8 (CAr), 
130.2 (CAr), 129.2 (2C, CHAr), 128.9 (2C, CHAr), 128.7 (CAr), 127.5 (CHAr), 124.7 
(CHAr), 120.9 (CHAr), 114.7 (CHAr), 101.7 (CHAr), 76.3 (CH2NO2), 52.0 (BnCH), 
36.4 (CHCH2NO2), 36.2 (PhCH2) ppm. 
MS (EI, 70 eV) m/z (%): 356.1 [M+2] (34), 354.1 [M
+
] (100), 307.1 (83). 
IR (ATR):3459, 3028, 2927, 1734, 1558, 1445, 1369, 1173, 1055, 965, 877, 812. 748, 
699 cm
-1
. 
HRMS (ESI): calcd for C19H15ClN2O3 [M+H]
+
: 355.0844; found: 355.0844. 
(1S,2R)-2-Benzyl-9-chloro-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one 
(166f) 
 
The compound 166f was prepared according to GP 1. The product was obtained as a 
yellow syrup. 
Yield: 66% (117 mg) 
TLC: Rf = 0.60 (n-pentane:Et2O = 1:1) 
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Optical rotation: [α]
D
24  = –298.7 (c = 0.24, CHCl3) 
dr: >20:1 
ee: 99% 
HPLC: Daicel OD, n-heptane:EtOH = 7:3, 1.0 mL/min, tR = 6.70 min (minor), 11.05 
min (major). 
1
H NMR (600 MHz, CDCl3): δ = 8.08 (d, J = 7.2 Hz, 1 H, Ar-H), 7.52 (d, J = 6.6 Hz, 
1 H, Ar-H), 7.40-7.24 (m, 7 H, Ar-H), 4.63-4.57 (m, 2 H, CH2NO2), 3.93-3.90 (m, 1 H, 
CHCH2NO2), 3.53-3.50 (m, 1 H, BnCH), 3.36 (dd, J = 13.8 Hz, 4.8 Hz, 1 H, PhCHH), 
3.15 (dd, J = 13.8 Hz, 7.8 Hz, 1 H, PhCHH) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 170.0 (C=O), 136.4 (CAr), 133.7 (CAr), 132.1 (CAr), 
129.4 (CAr), 129.1 (2C, CHAr), 129.0 (2C, CHAr), 127.4 (CHAr), 125.6 (CHAr), 125.0 
(CHAr), 118.6 (CHAr), 114.1 (CHAr), 106.3 (CAr), 74.6 (CH2NO2), 52.6 (BnCH), 36.3 
(PhCH2), 35.7 (CHCH2NO2) ppm. 
MS (EI, 70 eV) m/z (%):356.2 [M+2] (4), 354.2 [M
+
] (13), 307.2 (17), 91.1 (100). 
IR (ATR):3465, 3060, 3030, 2923, 2858, 1744, 1603, 1556, 1448, 1377, 1175, 1087, 
889, 750, 701, 603 cm
-1
. 
HRMS (ESI): calcd for C19H15ClN2O3 [M+Na]
+
: 377.0663; found: 377.0658. 
(1S,2R)-2-Benzyl-9-chloro-6-fluoro-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)
-one (166g) 
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The compound 166g was prepared according to GP 1. The product was obtained as a 
yellow oil.  
Yield: 65% (120 mg) 
TLC: Rf = 0.50 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = –110.4 (c = 0.37, CHCl3) 
dr: >20:1 
ee: 96% 
HPLC: Daicel OD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 8.99 min (major), 10.24 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 7.78 (dd, J = 8.4 Hz, 2.4 Hz, 1 H, Ar-H), 7.43 (dd, J 
= 9.0 Hz, 4.8 Hz, 1 H, Ar-H), 7.33-7.24 (m, 5 H, Ar-H), 7.11 (dt, J = 11.4 Hz, 2.4 Hz, 
1 H, Ar-H), 4.63-4.52 (m, 2 H, CH2NO2), 3.91-3.89 (m, 1 H (m, 1 H, CHCH2NO2)), 
3.53-3.50 (m, 1 H, BnCH), 3.35 (dd, J = 13.8 Hz, 4.8 Hz, 1 H, PhCHH), 3.12 (dd, J = 
14.4 Hz, 8.4 Hz, 1 H, PhCHH) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 170.0 (C=O), 161.2 (d, J = 202.9 Hz, CAr), 136.2 
(CAr), 133.8 (d, J = 3.2 Hz, CAr), 129.3 (CAr), 129.2 (CHAr), 129.1 (2C, CHAr), 129.0 
(d, J = 2.1 Hz, 2C, CHAr), 128.4 (CAr), 127.5 (CHAr), 119.7 (d, J = 8.1 Hz, CHAr), 
113.4 (d, J = 20.4 Hz, CHAr), 106.0 (CAr), 101.0 (d, J = 23.1 Hz, CHAr), 74.5 
(CH2NO2), 52.5 (BnCH), 36.3  (PhCH2), 35.7 (CHCH2NO2) ppm. 
MS (EI, 70 eV) m/z (%): 372.4 [M
+
] (74), 371.2 (41), 325.5 (100), 324.6 (77), 234.3 
(44), 91.1 (69). 
IR (ATR): 3477, 3031, 2926, 1744, 1555, 1442, 1365, 1189, 1119, 854, 811, 744, 699 
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cm
-1
. 
HRMS (ESI): calcd for C19H14ClFN2O3 [M+Na]
+
: 395.0569; found: 395.0567. 
(1S,2R)-2-Benzyl-7-bromo-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one 
(166h) 
 
The compound 166h was prepared according to GP 1. The product was obtained as a 
yellow solid. 
Yield: 69% (138 mg) 
Melting point: 98-99 ºC 
TLC: Rf = 0.60 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = –112.6 (c = 0.68, CHCl3) 
dr: >20:1 
ee: 97% 
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 17.10 min (major), 23.57 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 7.92 (d, J = 9.0 Hz, 1 H, Ar-H), 7.62 (d, J = 1.8 Hz, 
1 H, Ar-H), 7.42 (dd, J = 8.4 Hz, 1.8 Hz, 1 H, Ar-H), 7.34-7.25 (m, 5 H, Ar-H), 6.23 
(s, 1 H, Ar-H), 4.35 (dd, J = 13.2 Hz, 7.8 Hz, 1 H, CHHNO2), 4.19 (dd, J = 13.2 Hz, 
6.0 Hz, 1 H, CHHNO2), 3.95-3.92 (m, 1 H, CHCH2NO2), 3.43 (dd, J = 13.8 Hz, 4.8 
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Hz, 1 H, PhCHH), 3.27-3.24 (m, 1 H, BnCH), 3.03 (dd, J = 13.8 Hz, 9.6 Hz, 1 H, 
PhCHH) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 170.1 (C=O), 141.1 (CAr), 136.7 (CAr), 136.2 (CAr), 
129.2 (2C, CHAr), 129.0 (2C, CHAr), 128.9 (CHAr), 127.5 (CHAr), 127.4 (CHAr), 124.0 
(CHAr), 117.9 (CAr), 115.1 (CHAr), 101.6 (CHAr), 76.4 (CH2NO2), 52.0 (BnCH), 36.4 
(PhCH2), 36.2 (CHCH2NO2) ppm. 
MS (EI, 70 eV) m/z (%): 399.6 [M+2] (76), 398.2 [M
+
] (95), 350.9 (100), 351.8 (92), 
261.8 (65), 260.1 (47). 
IR (ATR):3454, 3030, 2925, 1741, 1562, 1447, 1378, 1173, 1045, 882, 806, 709, 649 
cm
-1
. 
CHN-Elemental Analysis: C19H15BrN2O3 (399) 
Anal. calcd. : C, 57.16; H, 3.79; N, 7.02 
found: C, 57.58; H, 3.56; N, 6.80 
(1S,2R)-2-Benzyl-1-(nitromethyl)-1H-pyrrolizin-3(2H)-one (166i) 
 
The compound 166i was prepared according to GP 1. The product was obtained as a 
yellow oil. 
Yield: 35% (47 mg) 
TLC: Rf = 0.30 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = +2.2 (c = 0.37, CHCl3) 
Experimental Part 
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dr: >20:1 
ee: 91% 
HPLC: Daicel OD, n-heptane:i-PrOH = 9:1, 1.0 mL/min, tR = 15.72 min (minor), 
23.47 min (major). 
1
H NMR (600 MHz, CDCl3): δ = 7.34-7.31 (m, 2 H, Ar-H), 7.28-7.23 (m, 3 H, Ar-H), 
7.07 (d, J = 3.0 Hz, 1 H, Ar-H), 6.45 (t, J = 3.0 Hz, 1 H, Ar-H), 5.97 (m, 1 H, Ar-H), 
4.29 (dd, J = 13.2 Hz, 8.4 Hz, 1 H, CHHNO2), 4.10 (dd, J = 13.2 Hz, 6.0 Hz, 1 H, 
CHHNO2),3.81 (m, 1 H, CHCH2NO2), 3.40 (dd, J = 13.8 Hz, 4.2 Hz, 1 H, PhCHH), 
3.19 (m, 1 H, BnCH), 3.00 (dd, J = 13.2 Hz, 9.6 Hz, 1 H, PhCHH) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 170.6 (C=O), 136.9 (CAr), 136.1 (CAr), 129.1 (2C, 
CHAr), 128.9 (2C, CHAr), 127.4 (CHAr), 119.5 (CHAr), 112.2 (CHAr), 106.4 (CHAr), 
76.8 (CH2NO2), 52.3 (BnCH), 36.4 (PhCH2), 36.1 (CHCH2NO2) ppm. 
MS (EI, 70 eV) m/z (%): 270.0 [M
+
] (34), 224.1 (26), 223.1 (100), 194.1 (12), 91.1 
(73). 
IR (ATR): 3480, 3029, 2926, 1746, 1553, 1459, 1400, 1284, 1209, 1083, 883, 815, 
707 cm
-1
. 
HRMS (ESI): calcd for C15H14N2O3 [M+Na]
+
: 293.0897; found: 293.0900. 
(1S,2R)-2-Methyl-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one (166j) 
 
The compound 166j was prepared according to GP 1. The product was obtained as a 
yellow solid. 
Experimental Part 
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Yield: 49% (60 mg) 
Melting point:127-128 ºC 
TLC: Rf = 0.50 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = +66.0 (c = 0.5, CHCl3) 
dr: >20:1 
ee: >99% 
HPLC: Daicel OD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 10.99 min (minor), 
14.67 min (major). 
1
H NMR (600 MHz, CDCl3): δ = 8.04 (d, J = 12.0 Hz, 1 H, Ar-H), 7.53-7.51 (m, 1 H, 
Ar-H), 7.34-7.26 (m, 2 H, Ar-H), 6.38 (s, 1 H, Ar-H) 4.76-4.61 (m, 2 H, CH2NO2), 
3.86-3.81 (m, 1 H, CHCH2NO2), 3.06-2.99 (m, 1 H, CH3CH), 1.53 (d, J = 11.4 Hz, 3 
H, CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 171.7 (C=O), 139.6 (CAr), 134.6 (CAr), 130.5 (CAr), 
124.6 (CHAr), 124.4 (CHAr), 121.2 (CHAr), 113.9 (CHAr), 102.2 (CHAr), 76.9 
(CH2NO2), 46.2 (CH3CH), 39.3 (CHCH2NO2), 16.3 (CH3) ppm. 
MS (EI, 70 eV) m/z (%):244.7 [M
+
] (82), 243.5 (65), 197.8 (100), 197.0 (84), 196.1 
(79), 167.7 (83), 166.8 (56), 154.0 (52). 
IR (ATR): 3450, 3004, 2929, 1727, 1549, 1450, 1373, 1176, 948, 896, 807, 751, 702 
cm
-1
. 
CHN-Elemental Analysis: C13H12N2O3 (244) 
Anal. calcd. : C, 63.93; H, 4.95; N, 11.47 
found: C, 63.89; H, 5.05; N, 11.31 
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(1S,2R)-2-Ethyl-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one (166k) 
 
The compound 166k was prepared according to GP 1. The product was obtained as a 
yellow oil. 
Yield: 64% (83 mg) 
TLC: Rf = 0.50 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = +70.5 (c = 0.21, CHCl3) 
dr: >20:1 
ee: >99% 
HPLC: Daicel OD, n-heptane:EtOH = 7:3, 1.0 mL/min, tR = 6.99 min (minor), 8.99 
min (major). 
1
H NMR (600 MHz, CDCl3): δ = 8.06 (d, J = 8.4 Hz, 1 H, Ar-H), 7.53 (d, J = 7.2 Hz, 
1 H, Ar-H), 7.34-7.28 (m, 2H, Ar-H), 6.38 (s, 1 H, Ar-H), 4.69-4.62 (m, J = 7.8 Hz, 
2.4 Hz, 2 H, CH2NO2), 3.96-3.93 (m, 1 H, CHCH2NO2), 2.96-2.93 (m, 1 H, 
CH3CHH), 2.02-1.99 (m, 1 H, C2H5CH), 1.98-1.89 (m, 1 H, CHCHH), 1.07 (t, J = 7.2 
Hz, 3 H, CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 171.1 (C=O), 140.1 (CAr), 134.7 (CAr), 130.4 (CAr), 
124.5 (CHAr), 124.4 (CHAr), 121.2 (CHAr), 113.9 (CHAr), 102.3 (CHAr), 76.8 
(CH2NO2), 52.0 (C2H5CH), 36.5 (CHCH2NO2), 24.2 (CH3CH2), 10.6 (CH3) ppm. 
MS (EI, 70 eV) m/z (%): 258.2 [M
+
] (78), 211.2 (100), 183.1 (99),168.1 (24), 154.1 
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(27), 115.1 (28). 
IR (ATR):3456, 3057, 2965, 2930, 2877, 1738, 1556,1451,1381,1315, 1174, 810, 753, 
668, 632 cm
-1
. 
HRMS (ESI): calcd for C14H14N2O3 [M+Na]
+
: 281.0897; found: 281.0895. 
(1S,2R)-2-Butyl-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one (166l) 
 
The compound 166l was prepared according to GP 1. The product was obtained as a 
yellow oil. 
Yield: 66% (95 mg) 
TLC: Rf = 0.50 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = +48.5 (c = 0.17, CHCl3) 
dr: >20:1 
ee: 99% 
HPLC: Daicel AD, n-heptane:i-PrOH = 9:1, 0.7 mL/min, tR = 13.22 min (minor), 
14.59 min (major). 
1
H NMR (600 MHz, CDCl3): δ = 8.06 (d, J = 7.8 Hz, 1H, Ar-H), 7.53 (d, J = 7.2 Hz, 
1H, Ar-H), 7.34-7.31 (m, 2H, Ar-H), 6.38 (s, 1H, Ar-H), 4.68-4.62 (m, 2 H, CH2NO2), 
3.96-3.92 (m, 1 H, CHCH2NO2), 2.98-2.95 (m, 1 H, C3H7CHH), 2.02-1.96 (m, 1 H, 
C4H9CH), 1.87-1.81 (m, 1 H, C3H7CHH), 1.47-1.37 (m, 4 H, CH3C2H4), 0.93 (t, J = 
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7.2 Hz, 3 H, CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 171.3 (C=O), 140.1 (CAr), 134.7 (CAr), 130.4 (CAr), 
124.5 (CHAr), 124.3 (CHAr), 121.2 (CHAr), 113.9 (CHAr), 102.3 (CHAr), 77.4 
(CH2NO2), 50.8 (C4H9CH), 37.1 (CHCH2NO2), 30.9 (C3H7CH2), 28.4 (C2H5CH2), 
22.5 (CH3CH2), 13.8 (CH3) ppm. 
MS (EI, 70 eV) m/z (%): 286.1 [M
+
] (72), 239.1 (24), 188.0 (42), 183.0 (55), 145.0 
(24), 83.0 (100). 
IR (ATR): 3450, 3055, 2932, 2865, 1739, 1558, 1452, 1379, 1173, 1102, 1029, 942, 
807, 751, 644 cm
-1
. 
HRMS (ESI): calcd for C16H18N2O3 [M+Na]
+
: 309.1210; found: 343.1202. 
(1S,2R)-2-Hexyl-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one (166m) 
 
The compound 166m was prepared according to GP 1. The product was obtained as a 
yellow oil. 
Yield: 78% (123 mg) 
TLC: Rf = 0.60 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = –160.0 (c = 0.17, CHCl3) 
dr: >20:1 
ee: 99% 
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HPLC: Daicel OD, n-heptane:i-PrOH = 7:3, 1.0 mL/min, tR = 7.95 min (major), 
13.34 min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.06 (d, J = 8.4 Hz, 1 H, Ar-H), 7.53 (d, J = 7.2 Hz, 
1 H, Ar-H), 7.34-7.28 (m, 2H, Ar-H), 6.38 (s, 1 H, Ar-H), 4.69-4.62 (m, 2 H, 
CH2NO2), 3.93-3.90 (m, 1 H, CHCH2NO2), 2.96-2.93 (m, 1 H, C5H11CHH), 2.00-1.95 
(m, 1 H, C6H13CH), 1.85-1.79 (m, 1 H, C5H11CHH), 1.46-1.27 (m, 8 H, CH3C4H8), 
0.88 (t, J = 7.2 Hz, 3 H, CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 171.3 (C=O), 140.1 (CAr), 134.7 (CAr), 130.4 (CAr), 
124.5 (CHAr), 124.4 (CHAr), 121.2 (CHAr), 113.9 (CHAr), 102.3 (CHAr), 77.4 
(CH2NO2), 50.8 (C6H13CH), 37.1 (CHCH2NO2), 31.5 (C5H11CH2), 31.3 (C4H9CH2), 
29.1(C3H7CH2), 26.3 (C2H5CH2), 22.5 (CH3CH2), 14.0 (CH3) ppm. 
MS (EI, 70 eV) m/z (%): 314.0 [M
+
] (100), 266.9 (66), 183.2 (89). 
IR (ATR): 3480, 2963, 1697, 1645, 1514, 1450, 1346, 1268, 1112, 1015, 936, 859, 
819, 750, 666 cm
-1
. 
HRMS (ESI): calcd for C18H22N2O3 [M+Na]
+
: 337.1522; found: 337.1519. 
(1S,2R)-2-Butyl-7-chloro-1-(nitromethyl)-1H-pyrrolo[1,2-a]indol-3(2H)-one 
(166n) 
 
The compound 166n was prepared according to GP 1. The product was obtained as a 
yellow oil. 
Yield: 70% (112 mg) 
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TLC: Rf = 0.60 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = +33.8 (c = 0.34, CHCl3) 
dr: >20:1 
ee: >99% 
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 1.0 mL/min, tR = 8.31 min (major), 12.20 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 7.98 (d, J = 8.4 Hz, 1 H, Ar-H), 7.51 (d, J = 1.8 Hz, 
1 H, Ar-H), 7.30 (dd, J = 8.4 Hz, 1.8 Hz, 1 H, Ar-H), 6.33 (s, 1H, Ar-H), 4.67 (d, J = 
7.2 Hz, 2 H, CH2NO2), 3.95-3.92 (m, 1 H, CHCH2NO2), 2.98-2.92 (m, 1 H, 
C3H7CHH), 2.02-1.96 (m, 1 H, C4H9CH), 1.87-1.81 (m, 1 H, C3H7CHH), 1.48-1.37 
(m, 4 H, CH3C2H4), 0.93 (t, J = 7.2 Hz, 3 H, CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 171.1 (C=O), 141.5 (CAr), 135.8 (CAr), 130.1 (CAr), 
128.7 (CAr), 124.6 (CAr), 120.9 (CHAr), 114.9 (CHAr), 114.7 (CHAr), 101.7 (CHAr), 
76.8 (CH2NO2), 50.6 (C4H9CH), 37.1 (CHCH2NO2), 30.9 (C3H7CH2), 28.4 
(C2H5CH2), 22.5 (CH3CH2), 13.8 (CH3) ppm. 
MS (EI, 70 eV) m/z (%):322.2 [M+2] (17), 320.2 [M
+
] (50), 273.2 (32), 217.1 (100). 
IR (ATR): 3448, 2926, 2861, 1740, 1558, 1451, 1382, 1169, 1061, 875, 806, 654 
cm
-1
. 
HRMS (ESI): calcd for C16H17ClN2O3 [M+H]
+
: 321.1000; found: 321.0996. 
GP 2 and analytical data for the derivatization of product (166a) 
tert-Butyl(((1S,2R)-2-benzyl-3-oxo-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)meth
yl)carbamate (175a) 
Experimental Part 
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To a suspension of 166a (64 mg, 0.2 mmol, 1 equiv.), NiCl2
.
H2O (29 mg, 0.2 mmol, 1 
equiv.) in 3 mL MeOH was carefully added NaBH4 (0.497 g, 13.14 mmol, 5 equiv.) 
and stirred at 0 °C for 1 h. The mixture was then quenched with sat. NH4Cl and 
extracted with DCM (3×20 mL). The combined organic layers were washed with 
brine and dried over MgSO4. The residue was concentrated to yield a yellow oil. 
Subsequently, the crude intermediate was dissolved in DCM at 0 °C, followed by the 
addition of NEt3 (40 mg, 0.4 mmol) and Boc anhydride (48 mg, 0.22 mmol). After 3 h 
stirring at room temperature the mixture was quenched with water and extracted with 
DCM (3×20 mL). The organic layer was washed with water and brine, dried over 
MgSO4 and concentrated. The residue was then purified by flash column 
chromatography (n-pentane:Et2O = 5:1) to yield 175a as an colorless oil. 
Yield: 51% (40 mg) 
TLC: Rf = 0.50 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
24  = –92.4 (c = 1.15, CHCl3) 
dr: >20:1 
ee: >99% 
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 7.46 min (major), 8.59 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.08 (d, J = 8.4 Hz, 1 H, Ar-H), 7.51 (d, J = 7.8 Hz, 
1 H, Ar-H), 7.32-7.22 (m, 7 H, Ar-H), 6.27 (s, 1H, Ar-H), 4.41 (s, 1 H, N-H), 
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3.43-3.40 (m, 1 H, CHHNHBoc), 3.35-3.33 (m, 2H, BnCH and CHCH2NHBoc), 
3.24-3.20 (m, 2 H, CHHNHBoc and BnCHH), 3.04 (dd, J = 13.2 Hz, 8.4 Hz, 1 H, 
BnCHH), 1.41 (s, 9 H,3xCH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 172.3 (C=O), 155.8 (CAr), 143.3 (CAr), 137.7, 
135.0 (CAr), 130.4 (CAr), 129.2 (2C, CHAr), 128.8 (2C, CHAr), 127.0 (CHAr), 124.2 
(CHAr), 123.7 (CHAr), 120.7 (CHAr), 113.9 (CHAr), 100.7 (CHAr), 79.8 (CO2CMe3), 
52.4 (CH2NHBoc), 43.0 (BnCH), 38.6 (CHCH2NHBoc), 36.4 (PhCH2), 28.3 (CH3) 
ppm. 
MS (EI, 70 eV) m/z (%):390.1 [M
+
] (64), 334.0 (100), 272.7 (65), 169.2 (43), 91.2 
(28). 
IR (ATR): 3420, 2924, 2534, 2307, 2199, 1714, 1588, 1448, 1386, 1041, 635 cm
-1
. 
HRMS (ESI): calcd for C24H26 N2O3 [M+Na]
+
: 413.1836; found: 413.1835. 
GP 3 and analytical data for further derivatization of product (166a) 
(1R,3aS,4R)-4-Benzyl-1-ethyl-2,3,3a,4-tetrahydrobenzo[b]pyrido[3,4,5-gh]pyrroli
zin-5(1H)-one (176a) 
 
To a suspension of 166a (250 mg, 0.78 mmol, 1 equiv.), NiCl2.H2O (222 mg, 0.94 
mmol, 1.2 equiv.) in 3 mL MeOH was carefully added NaBH4 (144 mg, 3.9 mmol, 5 
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equiv.) and stirred at 0 °C for 1 h. The mixture was then quenched with sat. NH4Cl 
and extracted with DCM (3×40 mL). The combined organic layers were washed with 
brine, dried over MgSO4 and concentrated to give a yellow oil. Subsequently, the 
crude intermediate was dissolved in a solution of propanal in CH2Cl2, followed by 
adding TFA (0.06 mL). The mixture was stirred for 24 h at room temperature. The 
solution was quenched with sat. NaHCO3 and extracted with CH2Cl2 (3×30 mL). The 
combined organic phases were dried over MgSO4. After filtered and concentrated, the 
residue was purified by flash column chromatography (DCM:MeOH =30:1) to yield 
176a as an brown syrup. 
Yield: 76% (195 mg, 0.59 mmol) 
TLC: Rf = 0.30 (DCM:MeOH =10:1) 
Optical rotation: [α]
D
24  = +167.4 (c = 1.00, CHCl3) 
dr: >20:1 
ee: 97% 
HPLC: Daicel AD, n-heptane:EtOH = 9:1, 1.0 mL/min, tR = 11.15 min (major), 16.44 
min (minor). 
1
H NMR (400 MHz, CDCl3): δ = 7.94-7.91 (m, 1 H, Ar-H), 7.42-7.40 (m, 1 H, Ar-H), 
7.34-7.24 (m, 7 H, Ar-H), 4.02-3.98 (m, 1H, EtCHNH), 3.42 (dd, J = 12.8 Hz, 3.2 Hz, 
1 H,NHCH2CH), 3.07-2.90 (m, 4 H, NHCH2 and PhCH2), 2.15 (dd, J = 12.0 Hz, 9.6 
Hz, 1 H, BnCH), 2.04-1.97 (m, 1 H, CH3CHH), 1.80-1.71 (m, 1 H, CH3CHH) ppm, 
1.73 (t, J = 7.2 Hz, 3H, CH3CH2) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 171.8 (C=O), 145.7 (CAr), 138.5 (CAr), 134.5 (CAr), 
133.2 (CAr), 128.8 (4C, CHAr), 126.8 (CHAr), 124.2 (CHAr), 123.4 (CHAr), 119.5 
(CHAr), 114.9 (CHAr), 56.5 (NHCH2), 54.9 (EtCHNH), 48.9 (BnCH), 37.4 
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(NHCH2CH), 36.1(PhCH2), 28.8 (CH3CH2), 10 (CH3) ppm. 
MS (EI, 70 eV) m/z (%):330.5 [M
+
] (3), 301.0 (57), 209.9 (100). 
IR (ATR): 3344, 3051, 2925, 2867, 1737, 1661, 1602, 1447, 1325, 1137, 743 cm
-1
. 
HRMS (ESI): calcd for C22H22N2O [M+H]
+
: 331.1805; found: 331.1804. 
General procedure 4 and analytical data for the synthesis of 
benzothiazolopyrimidinones (168) 
To a oven-dried and argon-filled Schlenk flask was added  2-benzothiazolimine 167 
(0.5 mmol, 1.0 equiv.), α-chloroaldehyde 79 (1.0 mmol, 2.0 equiv.), triazolium salt 
100b (0.05 mmol, 10 mol%) and DABCO (1.1 mmol, 2.2 equiv.) in toluene (5 ml). 
The mixture was stirred at room temperature and monitored by TLC until completion 
of the reaction. The solution was directly purified by flash chromatography on silica 
gel (n-pentane:Et2O = 10:1) to afford the products 168a-n. 
(2S,3S)-3-Benzyl-2-phenyl-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4(3H)-one 
(168a) 
 
The compound 168a was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a colorless 
solid. 
Yield: 63% (116 mg) 
Melting point: 154-155 
o
C 
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TLC: Rf = 0.50 (n-pentane:Et2O = 4:1) 
Optical rotation: [α]
D
22
 = +163.8 (c = 1.0, CHCl3) 
dr: >20:1 
ee: 90% 
HPLC: Daicel IC, n-heptane:i-PrOH = 9:1, 0.5 mL/min, tR = 8.85 min (major), 10.43 
min (minor).  
1
H NMR (600 MHz, CDCl3) δ = 8.26 (dd, J = 8.1, 1.2 Hz, 1H, Ar-H), 7.39 (d, J = 4.3 
Hz, 4H, Ar-H), 7.36 - 7.31 (m, 2H, Ar-H), 7.29 - 7.26 (m, 1H, Ar-H), 7.24 - 7.15 (m, 
4H, Ar-H), 7.02 - 6.88 (m, 2H, Ar-H), 5.03 (d, J = 5.8 Hz, 1H, PhCH), 3.31 (ddd, J = 
7.9, 6.6, 5.8 Hz, 1H, PhCH2CH), 3.00 (dd, J = 14.5, 7.9 Hz, 1H, PhCHHCH), 2.56 (dd, 
J = 14.5, 6.6 Hz, 1H, PhCHHCH) ppm. 
13
C NMR (150 MHz, CDCl3) δ = 169.62 (C=O), 155.83 (NCS), 138.05 (CAr), 137.69 
(CAr), 135.62 (CAr), 128.82 (4C, CHAr), 128.39 (2C, CHAr), 127.90 (CHAr), 127.36 
(2C, CHAr), 126.55 (CHAr), 126.50 (CHAr), 125.62 (CHAr), 123.16 (CAr), 121.75 
(CHAr), 116.76 (CHAr), 62.47 (PhCH), 47.38 (PhCH2CH), 31.04 (PhCH2CH) ppm. 
MS (EI, 70 eV) m/z (%): 370 [M
+
] (95), 279 (33), 239 (28), 238 (58), 237 (100).  
IR (ATR): 3034, 2928, 1709, 1642, 1453, 1301, 1176, 1014, 913, 865, 745, 697 cm
-1
.  
CHN-Elemental Analysis: C23H18N2OS (370) 
Anal. calcd. : C, 74.57; H, 4.90; N, 7.56 
found: C, 74.42; H, 4.91; N, 7.44 
(2S,3S)-3-Benzyl-2-(p-tolyl)-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4(3H)-one 
(168b) 
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The compound 168b was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) as a colorless solid.  
Yield: 49% (94 mg) 
Melting point: 141-142 
o
C 
TLC: Rf = 0.50 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +241.7 (c = 1.0, CHCl3) 
dr: >20:1 
ee: 99% 
HPLC: Daicel IA, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 11.14 min (minor), 11.91 
min (major). 
1
H NMR (600 MHz, CDCl3) δ = 8.26 (dd, J = 8.2, 1.2 Hz, 1H, Ar-H), 7.33 (dd, J = 
7.7, 1.4 Hz, 1H, Ar-H), 7.25 (ddd, J = 6.8, 4.5, 2.1 Hz, 3H, Ar-H), 7.23 - 7.15 (m, 6H, 
Ar-H), 6.98 (dd, J = 6.9, 1.8 Hz, 2H, Ar-H), 4.97 (d, J = 5.9 Hz, 1H, ArCH), 3.30 (td, 
J = 7.3, 6.2 Hz, 1H, PhCH2CH), 3.02 (dd, J = 14.4, 7.6 Hz, 1H, PhCHHCH), 2.56 (dd, 
J = 14.5, 6.8 Hz, 1H, PhCHHCH), 2.36 (s, 3H, CH3) ppm. 
13
C NMR (150 MHz, CDCl3) δ = 169.71 (C=O), 155.62 (NCS), 138.20 (CAr), 137.61 
(CAr), 135.64 (CAr), 134.51 (CAr), 129.49 (2C, CHAr), 128.83 (2C, CHAr), 128.38 (2C, 
CHAr), 127.25 (2C, CHAr), 126.51 (CHAr), 126.46 (CHAr), 125.57 (CHAr), 123.19 
(CAr), 121.73 (CHAr), 116.72 (CHAr), 62.29 (ArCH), 47.33 (PhCH2CH), 31.02 
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(PhCH2CH), 21.13 (CH3) ppm.  
MS (EI, 70 eV) m/z (%):384 [M
+
] (19), 293 (24), 252 (45), 251 (100), 131 (22), 91 
(78).  
IR (ATR): 3025, 2930, 1713, 1641, 1506, 1456, 1301, 1174, 1018, 923, 857, 803, 741, 
697 cm
-1
.  
HRMS (ESI): calcd for C24H20N2OS [M+H]
+
: 385.1369; found: 385.1371. 
(2S,3S)-3-Benzyl-2-(4-methoxyphenyl)-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4(
3H)-one (168c) 
 
The compound 168c was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a yellow solid.  
Yield: 34% (68 mg) 
Melting point: 149-150 
o
C 
TLC: Rf = 0.40 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +167.4 (c = 0.5, CHCl3) 
dr: 4:1 
ee: 87% 
HPLC: Daicel IA, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 14.96 min (minor), 17.15 
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min (major). 
1
H NMR (600 MHz, CDCl3) δ = 8.26 (dt, J = 8.2, 1.2 Hz, 1H, Ar-H), 7.29 - 7.24 (m, 
4H, Ar-H), 7.21 (tt, J = 9.9, 2.7 Hz, 4H, Ar-H), 7.03 - 6.96 (m, 2H, Ar-H), 6.95 - 6.87 
(m, 2H, Ar-H), 4.95 (d, J = 5.9 Hz, 1H, ArCH), 3.82 (s, 3H, OCH3), 3.30 (q, J = 6.9 
Hz, 1H, PhCH2CH), 3.05 (dd, J = 14.5, 7.6 Hz, 1H, PhCHHCH), 2.55 (dd, J= 14.5, 
6.9 Hz, 1H, PhCHHCH) ppm.  
13
C NMR (150 MHz, CDCl3) δ = 169.72 (C=O), 159.25 (CAr), 155.57 (NCS), 138.21 
(CAr), 135.63 (CAr), 131.35 (CAr), 128.82 (2C, CHAr), 128.53 (2C, CHAr), 128.41 (2C, 
CHAr), 126.52 (CHAr), 126.48 (CHAr), 125.58 (CHAr), 123.17 (CAr), 121.74 (CHAr), 
116.71 (CHAr), 114.19 (2C, CHAr), 61.97 (ArCH), 55.28 (OCH3), 47.35 (PhCH2CH), 
31.01 (PhCH2CH) ppm.  
MS (EI, 70 eV) m/z (%):400 [M
+
] (22), 308 (35), 268 (88), 267 (96), 135 (100), 91 
(43).  
IR (ATR): 3064, 3024, 2928, 2842, 1715, 1638, 1509, 1455, 1293, 1246, 1173, 1028, 
911, 826, 743, 697 cm
-1
.  
HRMS (ESI): calcd for C24H20N2O2S [M+Na]
 +
: 423.1138; found: 423.1131. 
(2S,3S)-3-Benzyl-2-(4-bromophenyl)-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4(3
H)-one (168d) 
 
The compound 168d was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a colorless 
solid.  
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Yield: 56% (125 mg) 
Melting point: 167-168 
o
C 
TLC: Rf = 0.50 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +164.5 (c = 1.0, CHCl3) 
dr: 11:1 
ee: 91% 
HPLC: Daicel IA, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 12.98 min (minor), 15.30 
min (major). 
1
H NMR (400 MHz, CDCl3) δ = 8.30 - 8.10 (m, 1H, Ar-H), 7.59 - 7.07 (m, 10H, 
Ar-H), 6.92 (dd, J = 7.4, 2.0 Hz, 2H, Ar-H), 4.98 (d, J = 5.6 Hz, 1H, ArCH), 3.25 (ddd, 
J = 8.0, 6.5, 5.6 Hz, 1H, PhCH2CH), 2.93 (dd, J = 14.4, 8.0 Hz, 1H, PhCHHCH), 2.52 
(dd, J = 14.4, 6.6 Hz, 1H, PhCHHCH) ppm. 
13
C NMR (100 MHz, CDCl3) δ = 169.32 (C=O), 156.21 (NCS), 137.62 (CAr), 136.92 
(CAr), 135.51 (CAr), 131.88 (2C, CHAr), 129.04 (2C, CHAr), 128.76 (2C, CHAr), 128.43 
(2C, CHAr), 126.65 (CHAr), 126.57 (CHAr), 125.74 (CHAr), 123.04 (CAr), 121.78 
(CHAr), 121.75 (CHAr), 116.80 (CHAr), 61.75 (ArCH) , 47.24 (PhCH2CH), 31.03 
(PhCH2CH) ppm. 
MS (EI, 70 eV) m/z (%):450 [M+2] (50), 448 [M
+
] (44), 359 (35), 357 (34), 318 (76), 
317 (100), 316 (67), 315 (78), 135 (24), 91 (19). 
IR (ATR): 3027, 2926, 1714, 1638, 1582, 1485, 1458, 1299, 1180, 1004, 914, 858, 
801, 746, 694 cm
-1
. 
HRMS (ESI): calcd for C23H17BrN2OS [M+Na]
+
: 471.0137; found: 471.0138. 
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(2S,3S)-3-Benzyl-2-(4-chlorophenyl)-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4- 
(3H)-one (168e) 
 
The compound 168e was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a colorless 
solid.  
Yield: 61% (123 mg) 
Melting point: 162-163 
o
C 
TLC: Rf = 0.50 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +166.0 (c = 1.0, CHCl3) 
dr: 11:1 
ee: 89% 
HPLC: Daicel AD, n-heptane:EtOH = 9:1, 1.0 mL/min, tR = 12.07min (minor), 14.44 
min (major). 
1
H NMR (600 MHz, CDCl3) δ = 8.24 (dd, J = 8.1, 1.2 Hz, 1H, Ar-H), 7.49 - 7.12 (m, 
10H, Ar-H), 7.04 - 6.83 (m, 2H, Ar-H), 5.01 (d, J = 5.6 Hz, 1H, ArCH), 3.35 - 3.20 (m, 
1H, ArCH2CH), 2.95 (dd, J = 14.4, 8.0 Hz, 1H, PhCHHCH), 2.53 (dd, J = 14.5, 6.6 
Hz, 1H, PhCHHCH) ppm.  
13
C NMR (150 MHz, CDCl3) δ = 169.35 (C=O), 156.24 (NCS), 137.66 (CAr), 136.38 
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(CAr), 135.53 (CAr), 133.65 (CAr), 128.95 (2C, CHAr), 128.77 (2C, CHAr), 128.72 (2C, 
CHAr), 128.44 (2C, CHAr), 126.66 (CHAr), 126.59 (CHAr), 123.06 (CAr), 125.75 
(CHAr), 121.79 (CHAr), 116.81 (CHAr), 61.71 (ArCH), 47.30 (PhCH2CH), 31.03 
(PhCH2CH) ppm.  
MS (EI, 70 eV) m/z (%): 406 [M+2] (33), 404 [M
+
] (83), 313 (35), 274 (30), 272 (89), 
270 (100), 135 (33), 91 (90).  
IR (ATR): 3062, 2933, 1714, 1638, 1463, 1301, 1177, 1093, 1009, 923, 852, 808, 740, 
696 cm
-1
. 
CHN-Elemental Analysis: C23H17ClN2OS (404) 
Anal. calcd. : C, 68.22; H, 4.23; N, 6.92 
found: C, 68.42; H, 4.15; N, 6.56 
(2S,3S)-3-Benzyl-2-(2-chlorophenyl)-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4- 
(3H)-one 168f 
 
The compound 168f was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a light yellow 
solid.  
Yield: 60% (121 mg) 
Melting point: 170-171 
o
C 
TLC: Rf = 0.40 (n-pentane:Et2O = 2:1) 
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Optical rotation: [α]
D
22  = +253.8 (c = 1.0, CHCl3) 
dr: >20:1 
ee: 97% 
HPLC: Daicel OJ, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 13.20 min (major), 17.14 
min (minor). 
1
H NMR (400 MHz, CDCl3) δ = 7.88 - 7.66 (m, 2H, Ar-H), 7.42 - 7.35 (m, 2H, Ar-H), 
7.33 - 7.24 (m, 4H, Ar-H), 7.23 - 7.16 (m, 3H, Ar-H), 7.07 - 6.93 (m, 2H, Ar-H), 5.93 
(d, J = 6.1 Hz, 1H, ArCH), 4.18 (ddd, J = 9.0, 6.8, 6.1 Hz, 1H, PhCH2CH), 2.75 (dd, J 
= 14.6, 9.0 Hz, 1H, PhCHHCH), 2.56 (dd, J = 14.6, 6.8 Hz, 1H, PhCHHCH) ppm. 
13
C NMR (100 MHz, CDCl3) δ = 166.70 (C=O), 149.30 (NCS), 137.18 (CAr), 133.28 
(CAr), 132.24 (CAr), 131.89 (CAr), 129.79 (CHAr), 129.51 (CHAr), 128.69 (2C, CHAr), 
128.38 (2C, CHAr), 127.75 (CHAr), 126.97 (CHAr), 126.58 (CHAr), 126.32 (CHAr), 
124.32 (CHAr), 122.68 (CHAr), 122.00 (CHAr), 121.36 (CHAr), 58.69 (ArCH), 56.38 
(ArCH2CH), 31.66 (ArCH2CH) ppm.  
MS (EI, 70 eV) m/z (%):406 [M+2] (7), 404 [M
+
] (19), 237 (100), 91 (22).  
IR (ATR): 3061, 2934, 1765, 1597, 1520, 1441, 1355, 1274, 1033, 899, 749, 668 
cm
-1
.  
HRMS (ESI): calcd for C23H17ClN2OS [M+Na]
+
: 427.0642; found: 427.0637. 
(2S,3S)-3-Benzyl-2-(furan-2-yl)-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4(3H)- 
one (168g) 
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The compound 168g was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a colorless 
solid.  
Yield: 69% (124 mg) 
Melting point: 52-53 
o
C 
TLC: Rf = 0.60 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +336.9 (c = 1.0, CHCl3) 
dr: 11:1 
ee: 93% 
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 10.76 min (minor), 13.45 
min (major).  
1
H NMR (400 MHz, CDCl3) δ = 8.41 - 8.27 (m, 1H, Ar-H), 7.34 (s, 1H, Ar-H), 7.32 - 
7.26 (m, 3H, Ar-H), 7.25 - 7.17 (m, 3H, Ar-H), 7.12 (d, J = 7.0 Hz, 2H, Ar-H), 6.37 - 
6.24 (m, 2H, Ar-H), 4.82 (d, J = 6.5 Hz, 1H, ArCH), 3.41 (dd, J = 14.3, 5.1 Hz, 1H, 
PhCH2CH), 3.32 (ddd, J = 9.1, 6.5, 5.1 Hz, 1H, PhCHHCH), 2.42 (dd, J = 14.3, 9.0 
Hz, 1H, PhCHHCH) ppm. 
13
C NMR (100 MHz, CDCl3) δ = 169.06 (C=O), 157.52 (NCS), 150.43 (CAr), 142.81 
(CHAr), 138.30 (CAr), 135.79 (CAr), 128.85 (2C, CHAr), 128.54 (2C, CHAr), 126.63 
(CHAr), 126.50 (CHAr), 125.47 (CHAr), 123.01 (CAr), 121.67 (CHAr), 116.72 (CHAr), 
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110.22 (CHAr), 109.12 (CHAr), 55.95 (ArCH), 45.24 (PhCH2CH), 30.99 (PhCH2CH) 
ppm. 
MS (EI, 70 eV) m/z (%):362 [M+2] (25), 361 [M+1] (72), 360 [M
+
] (100), 269 (50), 
228 (71), 200 (37), 187 (30), 91 (26). 
IR (ATR): 3028, 2927, 1719, 1633, 1462, 1301, 1172, 817, 740, 703 cm
-1
. 
HRMS (ESI): calcd for C21H17N2O2S [M+H]
+
: 361.1005; found: 361.1001. 
(2S,3S)-3-Benzyl-8-methyl-2-phenyl-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4- 
(3H)-one (168h) 
 
The compound 168h was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a colorless 
solid.  
Yield: 64% (123 mg) 
Melting point: 153-154 
o
C 
TLC: Rf = 0.50 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +150.9 (c = 1.0, CHCl3) 
dr: 20:1 
ee: 93% 
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HPLC: Daicel IC, n-heptane:i-PrOH = 9:1, 0.5 mL/min, tR = 10.54 min (major), 
12.31 min (minor). 
1
H NMR (400 MHz, CDCl3) δ = 8.11 (d, J = 8.4 Hz, 1H, Ar-H), 7.41- 7.27 (m, 5H, 
Ar-H), 7.22 - 7.10 (m, 4H, Ar-H), 7.09 - 7.00 (m, 1H, Ar-H), 7.00 - 6.87 (m, 2H, 
Ar-H), 5.00 (d, J = 5.8 Hz, 1H, PhCH), 3.28 (dt, J = 7.9, 6.3 Hz, 1H, ArCH2CH), 2.97 
(dd, J = 14.4, 7.9 Hz, 1H, ArCHHCH), 2.54 (dd, J = 14.4, 6.6 Hz, 1H, ArCHHCH), 
2.35 (s, 3H, CH3) ppm. 
13
C NMR (100 MHz, CDCl3) δ = 169.44 (C=O), 156.08 (NCS), 138.10 (CAr), 137.77 
(CAr), 135.65 (CAr), 133.36 (CAr), 128.81 (2C, CHAr), 128.78 (2C, CHAr), 128.36 (2C, 
CHAr), 127.84 (CHAr), 127.35 (2C, CHAr), 127.12 (CHAr), 126.51 (CHAr), 123.02 
(CAr), 122.09 (CHAr), 116.46 (CHAr), 62.47 (PhCH), 47.32 (ArCH2CH), 31.03 
(ArCH2CH), 21.12 (CH3) ppm.  
MS (EI, 70 eV) m/z (%):385 [M+1] (37), 384 [M
+
] (87), 293 (41), 253 (30), 252 (84), 
251 (100), 91 (25).  
IR (ATR): 3029, 2923, 1718, 1633, 1476, 1297, 1170, 910, 873, 819, 743, 699 cm
-1
.  
HRMS (ESI): calcd for C24H20N2OS [M+H]
+
: 385.1369; found: 385.1372. 
(2S,3S)-3-Benzyl-8-methoxy-2-phenyl-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4- 
(3H)-one (168i) 
 
The compound 168i was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a colorless 
solid. 
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Yield: 56% (111 mg) 
Melting point: 144-145 
o
C 
TLC: Rf = 0.60 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +131.0 (c = 1.0, CHCl3) 
dr: >20:1 
ee: 92% 
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 13.39 min (minor), 16.40 
min (major). 
1
H NMR (600 MHz, CDCl3) δ = 8.16 (d, J = 9.0 Hz, 1H, Ar-H), 7.41 - 7.28 (m, 5H, 
Ar-H), 7.22 - 7.14 (m, 3H, Ar-H), 6.97 - 6.93 (m, 2H, Ar-H), 6.89 (d, J = 2.6 Hz, 1H, 
Ar-H), 6.78 (dd, J = 9.0, 2.6 Hz, 1H, Ar-H), 5.02 (d, J = 5.8 Hz, 1H, PhCH), 3.82 (s, 
3H, OCH3), 3.28 (ddd, J = 7.9, 6.6, 5.7 Hz, 1H, ArCH2CH), 2.97 (dd, J = 14.5, 7.9 Hz, 
1H, ArCHHCH), 2.55 (dd, J = 14.4, 6.6 Hz, 1H, ArCHHCH) ppm. 
13
C NMR (150 MHz, CDCl3) δ = 169.25 (C=O), 157.47 (CAr), 156.04 (NCS), 138.10 
(CAr), 137.80 (CAr), 128.83 (2C, CHAr), 128.79 (2C, CHAr), 128.36 (2C, CHAr), 127.85 
(CHAr), 127.36 (2C, CHAr), 126.52 (CHAr), 124.44 (CAr), 117.54 (CHAr), 111.70 
(CHAr), 107.57 (CHAr), 104.56 (CHAr), 62.55 (PhCH), 55.71 (OCH3), 47.23 
(ArCH2CH), 31.03 (ArCH2CH) ppm. 
MS (EI, 70 eV) m/z (%): 401 [M+1] (32), 400 [M
+
] (93), 268 (100), 267 (89), 253 
(22), 91 (18). 
IR (ATR): 3061, 3027, 2964, 2841, 1713, 1641, 1595, 1479, 1328, 1255, 1175, 1027, 
916, 881, 827, 741, 696 cm
-1
. 
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CHN-Elemental Analysis: C24H20N2O2S (400) 
Anal. calcd. : C, 71.98; H, 5.03; N, 6.99 
found: C, 71.64; H, 5.17; N, 6.59 
(2S,3S)-3-Benzyl-8-chloro-2-phenyl-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4(3H)
-one (168j) 
 
The compound 168j was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a colorless 
solid. 
Yield: 78% (157 mg) 
Melting point: 63-64 
o
C 
TLC: Rf = 0.60 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +109.1 (c = 1.0, CHCl3) 
dr: 10:1 
ee: 91% 
HPLC: Daicel IC, n-heptane:EtOH = 7:3, 0.5 mL/min, tR = 18.59 min (minor), 20.67 
min (major). 
1
H NMR (400 MHz, CDCl3) δ = 8.16 (d, J = 8.8 Hz, 1H, Ar-H), 7.42 - 7.12 (m, 10H, 
Ar-H), 7.01 - 6.87 (m, 2H, Ar-H), 5.02 (d, J = 5.8 Hz, 1H, PhCH), 3.29 (ddd, J = 7.9, 
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6.5, 5.7 Hz, 1H, ArCH2CH), 2.95 (dd, J = 14.4, 7.9 Hz, 1H, ArCHHCH), 2.55 (dd, J = 
14.4, 6.6 Hz, 1H, ArCHHCH) ppm.
  
13
C NMR (100 MHz, CDCl3) δ = 169.44 (C=O), 155.12 (NCS), 137.82 (CAr), 137.47 
(CAr), 134.14 (CAr), 131.00 (CAr), 128.86 (2C, CHAr), 128.80 (2C, CHAr), 128.41 (2C, 
CHAr), 127.98 (CHAr), 127.28 (2C, CHAr), 126.63 (CHAr), 126.59 (CHAr), 124.95 
(CAr), 121.64 (CHAr), 117.46 (CHAr), 62.53 (PhCH), 47.29 (ArCH2CH), 31.03 
(ArCH2CH) ppm. 
MS (EI, 70 eV) m/z (%): 406 [M+2] (10), 404 [M
+
] (27), 274 (32), 273 (57), 272 (81), 
271 (100), 91 (90). 
IR (ATR): 3063, 3028, 2927, 1720, 1640, 1577, 1459, 1291, 1176, 1144, 1086, 908, 
865, 816, 736, 697 cm
-1
. 
HRMS (ESI): calcd for C23H17ClN2OS [M+Na]
+
: 427.0642; found: 427.0640. 
(2S,3S)-3-Benzyl-8-fluoro-2-phenyl-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4(3H)
-one (168k) 
 
The compound 168k was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a colorless 
solid. 
Yield: 71% (138 mg) 
Melting point: 55-56 
o
C 
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TLC: Rf = 0.60 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +126.4 (c = 1.0, CHCl3) 
dr: 17:1 
ee: 89% 
HPLC: Daicel IA, n-heptane:EtOH = 7:3, 0.5 mL/min, tR = 16.22 min (minor), 17.76 
min (major). 
1
H NMR (400 MHz, CDCl3) δ = 8.21 (dd, J = 9.1, 4.8 Hz, 1H, Ar-H), 7.40 - 7.31 (m, 
5H, Ar-H), 7.22 - 7.13 (m, 3H, Ar-H), 7.06 (dd, J = 7.7, 2.6 Hz, 1H, Ar-H), 6.94 (dd, J 
= 7.2, 1.6 Hz, 3H, Ar-H), 5.02 (d, J = 5.8 Hz, 1H, PhCH), 3.29 (ddd, J = 7.8, 6.6, 5.8 
Hz, 1H, ArCH2CH), 2.95 (dd, J = 14.4, 7.8 Hz, 1H, ArCHHCH), 2.55 (dd, J = 14.3, 
6.6 Hz, 1H, ArCHHCH) ppm.  
13
C NMR (100 MHz, CDCl3) δ = 169.40 (C=O), 160.08 (d, J = 246.4 Hz, CAr), 
155.46 (NCS), 137.71 (d, J = 35.8 Hz, CAr), 131.88 (CAr), 131.40 (CAr), 128.85 (2C, 
CHAr), 128.81 (2C, CHAr), 128.40 (2C, CHAr), 127.95 (CHAr), 127.31 (2C, CHAr), 
126.60 (CHAr), 124.90 (d, J = 9.9 Hz, CAr), 117.74 (d, J = 8.3 Hz, CHAr), 113.24 (d, J 
= 22.9 Hz, CHAr), 109.31 (d, J = 27.3 Hz, CHAr), 62.55 (PhCH), 47.22(ArCH2CH), 
31.03 (ArCH2CH) ppm. 
MS (EI, 70 eV) m/z (%):388 [M
+
] (66), 257 (26), 256 (86), 255 (100).  
IR (ATR): 3062, 3030, 2928, 2856, 1719, 1640, 1592, 1471, 1221, 1164, 899, 852, 
749, 698 cm
-1
. 
HRMS (ESI): calcd for C23H17FN2OS [M+Na]
+
: 411.0938; found: 427.0934. 
(2S,3S)-3-Butyl-2-phenyl-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4(3H)-one 
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(168l) 
 
The compound 168l was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a a yellow oil. 
Yield: 51% (86 mg) 
TLC: Rf = 0.50 (n-Pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +47.9 (c = 1.0, CHCl3) 
dr: 17:1 
ee: 87% 
HPLC: Daicel IC, n-heptane:i-PrOH = 9:1, 0.7 mL/min, tR = 4.90 min (minor), 5.41 
min (major). 
1
H NMR (400 MHz, CDCl3) δ = 8.32 (dd, J = 8.1, 1.3 Hz, 1H, Ar-H), 7.42 - 7.31 (m, 
5H, Ar-H), 7.31 - 7.18 (m, 3H, Ar-H), 5.05 (d, J = 5.2 Hz, 1H, PhCH), 2.93 - 2.78 (m, 
1H,C4H9CH), 1.57 - 1.46 (m, 1H, C3H7CHH), 1.30 - 1.16 (m, 4H,CH3C2H4), 0.92 - 
0.84 (m, 1H, C3H7CHH), 0.75 (t, J = 7.1 Hz, 3H, CH3) ppm. 
13
C NMR (100 MHz, CDCl3) δ = 170.66 (C=O), 155.64 (NCS), 138.30 (CAr), 135.78 
(CAr), 128.57 (2C, CHAr), 127.51, 127.12 (2C, CHAr), 126.45 (CHAr), 125.58 (CHAr), 
123.32 (CAr), 121.76 (CHAr), 116.90 (CHAr), 62.57 (PhCH), 45.77(C4H9CH), 29.28 
(C3H7CH2), 24.15 (C2H5CH2), 22.35(CH3CH2), 13.71(CH3) ppm. 
Experimental Part 
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MS (EI, 70 eV) m/z (%):336 [M
+
] (24), 334 (43), 292 (29), 291 (100), 254 (25), 237 
(37), 105 (63), 77 (30). 
IR (ATR): 3891, 3775, 3383, 3118, 2624, 2441, 2287, 2184, 2099, 1949, 1587, 1464, 
1269, 1178, 1108, 933, 802, 720. 
HRMS (ESI): calcd for C20H20N2OS [M+H]
+
: 337.1369; found: 337.1369. 
(2S,3S)-3-(4-Nitrobenzyl)-2-phenyl-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4(3H)
-one (168m) 
 
The compound 168m was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a colorless 
solid. 
Yield: 69% (143 mg) 
Melting point: 186-187 
o
C 
TLC: Rf = 0.30 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = +110.4.1 (c = 0.5, CHCl3) 
dr: 13:1 
ee: 92% 
Experimental Part 
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HPLC: Daicel IC, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 27.73 min (major), 39.53 
min (minor). 
1
H NMR (400 MHz, CDCl3) δ = 8.21 (dd, J = 7.8, 1.6 Hz, 1H, Ar-H), 8.02 (d, J = 8.4 
Hz, 2H, Ar-H), 7.42 – 7.30 (m, 6H, Ar-H), 7.25 (ddd, J = 9.0, 7.5, 1.6 Hz, 2H, Ar-H), 
7.10 (d, J = 8.2 Hz, 2H, Ar-H), 5.05 (d, J = 5.7 Hz, 1H, PhCH), 3.30 (dt, J = 8.4, 5.8 
Hz, 1H, ArCH2CH), 2.96 (dd, J = 14.4, 8.3 Hz, 1H, ArCHHCH), 2.67 (dd, J = 14.4, 
5.9 Hz, 1H, ArCHHCH) ppm.  
13
C NMR (100 MHz, CDCl3) δ = 168.95 (C=O), 155.88 (NCS), 146.71 (CAr), 146.09 
(CAr), 137.39 (CAr), 135.34 (CAr), 129.74 (2C, CHAr), 128.97 (2C, CHAr), 128.13 
(CHAr), 127.19 (2C, CHAr), 126.65 (CHAr), 125.95 (CHAr), 123.57 (2C, CHAr), 123.09 
(CAr), 121.88 (CHAr), 116.82 (CHAr), 62.44 (ArCH), 47.18 (ArCH2CH), 31.27 
(ArCH2CH) ppm. 
MS (EI, 70 eV) m/z (%):415 [M
+
] (36), 238 (49), 237 (100).  
IR (ATR): 3064, 2926, 2849, 1707, 1650, 1448, 1338, 1276, 1176, 1105, 854, 748, 
702 cm
-1
.  
HRMS (ESI): calcd for C23H17N3O3S [M+H]
+
: 416.1063; found: 416.1063. 
(1S,2S)-1-(Benzo[d]thiazol-2-ylamino)-2-benzyl-1H-pyrrolo[1,2-a]indol-3(2H)-on
e (168n) 
 
The compound 168n was prepared according to GP 4. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a brown solid. 
Experimental Part 
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Yield: 45% (91 mg) 
Melting point: 78-79 
o
C 
TLC: Rf = 0.40 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
22
 = -76.2 (c = 0.5, CHCl3) 
dr: 11:1 
ee: 93% 
HPLC: Daicel IA, n-heptane:EtOH = 7:3, 0.7 mL/min), tR = 10.10 min (minor), 12.19 
min (major). 
1
H NMR (400 MHz, CDCl3) δ = 8.07 (dq, J = 8.0, 0.9 Hz, 1H, Ar-H), 7.57 (ddd, J = 
8.4, 7.2, 1.1 Hz, 2H, Ar-H), 7.47 (dt, J = 7.6, 1.0 Hz, 1H, Ar-H), 7.39 - 7.26 (m, 5H, 
Ar-H), 7.24 - 7.11 (m, 4H, Ar-H), 6.45 (d, J = 1.0 Hz, 1H, Ar-H), 5.51 (s, 1H, N-H), 
5.43 (dd, J = 4.2, 1.4 Hz, 1H, N-CH), 3.51 - 3.44 (m, 2H, PhCH2), 3.37 (dd, J = 15.4, 
8.2 Hz, 1H, BnCH) ppm.  
13
C NMR (100 MHz, CDCl3) δ = 170.56 (C=O), 164.85 (NCS), 151.99 (CAr), 141.23 
(CAr), 137.06 (CAr), 134.60 (CAr), 130.96 (CAr), 130.37 (CAr), 129.49 (2C, CHAr), 
128.70 (2C, CHAr), 126.98 (CHAr), 126.08 (CHAr), 124.44 (CHAr), 124.39 (CHAr), 
122.38 (CHAr), 121.32 (CHAr), 120.87 (CHAr), 119.66 (CHAr), 114.09 (CHAr), 102.52 
(CHAr), 56.74 (N-CH), 52.09 (BnCH), 35.20 (PhCH2) ppm. 
MS (ESI) m/z (%):410.1314 [M+H], 432.1132 [M+Na].  
IR (ATR): 2932, 2564, 2176, 2026, 1736, 1616, 1537, 1447, 1365, 1215, 1133, 1018, 
935, 747, 699.  
HRMS (ESI): calcd for C25H19N3OS [M+Na]
+
: 432.1141; found: 432.1130. 
Experimental Part 
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General procedure 5 and analytical data for the synthesis of 
3,4-dihydropyrano[3,2-b]indol-2-ones (170) 
To a dried and argon-filled Schlenk tube was added 1-acetylindolin-3-one (169) (0.5 
mmol, 1.0 equiv.), 2-bromoaldehyde (108) (0.6 mmol, 1.2 equiv.), triazolium salt 16d 
(0.05 mmol, 10 mol%) and TMEDA (0.55 mmol, 1.1 equiv.) in 5 mL mesitylene. The 
mixture was stirred at room temperature and monitored by TLC until completion of 
the reaction. After purification by column chromatography on silica gel 
(n-pentane:Et2O = 3:1) the desired product 170 was obtained as a solid. 
(S)-5-Acetyl-4-phenyl-3,4-dihydropyrano[3,2-b]indol-2(5H)-one (170a) 
 
The compound 170a was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a colorless 
solid. 
Yield: 68% (104 mg) 
Melting point: 162-163 ºC 
TLC: Rf = 0.30 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25
 = +223.7 (c = 1.0, CHCl3) 
ee: 92% 
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 1.0 mL/min, tR = 6.74 min (minor), 8.01 
Experimental Part 
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min (major). 
1
H NMR (600 MHz, CDCl3): δ = 7.92 (d, J = 8.4 Hz, 1 H, Ar-H), 7.70 (d, J = 7.8 Hz, 
1 H, Ar-H), 7.42-7.22 (m, 5 H, Ar-H), 7.13 (d, J = 7.2 Hz, 2 H, Ar-H), 5.08 (d, J = 6.6 
Hz, 1 H, CH2CH), 3.34 (dd, J = 16.2 Hz, 7.8 Hz , 1 H, CHHCH), 3.02 (dd, J = 16.2 
Hz, 1.2 Hz , 1 H, CHHCH), 2.61 (s, 3 H, COCH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 169.0 (COCH3), 166.3 (COO), 140.3 (CAr), 138.4 
(CAr), 133.8 (CAr), 129.3 (2C, CHAr), 127.8 (CHAr), 126.7 (2C, CHAr), 126.0 (CHAr), 
123.8 (CHAr), 120.8 (AcNC), 119.8 (CO2C), 117.6 (CHAr), 115.3 (CHAr), 38.4 
(CHCH2), 38.3 (CHCH2), 26.9 (COCH3) ppm.  
MS (EI, 70 eV) m/z (%): 305 [M
+
] (93), 263 (88), 221 (100), 220 (79).  
IR (ATR): 3084, 3025, 2941, 2085, 1772, 1694, 1366, 1299, 1211, 1124, 991, 881, 
838, 750, 702, 661 cm
-1
. 
CHN-Elemental Analysis: C19H15NO3 (305) 
Anal. calcd. : C, 74.74; H, 4.95; N, 4.59 
found: C, 74.82; H, 5.20; N, 4.24 
(S)-5-Acetyl-7-chloro-4-phenyl-3,4-dihydropyrano[3,2-b]indol-2(5H)-one (170b) 
 
The compound 170b was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a colorless 
solid. 
Yield: 72% (123 mg) 
Experimental Part 
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Melting point: 116-117 ºC 
TLC: Rf = 0.30 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25  = +103.5 (c = 1.0, CHCl3) 
ee: 89% 
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 9.06 min (minor), 12.01 
min (major). 
1
H NMR (600 MHz, CDCl3): δ = 8.05 (s, 1 H, Ar-H), 7.60 (d, J = 8.4 Hz, 1 H, Ar-H), 
7.35 (dd, J = 8.4 Hz, 1.2 Hz, 1 H, Ar-H), 7.32-7.25 (m, 3H, Ar-H), 7.10 (d, J = 7.2 Hz, 
2 H, Ar-H), 5.01 (d, J = 6.6 Hz, 1 H, CH2CH), 3.35 (dd, J = 15.6 Hz, 7.8 Hz, 1 H, 
CHHCH), 3.04 (dd, J = 15.6 Hz, 1.2 Hz, 1 H, CHHCH), 2.57 (s, 3 H, COCH3) ppm.  
13
C NMR (150 MHz, CDCl3): δ = 168.7 (COCH3), 165.8 (COO), 139.9 (CAr), 138.1 
(CAr), 134.2 (CAr), 132.2 (CAr), 129.5 (2C, CHAr), 128.0 (CHAr), 126.6 (2C, CHAr), 
124.5 (CHAr), 119.9 (AcNC), 119.1 (CO2C), 118.2 (CHAr), 116.0 (CHAr), 38.4 
(CHCH2), 38.3 (CHCH2), 26.7 (COCH3) ppm. 
MS (EI, 70 eV) m/z (%): 341 [M+2] (26), 339 [M
+
] (68), 297 (96), 299 (37), 255 
(100), 254 (87), 243 (14). 
IR (ATR): 3025, 1772, 1708, 1621, 1473, 1289, 1211, 1153, 1013, 906, 821, 742, 701 
cm
-1
.  
CHN-Elemental Analysis: C19H14ClNO3 (339) 
Anal. calcd. : C, 67.16; H, 4.15; N, 4.12 
found: C, 66.61; H, 3.89; N, 4.02 
(S)-5-Acetyl-7-fluoro-4-phenyl-3,4-dihydropyrano[3,2-b]indol-2(5H)-one (170c) 
Experimental Part 
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The compound 170c was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a colorless 
solid. 
Yield: 62% (100 mg) 
Melting point: 122-123 ºC 
TLC: Rf = 0.30 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25  = +167.3 (c = 1.0, CHCl3) 
ee: 93% 
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 8.57 min (minor), 11.09 
min (major).  
1
H NMR (600 MHz, CDCl3): δ = 7.78 (dd, J = 10.2 Hz,1.8 Hz , 1 H, Ar-H), 7.62 (dd, 
J = 9.0 Hz, 6.0 Hz, 1 H, Ar-H), 7.32-7.25 (m, 3 H, Ar-H), 7.15-7.10 (m, 3 H, Ar-H), 
5.00 (dd, J = 7.8 Hz, 1.2 Hz, 1 H, CH2CH), 3.35 (dd, J = 15.6 Hz, 7.8 Hz, 1 H, 
CHHCH), 3.03 (dd, J = 15.6 Hz, 1.2 Hz, 1 H, CHHCH), 2.55 (s, 3 H, COCH3) ppm.  
13
C NMR (150 MHz, CDCl3): δ = 168.8 (COCH3), 165.9 (COO), 162.6 (CAr), 160.9 
(CAr), 140.0 (CHAr), 138.2 (CAr), 134.1 (J = 48.6 Hz, CAr), 129.5 (2C, CHAr), 128.0 
(CHAr), 126.6 (2C, CHAr), 119.3 (AcNC), 118.2 (J = 39.6 Hz, CHAr), 117.0 (CO2C), 
112.2 (J = 97.2 Hz, CHAr), 103.6 (J = 117.6 Hz, CHAr), 38.5 (CHCH2), 38.4 (CHCH2), 
26.6 (COCH3) ppm.  
Experimental Part 
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MS (EI, 70 eV) m/z (%):323 [M
+
] (53), 322 (40), 280 (39), 281 (41), 239 (40), 
238(100), 237 (70).  
IR (ATR): 3206, 3053, 1767, 1617, 1477, 1296, 1133, 1014, 912, 824, 703 cm
-1
.  
CHN-Elemental Analysis: C19H14FNO3 (323) 
Anal. calcd. : C, 70.58; H, 4.36; N, 4.33 
found: C, 70.52; H, 4.37; N, 4.20 
(S)-5-Acetyl-4-phenyl-8-(trifluoromethyl)-3,4-dihydropyrano[3,2-b]indol-2(5H)-o
ne (170d) 
 
The compound 170d was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a pink solid. 
Yield: 67% (125 mg) 
Melting point: 155-156 ºC 
TLC: Rf = 0.20 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25
 = +148.8 (c = 1.0, CHCl3) 
ee: 67% 
HPLC: Daicel IC, n-heptane:EtOH = 9:1, 1.0 mL/min, tR = 4.73 min (minor), 5.98 
min (major) 
1
H NMR (600 MHz, CDCl3): δ = 8.12 (d, J = 9.0 Hz, 1 H, Ar-H), 8.00 (s, 1 H, Ar-H), 
Experimental Part 
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7.65 (dd, J = 9.0 Hz, 1.2 Hz, 1 H, Ar-H), 7.33-7.25 (m, 3 H, Ar-H), 7.11 (d, J = 7.8 Hz, 
2 H, Ar-H), 5.05 (d, J = 7.2 Hz, 1 H, CH2CH), 3.36 (dd, J = 15.6 Hz, 7.8 Hz, 1 H, 
CHHCH), 3.07 dd, J = 15.6 Hz, 1.2 Hz, 1 H, CHHCH), 2.62 (s, 3 H, COCH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 168.8 (COCH3), 165.5 (COO), 139.7 (CAr), 138.2 
(CAr), 135.2 (CAr), 129.5 (2C, CHAr), 128.1 (CHAr), 126.6 (2C, CHAr), 126.3 (q, J = 
274 Hz, CF3) ,125.0 (CHAr), 122.73 (q, J = 26.4 Hz, CAr), 121.3 (AcNC), 120.4 
(CO2C), 115.9 (CHAr), 115.15 (q, J = 31.8 Hz, CHAr), 38.5 (CHCH2), 38.3 (CHCH2), 
26.8 (COCH3) ppm. 
MS (EI, 70 eV) m/z (%):373 [M
+
] (50), 332 (16), 331 (81), 290 (16), 289 (99), 288 
(100).  
IR (ATR): 3065, 3006, 2924, 2853, 1774, 1718, 1338, 1299, 1280, 1214, 1118, 1064, 
998, 893, 768, 704 cm
-1
. 
CHN-Elemental Analysis: C20H14F3NO3 (373) 
Anal. calcd. : C, 64.34; H, 3.78; N, 3.75 
found: C, 64.24; H, 3.94; N, 3.69 
(S)-5-Acetyl-4-(p-tolyl)-3,4-dihydropyrano[3,2-b]indol-2(5H)-one (170e) 
 
The compound 170e was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a colorless 
solid. 
Yield: 66% (105 mg) 
Experimental Part 
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Melting point: 158-159 ºC 
TLC: Rf = 0.30 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25  = +213.2 (c = 1.0, CHCl3) 
ee: 93% 
HPLC: Daicel AD, n-heptane:i-PrOH = 7:3, 1.0 mL/min, tR = 5.42 min (minor), 6.98 
min (major). 
1
H NMR (600 MHz, CDCl3): δ = 7.94 (d, J = 8.4 Hz, 1 H, Ar-H), 7.68 (d, J = 7.8 Hz, 
1 H, Ar-H), 7.42-7.35 (m, 2 H, Ar-H), 7.10 (d, J = 7.8 Hz, 2 H, Ar-H), 7.01 (d, J = 7.8 
Hz, 2 H, Ar-H), 5.03 (d, J = 7.8 Hz, 1 H, CH2CH), 3.32 (dd, J = 16.2 Hz, 7.8 Hz , 1 H, 
CHHCH), 3.00 (dd, J = 16.2 Hz, 1.8 Hz , 1 H, CHHCH), 2.61 (s, 3 H, COCH3),2.29 
(s, 3 H, ArCH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 169.0 (COCH3), 166.4 (COO), 138.4 (CAr), 137.5 
(CAr), 137.3 (CAr), 133.8 (CAr), 130.0 (2C, CHAr), 126.6 (2C, CHAr), 125.9 (CHAr), 
123.8 (CHAr), 120.8 (AcNC), 119.9 (CO2C), 117.6 (CHAr), 115.3 (CHAr), 38.5 
(CHCH2), 38.3 (CHCH2), 26.9 (COCH3), 21.0 (ArCH3) ppm.  
MS (EI, 70 eV) m/z (%):319 [M
+
] (100), 277 (84), 235 (96), 234 (41), 220 (51).  
IR (KBr): 2925, 2321, 2041, 1775, 1705, 1617, 1514, 1454, 1421, 1299, 1209, 1118, 
992, 882, 816, 748, 662 cm
-1
.  
CHN-Elemental Analysis: C20H17NO3 (319) 
Anal. calcd. : C, 75.22; H, 5.37; N, 4.39 
found: C, 75.29; H,5.33; N, 4.26 
(S)-5-Acetyl-4-(4-methoxyphenyl)-3,4-dihydropyrano[3,2-b]indol-2(5H)-one 
Experimental Part 
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(170f) 
 
The compound 170f was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a colorless 
solid. 
Yield: 66% (110 mg) 
Melting point: 147-148 ºC 
TLC: Rf = 0.20 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25  = +177.4 (c = 0.5, CHCl3) 
ee: 98% 
HPLC: Daicel AD, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 12.04 min (minor), 16.52 
min (major) 
1
H NMR (400 MHz, CDCl3): δ = 7.93 (d, J = 8.4 Hz, 1 H, Ar-H), 7.68 (d, J = 7.2 Hz, 
1 H, Ar-H), 7.42-7.33 (m, 2 H, Ar-H), 7.03 (d, J = 8.8 Hz, 2 H, Ar-H), 6.80 (d, J = 8.8 
Hz, 2 H, Ar-H), 5.01 (d, J = 6.8 Hz, 1 H, CH2CH), 3.74 (s, 3 H, OCH3), 3.31 (dd, J = 
12.0 Hz, 8.0 Hz , 1 H, CHHCH), 3.00 (dd, J = 12.0 Hz, 1.2 Hz, 1 H, CHHCH), 2.61 (s, 
3 H, COCH3) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 169.0 (COCH3), 166.4 (COO), 159.1 (CAr), 138.3 
(CAr), 133.8 (CAr), 132.3 (CAr), 127.8 (2C, CHAr), 125.9 (CHAr), 123.8 (CHAr), 120.8 
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(AcNC), 120.1 (CO2C), 117.6 (CHAr), 115.4 (CHAr), 114.7 (2C, CHAr), 55.2 (OCH3), 
38.6 (CHCH2), 37.6 (CHCH2), 26.9 (COCH3) ppm.  
MS (EI, 70 eV) m/z (%):335 [M
+
] (84), 293 (63), 251 (100), 250 (30).  
IR (ATR): 2944, 2907, 2834, 1768, 1703, 1637, 1607, 1511, 1370, 1337, 1301, 1247, 
1153, 1124, 1031, 994, 882, 820, 749, 656 cm
-1
.  
CHN-Elemental Analysis: C20H17NO4 (335) 
Anal. calcd. : C, 71.63; H, 5.11; N, 4.18 
found: C, 71.17; H, 4.86; N, 4.11 
(S)-5-Acetyl-4-(4-bromo-2-methoxyphenyl)-3,4-dihydropyrano[3,2-b]indol-2(5H)
-one (170g) 
 
The compound 170g was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a colorless 
solid. 
Yield: 70% (144 mg) 
Melting point: 185-186 ºC 
TLC: Rf = 0.50 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25
 = +200.9 (c = 1.0, CHCl3) 
Experimental Part 
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ee: 94% 
HPLC: Daicel AS, n-heptane:EtOH = 7:3, 1.0 mL/min, tR = 7.25 min (minor), 10.80 
min (major). 
1
H NMR (600 MHz, CDCl3): δ = 7.93 (d, J = 8.4 Hz, 1 H, Ar-H), 7.68 (d, J = 7.2 Hz, 
1 H, Ar-H), 7.42-7.33 (m, 3 H, Ar-H), 7.03 (d, J = 1.8 Hz, 1 H, Ar-H), 6.77 (d, J = 9.0 
Hz, 1 H, Ar-H), 5.28 (d, J = 7.8 Hz, 1 H, CH2CH), 3.83 (s, 3 H, OCH3),  3.22 (dd, J 
= 16.2 Hz, 8.4 Hz , 1 H, CHHCH), 3.00 (d, J = 16.2 Hz , 1 H, CHHCH), 2.61 (s, 3 H, 
COCH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 168.9 (COCH3), 166.5 (COO), 155.7 (CAr), 139.0 
(CAr), 133.8 (CAr), 131.7 (CHAr), 130.9 (CAr), 130.4 (CHAr), 125.9 (CHAr), 123.8 
(CHAr), 120.8 (AcNC), 117.9 (CO2C), 117.6 (CHAr), 115.2 (CHAr), 113.1 (CAr), 112.6 
(CHAr), 55.4 (OCH3), 35.9 (CHCH2), 33.2 (CHCH2), 26.7 (COCH3) ppm. 
MS (EI, 70 eV) m/z (%):415 [M+2] (74), 413 [M
+
] (74), 373 (90),372 (32), 371 (92), 
331 (33), 329 (33), 300 (96), 298 (100). 
IR (KBr): 3088, 2951, 2848, 2322, 2012, 1765, 1702, 1585, 1483, 1444, 1342, 1300, 
1249, 1155, 1106, 1024, 992, 819, 766, 664 cm
-1
.  
CHN-Elemental Analysis: C20H16BrNO4 (413) 
Anal. calcd. : C, 57.99; H, 3.89; N, 3.38 
found: C, 58.30; H, 3.97; N, 3.34 
(S)-5-Acetyl-4-(3-methoxyphenyl)-3,4-dihydropyrano[3,2-b]indol-2(5H)-one 
(170h) 
Experimental Part 
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The compound 170h was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a pink solid. 
Yield: 61% (102 mg) 
Melting point: 134-135 ºC 
TLC: Rf = 0.30 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25  = +201.6 (c = 1.0, CHCl3) 
ee: 92% 
HPLC: Daicel AD, n-heptane:i-PrOH = 7:3, 1.0 mL/min, tR = 6.76 min (minor), 8.55 
min (major). 
1
H NMR (600 MHz, CDCl3): δ = 7.93 (d, J = 8.4 Hz, 1 H, Ar-H), 7.70 (d, J = 7.8 Hz, 
1 H, Ar-H), 7.42-7.35 (m, 2 H, Ar-H), 7.22 (t, J = 8.4 Hz, 1 H, Ar-H), 6.77 (dd, J = 8.4 
Hz, 2.4 Hz, 1 H, Ar-H),6.71 (d, J = 7.8 Hz, 1 H, Ar-H ),6.66 (t, J = 1.8 Hz, 1 H, Ar-H), 
5.04 (d, J = 7.8 Hz, 1 H, CH2CH), 3.74 (s, 3 H, OCH3), 3.33 (dd, J = 16.2 Hz, 7.8 Hz , 
1 H, CHHCH), 3.00 (dd, J = 16.2 Hz,1.8 Hz, 1 H, CHHCH), 2.62 (s, 3 H, COCH3) 
ppm. 
13
C NMR (150 MHz, CDCl3): δ = 169.0 (COCH3), 166.2 (COO), 160.2 (CAr), 141.9 
(CAr), 138.5 (CAr), 133.8 (CAr), 130.4 (CHAr), 126.0 (CHAr), 123.8 (CHAr), 120.8 
(AcNC), 119.5 (CO2C), 118.9 (CHAr), 117.6 (CHAr), 115.3 (CHAr), 112.9 (CHAr), 
112.6 (CHAr), 55.2(OCH3), 38.4 (CHCH2), 38.3 (CHCH2), 26.9 (COCH3) ppm. 
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MS (EI, 70 eV) m/z (%): 335 [M
+
] (75), 293 (100), 251 (62), 250 (35), 220 (35).  
IR (ATR): 2928, 2842, 2323, 1775, 1702, 1597, 1338, 1299, 1209, 1159, 1121, 1030, 
997, 877, 832, 745, 661 cm
-1
.  
CHN-Elemental Analysis: C20H17NO4 (335) 
Anal. calcd. : C, 71.63; H, 5.11; N, 4.18 
found: C, 72.13; H, 5.01; N, 3.92 
(S)-5-Acetyl-4-(4-chlorophenyl)-3,4-dihydropyrano[3,2-b]indol-2(5H)-one (170i) 
 
The compound 170i was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a colorless 
solid. 
Yield: 71% (121 mg) 
Melting point: 148-149 ºC 
TLC: Rf = 0.30 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25
 = +181.4 (c = 1.0, CHCl3) 
ee: 89% 
HPLC: Daicel IC, n-heptane:EtOH = 9:1, 1.0 mL/min, tR = 6.53 min (minor), 7.98 
min (major). 
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1
H NMR (600 MHz, CDCl3): δ = 7.82 (d, J = 8.4 Hz, 1 H, Ar-H), 7.70 (d, J = 8.4 Hz, 
1 H, Ar-H), 7.44-7.36 (m, 2 H, Ar-H), 7.27-7.25 (m, 2 H, Ar-H), 7.07 (d, J = 8.4 Hz, 2 
H, Ar-H), 5.11 (d, J = 7.2 Hz, 1 H, CH2CH), 3.34 (dd, J = 15.6 Hz, 7.8 Hz , 1 H, 
CHHCH), 3.01 (dd, J = 15.6 Hz, 1.2 Hz , 1 H, CHHCH), 2.66 (s, 3 H, COCH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 169.0 (COCH3), 166.1 (COO), 139.1 (CAr), 138.4 
(CAr), 133.6 (CAr), 133.5 (CAr), 129.4 (2C, CHAr), 128.2 (2C,CHAr), 126.0 (CHAr), 
123.9 (CHAr), 120.8 (AcNC), 119.7 (CO2C), 117.8 (CHAr), 114.9 (CHAr), 38.2 
(CHCH2), 37.8 (CHCH2), 27.0 (COCH3) ppm. 
MS (EI, 70 eV) m/z (%): 341 [M+2] (21), 339 [M
+
] (61), 299 (27), 297 (82), 257 (33), 
255 (100), 220 (28). 
IR (ATR): 3095, 2924, 2871, 2839, 17768, 1707, 1621, 1585, 1510, 1487, 1460, 1211, 
1153, 1091, 1014, 830, 753, 692 cm
-1
.  
CHN-Elemental Analysis: C19H14ClNO3 (339) 
Anal. calcd. : C, 67.16; H, 4.15; N, 4.12 
found: C, 66.79; H, 4.39; N, 4.02 
(S)-5-Acetyl-4-(3-chlorophenyl)-3,4-dihydropyrano[3,2-b]indol-2(5H)-one (170j) 
 
The compound 170j was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a colorless 
solid. 
Yield: 60% (101 mg) 
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Melting point: 158-159 ºC 
TLC: Rf = 0.30 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25  = +220.7 (c = 1.0, CHCl3) 
ee: 97% 
HPLC: Daicel AD, n-heptane:i-PrOH = 7:3, 1.0 mL/min, tR = 6.07 min (minor), 7.59 
min (major). 
1
H NMR (600 MHz, CDCl3): δ = 7.83 (d, J = 8.4 Hz, 1 H, Ar-H), 7.72 (d, J = 7.8 Hz, 
1 H, Ar-H), 7.45-7.37 (m, 2 H, Ar-H), 7.23-7.22 (m, 2 H, Ar-H), 7.12 (s, 1 H, Ar-H), 
7.02-7.01 (m, 1 H, Ar-H), 5.11 (d, J = 7.8 Hz, 1 H, CH2CH), 3.33 (dd, J = 16.2 Hz, 
7.8 Hz , 1 H,CHHCH), 3.01 (dd, J = 16.2 Hz, 1.2 Hz , 1 H, CHHCH), 2.67 (s, 3 H, 
COCH3) ppm.  
13
C NMR (150 MHz, CDCl3): δ = 168.9 (COCH3), 165.9 (COO), 142.6 (CAr), 138.6 
(CAr), 135.1 (CAr), 133.5 (CAr), 130.5 (CHAr), 128.0 (CHAr), 127.0 (CHAr), 126.1 
(CHAr), 124.9 (CHAr), 123.9 (CHAr), 120.8 (AcNC), 119.3 (CO2C), 117.9 (CHAr), 
114.9 (CHAr), 38.1 (CHCH2), 38.0 (CHCH2), 27.1 (COCH3) ppm. 
MS (EI, 70 eV) m/z (%): 341 [M+2] (27), 339 [M
+
] (81), 299 (37), 297 (100), 257 
(33), 256 (29), 255 (99), 254 (41), 220 (32). 
IR (ATR): 3087, 2927, 2323, 1772, 1699, 1335, 1301, 1209, 1119, 993, 800, 746, 688 
cm
-1
. 
CHN-Elemental Analysis: C19H14ClNO3 (339) 
Anal. calcd. : C, 67.16; H, 4.15; N, 4.12 
found: C, 66.95; H, 4.36; N, 3.93 
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(S)-5-Acetyl-4-(4-fluorophenyl)-3,4-dihydropyrano[3,2-b]indol-2(5H)-one (170k) 
 
The compound 170k was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a colorless 
solid. 
Yield: 68% (110 mg) 
Melting point: 142-143 ºC 
TLC: Rf = 0.30 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25  = +194.6 (c = 1.0, CHCl3) 
ee: 93% 
HPLC: Daicel AD, n-heptane:i-PrOH = 7:3, 1.0 mL/min, tR = 5.84 min (minor), 7.18 
min (major). 
1
H NMR (600 MHz, CDCl3): δ = 7.90 (d, J = 8.4 Hz, 1 H, Ar-H), 7.71 (d, J = 7.8 Hz, 
1 H, Ar-H), 7.43-7.32 (m, 2 H, Ar-H), 7.12-7.10 (m, 2 H, Ar-H), 6.98 (t, J = 8.4 Hz, 2 
H, Ar-H), 5.11 (d, J = 7.2 Hz, 1 H, CH2CH), 3.34 (dd, J = 16.2 Hz, 7.8 Hz , 1 H, 
CHHCH), 3.01 (dd, J = 16.2 Hz, 1.2 Hz , 1 H, CHHCH), 2.66 (s, 3 H, COCH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 169.0 (COCH3), 166.2 (COO), 162.6 (J = 380.4, 
FCAr), 138.3 (CAr), 136.3 (J = 12.6, CAr), 133.6 (CHAr), 128.4 (J = 32.4) (2C, CHAr), 
126.0 (2C, CHAr), 123.9 (CAr), 120.8 (AcNC), 120.0 (CO2C), 117.8 (CHAr), 116.1 (J = 
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85.8, CHAr), 115.0 (CHAr), 38.2 (CHCH2), 37.8 (CHCH2), 27.0 (COCH3) ppm. 
MS (EI, 70 eV) m/z (%): 323 [M
+
] (61), 281 (70), 239 (100), 238 (50).  
IR (ATR): 3066, 2913, 1773, 1701, 1638, 1604, 1507, 1335, 1298, 1210, 1113, 995, 
830, 748, 660 cm
-1
.  
CHN-Elemental Analysis: C19H14FNO3 (323) 
Anal. calcd. : C, 70.58; H, 4.36; N, 4.33 
found: C, 70.53; H, 4.36; N, 4.20 
(R)-5-Acetyl-4-(furan-2-yl)-3,4-dihydropyrano[3,2-b]indol-2(5H)-one (170l) 
 
The compound 170l was prepared according to GP 5. The product was purified by 
flash column chromatography (n-pentane:Et2O = 3:1) and obtained as a yellow solid. 
Yield: 60% (88 mg) 
Melting point: 126-127 ºC 
TLC: Rf = 0.40 (n-pentane:Et2O = 1:1) 
Optical rotation: [α]
D
25
 = +59.7 (c = 1.0, CHCl3) 
ee: 95% 
HPLC: Daicel IC, n-heptane:EtOH = 7:3, 0.5 mL/min), tR = 8.15 min (minor), 9.40 
min (major). 
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1
H NMR (600 MHz, CDCl3): δ = 7.85 (d, J = 8.4 Hz, 1 H, Ar-H), 7.66 (d, J = 7.8 Hz, 
1 H, Ar-H), 7.41-7.32 (m, 2 H, Ar-H), 7.31 (d, J = 1.2 Hz, 1 H, Ar-H), 6.25-6.24 (m, 1 
H, Ar-H), 6.09 (d, J = 3.0 Hz, 1 H, Ar-H), 5.26 (dd, J = 7.2 Hz, 2.4 Hz, 1 H, 
CH2CH),3.26-3.20 (m, 2 H, CH2CH), 2.73 (s, 3 H, COCH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 169.1 (COCH3), 166.2 (COO), 152.6  (CAr), 142.5 
(CHAr), 138.2 (CAr), 133.6 (CAr), 125.9 (CHAr), 123.8 (CHAr), 120.9 (AcNC), 118.0 
(CO2C), 117.8 (CHAr), 115.0 (CHAr), 110.4 (CHAr), 106.5 (CHAr), 35.2 (CHCH2), 32.1 
(CHCH2), 27.0 (COCH3) ppm.  
MS (EI, 70 eV) m/z (%): 295 [M
+
] (74), 253 (53), 211 (100). 
IR (ATR): 3122, 2999, 2924, 2326, 2077, 1772, 1698, 1644, 1502, 1458, 1336, 1302, 
1211, 1124, 1004, 912, 880, 826, 738, 659 cm
-1
.  
HRMS (ESI): calcd. for C17H13NO4 [M+Na]
+
: 318.0737; found: 318.0737. 
General procedure 6 and analytical data for the synthesis of 
dihydro-1H-benzothiazolopyridines (172) 
To a dried and argon-filled Schlenk tube was added 2-(benzimidazol-2-yl) acetate 
(171), 2-bromoenal (108) (0.75 mmol, 1.5 equiv.), triazolium salt 16d (0.05 mmol, 10 
mol%) and DIPEA (0.6 mmol, 1.2 equiv.) in 5 mL toluene. The mixture was stirred at 
room temperature for 20h. After then, the solution was purified by flash 
chromatography on silica gel (n-pentane:Et2O = 10:1 or n-pentane:DCM = 1:1→1:2) 
to afford the products 172a-k as yellow or orange solids. 
Ethyl (S)-1-oxo-3-phenyl-2,3-dihydro-1H-benzo[4,5]-thiazolo[3,2-a]pyridine-4- 
carboxylate (172a) 
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The compound 172a was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:Et2O = 6:1) and obtained as a light yellow 
solid. 
Yield: 77% (135.6 mg) 
Melting point: 125-127 
o
C 
TLC: Rf = 0.50 (n-pentane:Et2O = 4:1) 
Optical rotation: [α]
D
23  = + 236.9 (c = 1.0, CHCl3) 
ee: 65% (99% after recrystallization) 
HPLC: Daicel IC, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 4.53 min (major), 5.35 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.44 (d, J = 8.4 Hz, 1H, Ar-H), 7.45 (dd, J = 7.2 Hz, 
1.2 Hz, 1H, Ar-H), 7.30-7.18 (m, 7H, Ar-H), 4.33-4.32 (m, 1H, CH2CH), 4.28-4.16 (m, 
2H, CH2CH3), 3.24 (dd, J = 16.2 Hz, 8.4 Hz, 1H, CHHCH), 3.02 (dd, J = 16.2 Hz, 1.8 
Hz, 1H, CHHCH), 1.23 (t, J = 7.2 Hz, 3H, CH2CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 168.2 (C=O), 166.6 (CO2Et), 152.3 (NCS), 141.4 
(CAr), 136.8 (CAr), 128.9 (2C, CHAr), 127.2 (CHAr), 127.0 (CAr), 126.5 (2C, CHAr), 
126.5 (CHAr), 125.5 (CHAr), 121.4 (CHAr), 117.4 (CHAr), 100.4 (CCO2Et), 60.7 
(OCH2CH3), 40.1 (CHCH2), 36.8 (CHCH2), 14.3 (OCH2CH3) ppm. 
MS (EI, 70 eV) m/z (%): 351 [M
+
] (100), 322 (36), 278 (40), 249 (44), 236 (71), 115 
(19), 77 (17). 
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IR (ATR): 3851, 3613, 3401, 3060, 2980, 2921, 2645, 2325, 2037, 1903, 1803, 1707, 
1660, 1556, 1455, 1359, 1305, 1263, 1194, 1146, 1106, 1034, 939, 906, 853, 795, 748, 
697 cm
-1
. 
HRMS (ESI): calcd for C20H17NO3S [M]
+
: 351.0924; found: 351.0933. 
Methyl (S)-1-oxo-3-phenyl-2,3-dihydro-1H-benzo[4,5]-thiazolo[3,2-a]pyridine-4- 
carboxylate (172b) 
 
The compound 172b was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:DCM = 1:1→1:2) and obtained as a yellow 
solid. 
Yield: 91% (153.0 mg) 
Melting point: 150-152 
o
C 
TLC: Rf = 0.30 (n-pentane:DCM = 1:1) 
Optical rotation: [α]
D
23  = + 207.5 (c = 1.0, CHCl3) 
ee: 64% 
HPLC:Daicel AD, n-heptane:EtOH = 7:3, 1.0 mL/min, tR = 7.60 min (major), 26.53 
min (minor). 
1
H NMR (600 MHz, CDCl3) δ 8.42 (d, J = 8.2 Hz, 1H, Ar-H), 7.51 - 7.40 (m, 1H, 
Ar-H), 7.31 - 7.26 (m, 3H, Ar-H), 7.25 - 7.20 (m, 2H, Ar-H), 7.20 - 7.16 (m, 2H, 
Ar-H), 4.33 (dd, J = 7.9 Hz, 1.7 Hz, 1H, CH2CH), 3.75 (s, 3H, CO2CH3), 3.24 (dd, J = 
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16.2 Hz, 7.9 Hz, 1H, CHHCH), 3.02 (dd, J = 16.2 Hz, 1.8 Hz, 1H, CHHCH) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 168.1 (C=O), 167.0 (CO2Me), 152.8 (NCS), 141.1 
(CAr), 136.8 (CAr), 128.9 (CHAr), 127.3 (CHAr), 126.9 (CAr), 126.54 (CHAr), 126.52 
(CHAr), 125.5 (CHAr), 121.5 (CHAr), 117.4 (CHAr), 99.9 (CCO2Me), 51.9 (CO2CH3), 
40.3 (CHCH2), 36.7 (CHCH2) ppm. 
Ms (EI, 70 eV) m/z (%): 337 [M
+
] (39), 294 (22), 278 (12), 236 (20), 115 (20), 77 
(60), 59 (100). 
IR (ATR): 3848, 3342, 3080, 3016, 2944, 2697, 2307, 2101, 2038, 1713, 1669, 1559, 
1443, 1301, 1184, 1138, 1088, 1039, 945, 911, 747, 701 cm
-1
. 
HRMS (ESI): calcd for C19H15NO3S [M+Na]
+
: 360.0665; found: 360.0664. 
(S)-1-Oxo-3-phenyl-2,3-dihydro-1H-benzo[4,5]thiazolo[3,2-a]pyridine-4-carbonit
rile (172c) 
 
The compound 172c was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:Et2O = 10:1) and obtained as a light yellow 
solid. 
Yield: 74% (111.8 mg) 
Melting point: 196-197 
o
C 
TLC: Rf = 0.50 (n-pentane:Et2O = 2:1) 
Optical rotation: [α]
D
23
 = +88.2 (c = 1.0, CHCl3) 
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ee: 32% 
HPLC:Daicel OD, n-heptane:EtOH = 7:3, 1.0 mL/min, tR = 9.63 min (major), 11.05 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.37 (d, J = 8.4 Hz, 1H, Ar-H), 7.39-7.35 (m, 3H, 
Ar-H), 7.32-7.29 (m, 2H, Ar-H), 7.28-7.23 (m, 3H, Ar-H), 4.02 (t, J = 6.6 Hz, 1H, 
CH2CH), 3.19 (dd, J = 16.8 Hz, 7.2 Hz, 1H, CHHCH), 3.04 (dd, J = 16.2 Hz, 6.0 Hz, 
1H, CHHCH) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 166.4 (C=O), 153.6 (NCS), 139.1 (CAr), 137.5(CAr), 
129.3 (2C, CHAr), 128.2 (CHAr), 127.1 (CHAr), 126.7 (2C, CHAr), 126.1 (CHAr), 123.6 
(CAr), 121.8 (CHAr), 117.9 (CN), 117.7 (CHAr), 81.6 (CCN), 39.9 (CHCH2), 39.4 
(CHCH2) ppm. 
MS (EI, 70 eV) m/z (%): 304 [M
+
] (26), 260 (52), 259 (100), 196 (16), 138 (18), 107 
(16), 102 (23), 78 (20), 69 (24), 58 (60). 
IR (ATR): 3804, 3400, 3070, 3023, 2887, 2654, 2331, 2191, 2109, 1707, 1601, 1455, 
1310, 1208, 1163, 1073, 1025, 935, 852, 745, 696 cm
-1
. 
HRMS (ESI): calcd for C18H12N2OS [M]
+
: 304.0665; found: 304.0656. 
(S)-1-Oxo-3-phenyl-2,3-dihydro-1H-benzo[4,5]oxazolo[3,2-a]pyridine-4-carbonit
rile (172d) 
 
The compound 172d was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:DCM = 1:1→1:2) and obtained as a yellow 
solid. 
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Yield: 43% (62.5 mg) 
Melting point: 188-190 
o
C 
TLC: Rf = 0.20 (n-pentane:DCM = 1:1) 
Optical rotation: [α]
D
23  = +114.3 (c = 0.9, CHCl3) 
ee: 55% 
HPLC: Daicel IC, n-heptane:EtOH = 7:3, 0.7 mL/min, tR = 10.50 min (major), 12.19 
min (minor). 
1
H NMR (600 MHz, CDCl3) δ 7.93 (dd, J = 6.2 Hz, 2.1 Hz, 1H, Ar-H), 7.37 (m, 2H, 
Ar-H), 7.33 - 7.26 (m, 6H, Ar-H), 4.09 (dd, J = 7.4 Hz, 6.2 Hz, 1H, CH2CH), 3.17 (dd, 
J = 17.0 Hz, 7.4 Hz, 1H, CHHCH), 3.01 (dd, J = 17.0 Hz, 6.1 Hz, 1H, CHHCH) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 164.7 (C=O), 157.9 (NCO), 146.7 (CAr), 139.6 
(CAr), 129.3 (2C, CHAr), 128.2 (CHAr), 127.1 (CAr), 126.6 (2C, CHAr), 125.9 (CHAr), 
125.0 (CHAr), 115.9 (CN), 114.7 (CHAr), 110.3 (CHAr), 63.5 (CCN), 39.4 (CHCH2), 
37.6 (CHCH2) ppm. 
MS (EI, 70 eV) m/z (%): 288 [M
+
] (33), 245 (100), 104 (27), 77 (39), 63 (52), 51 (34). 
IR (ATR): 3837, 3403, 3063, 2912, 2669, 2323, 2201, 2105, 1984, 1896, 1792, 1700, 
1612, 1473, 1362, 1293, 1190, 1127, 1001, 929, 836, 739, 694 cm
-1
. 
HRMS (ESI): calcd for C18H12N2O2 [M+Na]
+
: 311.0791; found: 311.0790. 
 
Ethyl (S)-1-oxo-3-(p-tolyl)-2,3-dihydro-1H-benzo[4,5]thiazolo[3,2-a]pyridine-4- 
carboxylate (172e) 
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The compound 172e was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:DCM = 1:1→1:2) and obtained as a yellow 
solid. 
Yield: 64% (117.0 mg) 
Melting point: 129-131 
o
C 
TLC: Rf = 0.50 (n-pentane:DCM = 1:1) 
Optical rotation: [α]
D
23  = +244.0 (c = 1.0, CHCl3) 
ee: 68% 
HPLC: Daicel IC, n-heptane:i-PrOH = 9:1, 1.0 mL/min, tR = 5.50 min (major), 7.97 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.43 (dd, J = 8.4 Hz, 0.6 Hz, 1H, Ar-H), 7.44 (dd, J 
= 7.8 Hz, 0.6 Hz, 1H, Ar-H), 7.29-7.27 (m, 1H, Ar-H), 7.24-7.22 (m, 1H, Ar-H), 7.07 
(dd, J = 12.0 Hz, 8.4 Hz, 4H, Ar-H), 4.30-4.15 (m, 3H, CH2CH3 and CH2CH), 3.22 
(dd, J = 16.2 Hz, 8.4 Hz, 1H, CHHCH), 3.00 (dd, J = 16.2 Hz, 1.8 Hz, 1H, CHHCH), 
2.28 (s, 3H, ArCH3), 1.24 (t, J = 7.2 Hz, 3H, CH2CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 168.4 (C=O), 166.6 (CO2Et), 152.1 (NCS), 138.3 
(CAr), 136.8 (CAr), 136.8 (CAr), 129.5 (2C, CHAr), 127.0 (CAr), 126.5 (CHAr), 126.4 
(2C, CHAr), 125.4 (CHAr), 121.4 (CHAr), 117.4 (CHAr), 100.6 (CCO2Et), 60.7 
(OCH2CH3), 40.2 (CHCH2), 36.3 (CHCH2), 21.0 (ArCH3), 14.4 (OCH2CH3) ppm. 
MS (EI, 70 eV) m/z (%): 365 [M
+
] (100), 336 (27), 322 (29), 292 (46), 274 (16), 264 
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(21), 250 (42), 115 (15). 
IR (ATR): 3880, 3459, 2972, 2645, 2326, 2207, 2165, 2097, 2028, 1992, 1929, 1735, 
1662, 1561, 1455, 1365, 1302, 1266, 1200, 1141, 1105, 1027, 942, 908, 825, 754 
cm
-1
. 
HRMS (ESI): calcd for C21H19NO3S [M]
+
: 365.1080; found: 365.1084. 
Ethyl (S)-3-(4-methoxyphenyl)-1-oxo-2,3-dihydro-1H-benzo[4,5]thiazolo[3,2-a] 
pyridine-4-carboxylate (172f) 
 
The compound 172f was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:DCM = 1:1→1:2) and obtained as a yellow 
solid. 
Yield: 69% (132.0 mg) 
Melting point: 124-126 
o
C 
TLC: Rf = 0.40 (n-pentane:DCM = 1:1) 
Optical rotation: [α]
D
23
 = +225.8 (c = 1.0, CHCl3) 
ee: 62% (99% after recrystallization) 
HPLC: Daicel IC, n-heptane:i-PrOH = 9:1, 1.0 mL/min, tR = 7.78 min (major), 11.48 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.43 (d, J = 8.4 Hz, 1H, Ar-H), 7.44 (d, J = 7.8 Hz, 
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1H, Ar-H), 7.29-7.27 (m, 1H, Ar-H), 7.24-7.22 (m, 1H, Ar-H), 7.11 (d, J = 9.0 Hz, 2H, 
Ar-H), 6.79 (d, J = 9.0 Hz, 2H, Ar-H), 4.28-4.16 (m, 3H, CH2CH3 and CH2CH), 3.75 
(s, 3H, OCH3), 3.21 (dd, J = 16.2 Hz, 7.8 Hz, 1H, CHHCH), 3.00 (dd, J = 16.2 Hz, 
1.2 Hz, 1H, CHHCH), 1.25 (t, J = 7.2 Hz, 3H, CH2CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 168.4 (C=O), 166.6 (CO2Et), 158.7 (CAr), 152.0 
(NCS), 136.8 (CAr), 133.4 (CAr), 127.6 (2C, CHAr), 127.0 (CAr), 126.5 (CHAr), 125.5 
(CHAr), 121.4 (CHAr), 117.4 (CHAr), 114.2 (2C, CHAr), 100.8 (CCO2Et), 60.7 
(OCH2CH3), 55.2 (OCH3), 40.3 (CHCH2), 36.0 (CHCH2), 14.4 (OCH2CH3) ppm. 
MS (EI, 70 eV) m/z (%): 381 [M
+
] (100), 336 (27), 352 (32), 338 (33), 308 (44), 266 
(33), 236 (16), 223 (32). 
IR (ATR): 3860, 3389, 3225, 2970, 2926, 2640, 2322, 2080, 1897, 1706, 1663, 1567, 
1511, 1455, 1354, 1302, 1254, 1192, 1143, 1033, 941, 908, 829, 747 cm
-1
. 
HRMS (ESI): calcd for C21H19NO4S [M]
+
: 381.1029; found: 381.1032. 
Ethyl (S)-3-(5-bromo-2-methoxyphenyl)-1-oxo-2,3-dihydro-1H-benzo[4,5]thiazol- 
o[3,2-a]pyridine-4-carboxylate (172g) 
 
The compound 172g was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:DCM = 1:1→1:2) and obtained as a yellow 
solid. 
Yield: 86% (198.0 mg) 
Melting point: 147-148 
o
C 
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TLC: Rf = 0.40 (n-pentane:DCM = 1:1) 
Optical rotation: [α]
D
23  = +305.1 (c = 1.0, CHCl3) 
ee: 66% (92% after recrystallization) 
HPLC: Daicel IC, n-heptane:i-PrOH = 9:1, 1.0 mL/min, tR = 6.32 min (major), 7.52 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.48 (d, J = 8.4 Hz, 1H, Ar-H), 7.45 (d, J = 7.8 Hz, 
1H, Ar-H), 7.31-7.28 (m, 2H, Ar-H), 7.25-7.22 (m, 1H, Ar-H), 7.18 (d, J = 2.4 Hz, 1H, 
Ar-H), 6.70 (d, J = 9.0 Hz, 1H, Ar-H), 4.40 (d, J = 9.6 Hz, 1H, CH2CH), 4.22-4.16 (m, 
2H, CH2CH3), 3.68 (s, 3H, OCH3), 3.16 (dd, J = 16.8 Hz, 9.6 Hz, 1H, CHHCH), 2.95 
(d, J = 16.8 Hz, 1H, CHHCH), 1.24 (t, J = 7.2 Hz, 3H, CH2CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 168.1 (C=O), 166.7 (CO2Et), 156.4  (CAr), 152.9 
(NCS), 137.0 (CAr), 131.9 (CHAr), 131.7 (CAr), 130.9 (CHAr), 126.8 (CAr), 126.5 
(CHAr), 125.2 (CHAr), 121.4 (CHAr), 117.1 (CHAr), 112.6 (CAr), 112.4 (CHAr), 97.2 
(CCO2Et), 60.7 (OCH2CH3), 55.2 (OCH3), 37.9 (CHCH2), 34.0 (CHCH2), 14.3 
(OCH2CH3) ppm. 
MS (EI, 70 eV) m/z (%): 461 [M+2] (100), 459 [M
+
] (84), 388 (78), 386 (85), 360 
(42), 358 (44), 344 (19), 333 (19), 274 (53), 228 (33), 172 (37), 118 (31), 63 (24). 
IR (ATR): 3882, 3739, 3631, 3457, 3210, 3066, 2983, 2841, 2453, 2246, 2165, 2115, 
2022, 1968, 1860, 1712, 1658, 1559, 1458, 1362, 1300, 1245, 1157, 1078, 1023, 944, 
900, 800, 743, 661 cm
-1
. 
HRMS (ESI): calcd for C21H18BrNO4S [M]
+
: 459.0134; found: 459.0131. 
Ethyl (S)-3-(2-methoxyphenyl)-1-oxo-2,3-dihydro-1H-benzo[4,5]thiazolo[3,2-a] 
pyridine-4-carboxylate (172h) 
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The compound 172h was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:DCM = 1:1→1:2) and obtained as a yellow 
solid. 
Yield: 80% (152.0 mg) 
Melting point: 126-128 
o
C 
TLC: Rf = 0.50 (n-pentane:DCM = 1:1) 
Optical rotation: [α]
D
23  = +219.8 (c = 1.0, CHCl3) 
ee: 65% (99% after recrystallization) 
HPLC: Daicel IC, n-heptane:i-PrOH = 9:1, 1.0 mL/min, tR = 7.17 min (major), 7.90 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.46 (d, J = 8.4 Hz, 1H, Ar-H), 7.44 (dd, J = 7.8 Hz, 
0.6 Hz, 1H, Ar-H), 7.29-7.26 (m, 1H, Ar-H), 7.23-7.17 (m, 2H, Ar-H), 7.05 (dd, J = 
7.2 Hz, 1.2 Hz, 1H, Ar-H), 6.84 (d, J = 7.8 Hz, 1H, Ar-H), 6.81 (t, J = 7.2 Hz, 1H, 
Ar-H), 4.51 (d, J = 8.4 Hz, 1H, CH2CH), 4.24-4.10 (m, 2H, CH2CH3), 3.73 (s, 3H, 
OCH3), 3.15 (dd, J = 16.2 Hz, 9.0 Hz, 1H, CHHCH), 2.99 (dd, J = 16.2 Hz, 1.2 Hz, 
1H, CHHCH), 1.21 (t, J = 7.2 Hz, 3H, CH2CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 168.6 (C=O), 166.8 (CO2Et), 157.2  (CAr), 152.5 
(NCS), 137.0 (CAr), 129.2 (CAr), 128.5 (CHAr), 128.3 (CHAr), 127.0 (CAr), 126.4 
(CHAr), 125.1 (CHAr), 121.3 (CHAr), 120.4 (CHAr), 117.1 (CHAr), 110.6 (CHAr), 98.5 
(CCO2Et), 60.5 (OCH2CH3), 55.0 (OCH3), 38.4 (CHCH2), 33.4 (CHCH2), 14.3 
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(OCH2CH3) ppm. 
MS (EI, 70 eV) m/z (%): 381 [M
+
] (100), 334 (16), 308 (91), 280 (52), 236 (26), 161 
(21), 131 (20), 77 (15). 
IR (ATR): 3880, 3416, 3074, 2955, 2837, 2645, 2276, 2212, 2164, 2116, 1979, 1926, 
1716, 1660, 1563, 1458, 1352, 1299, 1264, 1142, 1102, 1036, 952, 908, 856, 754, 663 
cm
-1
. 
HRMS (ESI): calcd for C21H19NO4S [M]
+
: 381.1029; found: 381.1037. 
Ethyl (S)-3-(4-chlorophenyl)-1-oxo-2,3-dihydro-1H-benzo[4,5]thiazolo[3,2-a] 
pyridine-4-carboxylate (172i) 
 
The compound 172i was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:DCM = 1:1→1:2) and obtained as a yellow 
solid. 
Yield: 72% (139.0 mg) 
Melting point: 128-130 
o
C 
TLC: Rf = 0.40 (n-pentane:DCM = 1:1) 
Optical rotation: [α]
D
23
 = +250.4 (c = 1.0, CHCl3) 
ee: 73% 
HPLC:Daicel IC, n-heptane:i-PrOH = 9:1, 1.0 mL/min, tR = 4.92 min (major), 8.05 
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min (minor). 
1
H NMR (400 MHz, CDCl3): δ = 8.45 (d, J = 8.0 Hz, 1H, Ar-H), 7.48 (dd, J = 7.6 Hz, 
1.6 Hz, 1H, Ar-H), 7.35-7.27 (m, 4H, Ar-H), 7.16-7.14 (m, 2H, Ar-H), 4.34 (dd, J = 
8.0 Hz, 1.6 Hz, 1H, CH2CH), 4.30-4.18 (m, 2H, CH2CH3), 3.27 (dd, J = 16.4 Hz, 8.0 
Hz, 1H, CHHCH), 3.00 (dd, J = 16.4 Hz, 2.0 Hz, 1H, CHHCH), 1.27 (t, J = 7.2 Hz, 
3H, CH2CH3) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 167.9 (C=O), 166.4 (CO2Et), 152.6 (NCS), 140.0  
(CAr), 136.7 (CAr), 133.1 (CAr), 129.1 (2C, CHAr), 128.0 (2C, CHAr), 126.9 (CAr), 
126.6 (CHAr), 125.6 (CHAr), 121.5 (CHAr), 117.4 (CHAr), 99.9 (CCO2Et), 60.8 
(OCH2CH3), 40.1 (CHCH2), 36.3 (CHCH2), 14.4 (OCH2CH3) ppm. 
MS (EI, 70 eV) m/z (%): 387 [M+2] (48), 385 [M
+
] (100), 358 (16), 342 (35), 312 
(52), 270 (48), 248 (46), 235 (39). 
IR (ATR): 3881, 3610, 3390, 3067, 2920, 2857, 2658, 2531, 2326, 2245, 2157, 2112, 
1998, 1897, 1795, 1708, 1661, 1560, 1490, 1455, 1408, 1364, 1301, 1264, 1193, 1145, 
1098, 1013, 942, 908, 834, 748, 660 cm
-1
. 
HRMS (ESI): calcd for C20H16ClNO3S [M]
+
: 385.0534; found: 385.0533. 
Ethyl (S)-3-(4-bromophenyl)-1-oxo-2,3-dihydro-1H-benzo[4,5]thiazolo[3,2-a] 
pyridine-4-carboxylate (172j) 
 
The compound 172j was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:DCM = 1:1→1:2) and obtained as a yellow 
solid. 
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Yield: 83% (178.2 mg) 
Melting point: 133-135 
o
C 
TLC: Rf = 0.40 (n-pentane:DCM = 1:1) 
Optical rotation: [α]
D
23  = +234.3 (c = 1.0, CHCl3) 
ee: 70% (99% after recrystallization) 
HPLC: Daicel AS, n-heptane:EtOH = 97:3, 1.0 mL/min, tR = 9.66 min (major), 12.19 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.42 (d, J = 8.4 Hz, 1H, Ar-H), 7.45 (d, J = 7.8 Hz, 
1H, Ar-H), 7.39-7.38 (m, 2H, Ar-H), 7.31-7.28 (m, 1H, Ar-H), 7.24 (dd, J = 7.8 Hz, 
1.2 Hz, 1H, Ar-H), 7.07-7.06 (m, 2H, Ar-H), 4.29 (d, J = 7.2 Hz, 1H, CH2CH), 
4.26-4.16 (m, 2H, CH2CH3), 3.24 (dd, J = 16.2 Hz, 8.4 Hz, 1H, CHHCH), 2.97 (dd, J 
= 16.2 Hz, 1.8 Hz, 1H, CHHCH), 1.23 (t, J = 7.2 Hz, 3H, CH2CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 167.8 (C=O), 166.3 (CO2Et), 152.6 (NCS), 140.4 
(CAr), 136.7 (CAr), 132.0 (2C,CHAr), 128.3 (2C, CHAr), 126.8 (CAr), 126.6 (CHAr), 
125.6 (CHAr), 121.5 (CHAr), 121.1 (CAr), 117.4 (CHAr), 99.7 (CCO2Et), 60.8 
(OCH2CH3), 40.0 (CHCH2), 36.3 (CHCH2), 14.4 (OCH2CH3) ppm. 
MS (EI, 70 eV) m/z (%): 431 [M+2] (79), 429 [M
+
] (84), 358 (26), 316 (16), 274 (30), 
248 (100), 235 (88), 172 (38), 102 (27). 
IR (ATR): 3852, 3748, 3621, 3404, 3075, 2983, 2920, 2646, 2451, 2290, 2201, 2164, 
2106, 2056, 2015, 1911, 1789, 1708, 1665, 1560, 1458, 1403, 1359, 1299, 1185, 1144, 
1082, 1011, 943, 909, 828, 748 cm
-1
. 
HRMS (ESI): calcd for C20H16BrNO3S [M]
+
: 429.0028; found: 428.9982. 
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Ethyl (R)-3-(furan-2-yl)-1-oxo-2,3-dihydro-1H-benzo[4,5]thiazolo[3,2-a]pyridine- 
4-carboxylate (172k) 
 
The compound 172k was prepared according to GP 6. The product was purified by 
flash column chromatography (n-pentane:DCM = 1:1→1:2) and obtained as a orange 
solid. 
Yield: 77% (131.7 mg) 
Melting point: 142-144 
o
C 
TLC: Rf = 0.50 (n-pentane:DCM= 1:1) 
Optical rotation: [α]
D
23  = +171.4 (c = 1.0, CHCl3) 
ee: 58% 
HPLC:Daicel IC, n-heptane:i-PrOH = 9:1, 1.0 mL/min, tR = 5.16 min (major), 7.94 
min (minor). 
1
H NMR (600 MHz, CDCl3): δ = 8.46 (d, J = 8.4 Hz, 1H, Ar-H), 7.42 (d, J = 7.8 Hz, 
1H, Ar-H), 7.30-7.27 (m, 2H, Ar-H), 7.22 (t, J = 7.8 Hz, 1H, Ar-H), 6.22 (dd, J = 3.0 
Hz, 1.8 Hz, 1H, Ar-H), 6.05-6.04 (m, 1H, Ar-H), 4.40 (dd, J = 7.2 Hz, 1.8 Hz, 
1H,CH2CH), 4.29 (q, J = 7.2 Hz, 2H, CH2CH3), 3.15 (dd, J = 16.2 Hz, 1.8 Hz, 
1H,CHHCH), 3.09 (dd, J = 16.2 Hz, 7.2 Hz, 1H, CHHCH), 1.32 (t, J = 7.2 Hz, 
3H,CH2CH3) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 168.1 (C=O), 166.3 (CO2Et), 153.8 (NCS), 152.9 
(CAr), 142.1 (CHAr), 136.8 (CAr), 126.8 (CAr), 126.5 (CHAr), 125.4 (CHAr), 121.4 
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(CHAr), 117.5 (CHAr), 110.1 (CHAr), 105.6 (CHAr), 98.0 (CCO2Et), 60.8 (OCH2CH3), 
37.1 (CHCH2), 30.9 (CHCH2), 14.4 (OCH2CH3) ppm. 
MS (EI, 70 eV) m/z (%): 341 [M
+
] (100), 268 (55), 258 (29), 240 (25), 210 (18), 197 
(16). 
IR (ATR): 3836, 3452, 3390, 3153, 2978, 2926, 2643, 2443, 2278, 2166, 2094, 2030, 
1994, 1911, 1728, 1667, 1568, 1456, 1369, 1297, 1265, 1218, 1158, 1114, 1080, 1016, 
922, 856, 735 cm
-1
. 
HRMS (ESI): calcd for C18H15NO4S [M]
+
: 341.0716; found: 341.0724. 
General procedure 7 for the synthesis of 2-nitrovinyl-indoles 165 
To a solution of indole-2-carboxylic acid (90 mmol, 14.4g) in dry THF was slowly 
added LiAlH4 (186 mmol, 7.4g) at 0 °C. The mixture was stirred overnight and then 7 
mL H2O was slowly added, followed by 7 mL 15% NaOH and 21 mL H2O. After 
filtration by vacuum, the filtrate was concentrated. The yielded 10 g 
(1H-indol-2-yl)methanol (white solid) was dissolved in 100 mL DCM. To the solution 
was added MnO2 (10 equiv., 58g). The mixture was stirred for 6 h (monitored by 
TLC). After vacuum filtration and concentration of the filtrate by vacuum, 9.7 g 
indole-2-carbaldehyde was obtained as brown solid, which was directly used without 
further purification. To a solution of indole-2-carbaldehyde (6.9 mmol, 1g) in 10 mL 
CH3NO2 was added NH4OAc (1 equiv., 0.5g). The mixture was reflux for 2h. The 
solution was diluted with DCM, washed with H2O and brine, dried over MgSO4. The 
concentrated residue was purified by column chromatography on silica gel 
(n-pentane:Et2O = 3:1). The desired 2-nitrovinyl-indoles 165a was obtained as a 
orange solid (1.0 g, 77% yield). 
1
H NMR (400 M, CDCl3): δ = 8.31 (s, 1H, N-H), 8.04 (d, J = 13.6 Hz, 1H, 
NO2CH=CH), 7.65 (dq, J = 8.1, 0.9 Hz, 1H, Ar-H), 7.49 (dd, J = 13.6, 0.6 Hz, 1H, 
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NO2CH=CH), 7.41 - 7.30 (m, 2H, Ar-H), 7.16 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H, Ar-H), 
7.07 - 7.03 (m, 1H, Ar-H). 
The analytical data is in agreement with the previous report.
[77]
 
General procedure 8 for the synthesis of 2-benzothiazolimine (167) 
To a solution of 2-benzothiazolamine (20 mmol, 3.0g) in100 mL toluene was added 
benzaldehyde (24 mmol, 2.4 mL), Clay (1g) and 4 Å Ms. The mixture was refluxed 
overnight. After filtration, the solvent was removed by vacuum. The crude product 
was recrystallized in i-PrOH to give 3.5 g 167a as yellow solid (73% yield). 
1
H NMR (300 MHz, CDCl3) δ = 9.08 (s, 1H, N=CHPh), 8.11 - 7.94 (m, 3H, Ar-H), 
7.84 (ddd, J = 8.0, 1.4, 0.7 Hz, 1H, Ar-H), 7.60 - 7.44 (m, 4H, Ar-H), 7.37 (ddd, J = 
7.9, 7.3, 1.2 Hz, 1H, Ar-H). 
The analytical data are in agreement with the previous report.
[92]
 
General procedure 9 for the synthesis of indolin-3-ones (169) 
To a suspension of 2-chlorobenzoic acid (63.8 mmol, 10 g), glycine (140 mmol, 10.5 
g) and copper powder (10 mol%, 0.4 g) in 100 mL DMF was slowly added K2CO3 
(191 mmol, 26.5 g). The mixture was heated to reflux for 2 h. After cooling to room 
temperature, the suspension was poured into cold 6 M aqueous HCl and stirred for 30 
min. After filtering, 9.6 g 2-(carboxymethyl)amino benzoic acid was obtained as 
white solid, which was subsequently dissolved in 100 mL Ac2O. 5 g NaOAc was 
added. After reflux for 5 h the mixture was concentrated to remove Ac2O by rotary 
evaporator. The residue was diluted with 50 mL H2O. Then the mixture was extracted 
with DCM. The combined organic phase was washed with brine and dried over 
MgSO4. After filtration, the filtrate was concentrated to give 4.7g brown solid. The 
obtained solid was dissolved in 60 mL EtOH and 60 mL sat. Na2SO3 was added. The 
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mixture was stirred under reflux for 2 h. The solvent was removed by vacuum. After 
addition of 50 mL H2O, the mixture was extracted with DCM. The combined DCM 
was washed with brine, dried with MgSO4, filtered and concentrated. The residue was 
purified by column chromatography on silica gel (n-pentane:EtOAc = 2:1) to give 
indolin-3-one 169a as brown solid (2.0 g, 18% yield over three steps). 
1
H NMR (400 MHz, CDCl3) δ = 8.55 (d, J = 8.4 Hz, 1H, Ar-H), 7.74 (d, J = 7.7 Hz, 
1H, Ar-H), 7.65 (ddd, J = 8.6, 7.2, 1.4 Hz, 1H, Ar-H), 7.21 (ddd, J = 7.9, 7.3, 0.8 Hz, 
1H, Ar-H), 4.28 (s, 2H, COCH2), 2.31 (s, 3H, COCH3). 
The analytical data are in agreement with the previous report.
[93]
 
General procedure 10 for the synthesis of mesitylhydrazine 
hydrochloride 
 
To a solution of di-tert-butyl azodicarboxylate (10 mmol, 2.3g) in dry THF at –78 °C 
under argon was added 2-mesitylmagnesium bromide (10 mL, 1 M in Et2O).  After 
stirring for 30 min, the mixture was quenched with AcOH (10 mmol), warmed up to rt, 
H2O (50 mL) was added, and then extracted with Et2O. The organic phase was 
washed with brine, dried over MgSO4, filtered and concentrated to give 3.7 g yellow 
liquid, which was subsequent dissolved in i-PrOH (25 mL). To the solution was added 
HCl (25 mL, 4 M in dioxane). The mixture was refluxed for 30 min and then cooled 
to 0 °C and diluted with Et2O (25 mL). The precipitate was filtered and washed with 
cold Et2O, dried over vacuum to give mesitylhydrazine hydrochloride as a white solid 
(1 g, 54% yield). [Note: the mesitylhydrazine is unstable, so it should be prepared in 
fresh via neutralization of mesitylhydrazine hydrochloride in a mixture of 1 M NaOH 
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and Et2O at –10 °C. Until the solid has dissolved, the mixture was extracted with Et2O, 
dried over MgSO4, filtered and concentrated to yield a colorless oil, which was used 
immediately.] 
1
H NMR (400 MHz, DMSO-d6) δ = 9.62 (br, 3H, N-H), 6.89 (s, 2H, Ar-H), 2.34 (s, 
6H, CH3), 2.21 (s, 3H, CH3). 
The analytical data is in agreement with the previous report.
[94]
 
General procedure 11 for the synthesis of triazolium precatalysts 
 
To a solution of pyrrolidin-2-one (10 mmol) in dry DCM was added Me3O·BF4 (10 
mmol, 1.48 g). The mixture was stirred overnight at rt. The mesitylhydrazine (1.0 
equiv.) was added and the resulting red solution was stirred for another 18 h at rt. 
Then the mixture was concentrated in vacuum. The crude red solid was dissolved in 
30 mL PhCl and 10 mL CH(OEt)3. The mixture was stirred at 110 °C for 48 h. The 
mixture was concentrated and recrystallized from toluene or purified by flash column 
chromatography. 
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7. List of Abbreviations 
Å Ångström 
Ac Acetyl 
Ar Aryl 
Bn Benzyl 
Boc tert-Butyloxycarbonyl 
Bu Butyl 
cat. Catalyst 
CDI Carbonyldiimidazole 
DABCO 1,4-Diazabicyclo[2.2.2]octane 
DBU 1,8-Diazabicyclo-[5.4.0]undec-7-ene 
DCM Dichloromethane 
DIPEA N,N-Diisopropylethylamine 
DIBAL-H Diisobutylaluminium hydride 
DMAP 4-Dimethylaminopyridine  
DPE  1,2-Di(pyrrolidinyl)ethane 
d day 
dr diastereomeric ratio 
E Electrophile 
ee  enantiomeric excess  
EI Electron Ionization 
equiv.  equivalent 
ESI  Electron Spray Ionization  
Et Ethyl 
h hour 
HRMS  High Resolution Mass Spectroscopy  
Hz Hertz 
i-Pr iso-Propyl  
J coupling constant (in NMR spectroscopy) 
Abbreviation 
150 
 
m-CPBA meta-Chloroperoxybenzoic acid 
Me Methyl 
Mes 2,4,6-Trimethylphenyl 
MS Molecular Sieve 
MTBE Methyl tert-butyl ether 
NHC N-Heterocyclic Carbene 
NMR Nuclear Magnetic Resonance 
NOE Nuclear Overhauser Effect 
n.r. no reaction 
Nu Nucleophile 
PG Protecting Group 
Ph  Phenyl 
rt room temperature 
TBD 1,5,7-Triazabicyclo[4.4.0]dec-5-ene 
TBDPS tert-Butyldiphenylsilyl 
TBS tert-Butyldimethylsilyl 
t-Bu tert-Butyl  
TFA Trifluoroacetic acid 
THF  Tetrahydrofuran  
TIPS  Triisopropylsilyl 
TLC Thin Layer Chromatography 
TMEDA Tetramethylethylenediamine 
TMS Trimethylsilyl 
Ts  Tosyl 
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